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Summary 
Cytokines exert multiple biological responses through interaction with their specific 
receptors that results in the activation of JAK−STAT pathways. STATs (signal 
transducers and activators of transcription) are a family of latent cytoplasmic 
transcription factors which are activated by recruitment to the cytokine receptors and 
subsequent phosphorylation by the receptor-associated Janus kinases (JAKs). Stat 
proteins form homo- or heterodimers by reciprocal interaction between SH2 domains 
and phosphorylated tyrosine residues, translocate into the nucleus, bind to DNA and 
regulate their target gene expression. Stat3 originally was cloned as an acute-phase 
response factor activated by interleukin-6, and also by homology to Stat1. Growth 
factors can also stimulate Stat3 activity. Stat3 plays crucial roles in early embryonic 
development, as well as in other biological responses including cell growth and 
anti-apoptosis. Stat3 is constitutively activated in oncogenic tyrosine kinase v-Src- or 
v-abl-transformed cells, and various primary tumors and cell lines. Stat3 itself acts as 
an oncogene in NIH-3T3 cells. Therefore, the control of both the activation and 
inactivation of Stat3 is equally important to maintain normal cell growth. 
 
In the first part of this thesis, I described the identification of GRIM-19 as a novel 
regulator of Stat3 that suppresses it activity via functional interaction. I examined Stat3 
potential regulators by yeast two-hybrid screening. GRIM-19, a gene product related to 
interferon-beta- and retinoic acid-induced cancer cell death, was identified and 
demonstrated to interact with Stat3 in various cell types. The interaction is specific for 
 xiv
Stat3, but not for Stat1 and Stat5a. The interaction regions in both proteins were 
mapped, and the cellular localization of the interaction was examined. GRIM-19 itself 
co-localizes with mitochondrial markers, and forms aggregates at the perinulear region 
with co-expressed Stat3, which inhibits Stat3 nuclear translocation stimulated by EGF. 
GRIM-19 represses Stat3 transcriptional activity and its target gene expression, and 
also suppresses cell growth in Src-transformed cells and a Stat3-expressing cell line.  
 
In addition to the tyrosine phosphorylation, phosphorylation at Stat3 Ser727 residue 
also plays an important role in the regulation of Stat3 transactivation. In the second 
part of this thesis, I reported peptidyl-prolyl isomerase Pin1 as a key regulator that 
positively regulates Stat3 activity via its serine phosphorylation site. Pin1 binds 
specifically to the activated Stat3 upon cytokine/ growth factor stimulation via its 
Ser727 site. Pin1 was demonstrated to promote Stat3 transcriptional activity and target 
gene expression in various cell types, but not that of the Stat3 S727A mutant. Stat3 
DNA binding ability is significantly compromised in Pin1 deficient cells, and 
expression of Pin1 dramatically increases the cytokine-induced interaction between 
Stat3 and p300 coactivator. In addition, Pin1 was also shown to protect activated Stat3 
from ubiquitination.  
 
In summary, my data suggest GRIM-19 and Pin1 as two novel associated proteins of 
Stat3, which regulate its activity by distinct mechanisms. 













Chapter 1: Introduction 
 2
Signal transduction in mammalian cells 
Cells receive various extracellular stimuli from the environment and respond to these 
signals by altering multiple cellular activities including cell growth, cell differentiation, 
apoptosis or cell movement. Studies of signal transduction in mammalian cells mainly 
focus on the process how the extracellular stimuli received at the cell surface are 
transmitted into the cell and trigger the subsequent intracellular responses. One of the 
typical processes in cell signaling involves the selective recognition of ligands, such as 
growth factors and cytokines, by the extracellular domain of cell surface receptors that 
are usually transmembrane proteins. The specific ligand binding to the receptors 
triggers dimerization/ oligomerization of the receptors (probably involving other 
membrane proteins), or in some other cases induces conformational change in the 
receptor cytosolic domains, and in both cases leads to the subsequent activation of 
receptors. The activated receptors in turn recruit a group of intracellular signaling 
molecules to the receptors, which enables propagation of the incoming signal via 
multiple pathways. Some terminal signal recipients can migrate into the nucleus where 
they activate nuclear transcription factors to the target genes, while some others are 
already latent cytoplasmic transcription factors themselves, which can bind to DNA 
directly upon the nuclear translocation. Cellular responses to the outside stimuli are 
eventually achieved by the expression of various target genes and subsequent alteration 
of multiple cellular events. 
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1.1 STAT family proteins 
Signal transducers and activators of transcription (STATs) are a family of latent 
cytoplasmic transcription factors that play important roles in multiple cytokine 
signaling. As indicated by their name, STATs are signaling proteins with dual functions, 
transmitting signals from the cell surface through the cytoplasm and directly 
participating in the gene regulation within the nucleus. To date all together seven 
mammalian STAT family proteins have been identified, namely Stat1, Stat2, Stat3, 
Stat4, Stat5a, Stat5b and Stat6.  
 
1.21 Isolation of STAT genes 
The STAT gene family was first identified through a genetic screening for the signaling 
molecules required for the interferon (IFN)-induced transcription. Following the 
isolation of a group of complementary DNA (cDNAs) corresponding to the 
interferon-induced mRNA, a DNA response element, named as interferon-stimulated 
response element (ISRE) was identified (Levy et al., 1988). Subsequently an ISRE 
binding complex was purified and termed as interferon-stimulated gene factor-3 
(ISGF3) (Kessler et al., 1990), followed by the identification of four constituent 
components of the ISGF3 complex, three of which were highly related to each other 
(p84, p91 and p113) (Fu et al., 1990). Further characterization of these ISGF3 
components led to the cloning of both Stat1 and Stat2 genes (Fu et al., 1992; Schindler 
et al., 1992). The components p91 and p84 actually were products of the same gene 
through alternative splicing, known as Stat1α and Stat1β now, and the p113 
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component is now Stat2. 
Stat3 and Stat4 were identified by a few research groups through low stringency 
hybridization in the cDNA library using a probe from the most highly conserved SH2 
domain of the Stat1 gene (Zhong et al., 1994a, Zhong et al., 1994b, Raz et al., 1994, 
Yamatomo et al., 1994). Stat3 was also isolated independently as a DNA binding factor 
to the IL-6 response element present in the promoter region of acute phase genes, and 
named acute phase response factor (APRF) (Akira et al., 1994). There are also two 
alternatively spliced transcripts of the Stat3 gene, Stat3α and Stat3β (Schaefer et al., 
1995). The difference resides at the carboxyl-terminal where Stat3β lacks the 55 
C-terminal amino acid sequence of Stat3α, but has additional seven residues instead.  
Stat5 was originally purified as a mammary gland factor from the prolactin-stimulated 
mammary tissue, binding to the regulatory elements of the β-casein gene (Wakao et al., 
1994), and also as the DNA binding factor in IL3-stimulated myeloid cells (Azam et al. 
1995). Two related clones of Stat5 were subsequently isolated and named Stat5a and 
Stat5b, which are encoded by two separate genes (Copeland et al., 1995). Similarly, 
Stat6 was discovered from IL-4-stimulated myeloid cells as an IL-4-induced DNA 
binding factor (Hou et al., 1994).  
STAT homologues have been identified in various species other than mammals, such 
as chicken, Tetraodon fluviatilis (puffer fish), Danio rerio (zebrafish), Xenopus laevis, 
Drosophila melanogaster and C. elegans. Both Stat1 and Stat3 homologues have been 
isolated in zebrafish (Oates et al., 1999), in which the expression of zebrafish Stat3 is 
tissue-specific during embryogenesis. The Drosophila STAT homologue Stat92E was 
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isolated independently by two groups (Hou et al., 1996; Yan et al., 1996). It plays an 
important role in the early embryonic development of flies, and is downstream of 
Hopscotch (Drosophila JAK), which indicates the presence of JAK-STAT signaling in 
invertebrates. STAT homologues related to Stat5 have been identified in both Xenopus 
(Pascal et al., 2001) and C. elegans (Liu et al., 1999). Even in the low eukaryote 
Dictyostelium (slime mold), a STAT protein, which also functions through 
phosphotyrosine-SH2 reciprocal dimerization, has been isolated (Kawata et al., 1997), 
which suggests that STAT genes are evolutionarily conserved. 
 
1.2.2 Functional domains of STATs 
All the seven members of STAT proteins are 750 to 850 amino acids in length, having 
molecular mass as from ~90 to ~115 kDa. They all share a similar organization of 










In the year 1998, three-dimensional crystal structures of both DNA-bound Stat1 and 
DNA Binding Linker SH2 TAD N-domain Coiled-coil 
pY  
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Stat3β (short form of Stat3α lacking the C-terminal domain) dimers were resolved, 
which share very high structural similarity to each other. As show in Figure 1.2, The 
STAT homodimer grips the DNA like a pair of pliers, and the only contacts between 
the monomers occurs between the SH2 domains (Becker et al., 1998; Chen et al., 
1998). The coiled-coil domain is a bundle of four antiparallel helices, two long ones 
(α1 and α2) and two short ones (α3 and α4). The predominantly hydrophilic surface 
of the coiled-coil structure has been suggested to mediate the interaction with other 
proteins. The DNA-binding domain resembles an eight-stranded β-barrel, where 
several loops between the β strands of this domain participate in DNA-binding. 
Between the DNA binding and SH2 domain is the linker region, a small helical domain 
formed by two helix-loop-helix modules. The STAT SH2 domain shares homology 
with other SH2 modules with a central three-stranded β-pleated sheet flanked by two 
helices, whereas the carboxyl-portion of STAT SH2 is more divergent from the 
classical ones. 
  
1.2.2.1 N-terminal domain 
The very N-terminal domain (123 to 145 amino acids in length) of STAT proteins is a 
stable domain sharing a high degree of sequence similarity within different STAT 
members. This domain has been suggested to mediate the cooperative interaction, 
namely the tetramerization of two STAT protein dimers bound to DNA, and such 
cooperative binding leads to a prolonged half-life of the STAT protein-DNA complex 
(Xu et al., 1996; Vinkemeier et al., 1996). The crystal structure of the Stat4 N-terminal 
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domain has been resolved, which consists of eight helices that are assembled into a 
hook-like structure. It was suggested that the N-terminal domains may interact through 
an extensive interface formed by polar interaction (Vinkemeier et al., 1998). Later an 
alternative interface that is more extensive and involves hydrophobic interactions was 
suggested (Figure 1.3), and point mutations of several residues at this interface 
obviously affected the N-terminal dimer stability (Chen et al., 2003). Recently, the 
crystal structure of unphosphorylated human Stat1 complexed with an IFNγ receptor α 
chain-derived phosphopeptide has been resolved, which reveals two dimer interfaces, 
one of which is between the N-terminal domains. It was suggested that Stat1 is 
predominantly dimeric before activation, and the dimerization is mediated by the 
N-domain interactions (Mao et al., 2005). 
Methylation of Stat1 Arg31 residue by methyl-transferase PRMT1 was also described, 
which increased Stat1 DNA binding and transcriptional activity by interfering with the 
binding of activated Stat1 to its negative regulator PIAS1 (Mowen et al., 2001).  
Interaction of the N-terminal domain with various other proteins has been reported, 
including the interaction between the Stat1 N-domain with transcriptional coactivator 
p300/CBP through the CREB-binding domain (Zhang et al., 1996), and STAT 
N-domain binding to the intracellular regions of cytokine receptors (Li et al., 1997, 
Murphy et al., 2000). A regulatory role of the N-terminal domain in STAT nuclear 
translocation has also been uncovered by studies in which replacement of the Stat1 
N-domain with the homologous domain of other STATs leads to impaired nuclear 
translocation of the mosaic mutants (Strehlow and Schindler, 1998). 




























































Figure 1.2. Ribbon diagram of the Stat3β homodimer–DNA complex.  
The N-terminal 4-helix bundle is shown in blue, the β-barrel domain in red, the 
connector domain in green, and the SH2 domain and phosphotyrosine-containing 
region in yellow. Disordered regions between helices α1 and α2 and residues 689 to 
701 have been modeled in grey. Views are shown a, along the DNA axis (the dyad of 
the complex running vertically); b, from the side, with monomer 2 depicted in grey; 
and c, from the top. Phosphotyrosines are indicated by a Y in c. 
 
















Figure 1.3. The STAT4 N-domain dimer suggested by crystal packing Close-up 
views of the alternate dimer interface are presented, and the residues involved in dimer 
formation are indicated.  
(This figure is from Chen et al., 2003) 
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1.2.2.2 Coiled-coil domain 
A structure consisting of three helices, from the amino acid 137 to 283, was initially 
predicted for the Stat2 protein based on its primary amino acid sequence (Fu et al., 
1992). Later the crystal structure of Stat1 and Stat3β further confirmed the coiled-coil 
structure of this region in STATs, by revealing a bundle of four antiparallel 
alpha-helices connected by short loops within the domain. The exposed position and 
extended helices structure suggest a potential important role of this domain in the 
interaction of Stat3 with other proteins. 
Interactions between STAT coiled-coil domains and various other proteins have been 
reported in the past several years. The Stat1 coiled-coil domain interacts with 
p48/IRF9 upon IFN-α stimulation during formation of the ISGF3 complex (Horvath et 
al., 1996). Nmi, an N-myc interactor protein, has been shown to bind the coiled-coil 
domain of all STATs except for Stat2, and the binding of Nmi can enhance the 
IFNγ-dependent Stat1- or IL-2-dependent Stat5-mediated transcription (Zhu et al., 
1999). The first α-helix of the coiled-coil domain of Stat3 has been found to interact 
with transcriptional factor c-Jun. Both cooperatively activate the transcription of the 
IL-6-responsive α2-macroglobulin gene (Zhang et al., 1999). Interaction between 
Stat3 and StIP1, a potential regulator of Stat3 ligand-dependent activation, is also 
mediated by the coiled-coil domain (Collum et al., 2000). In addition, the Stat5 
coiled-coil domain has been found to be required for the interaction between 
Stat5a/Stat5b and the nuclear receptor co-repressor SMRT, which in turn 
downregulates Stat5 activity (Nakajima et al., 2001). 
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Recent work from our laboratory indicates that the coiled-coil domain is essential for 
the early events of IL-6- and EGF-induced Stat3 activation and functions, including the 
recruitment of Stat3 to the receptors and subsequent tyrosine phosphorylation (Zhang 
et al., 2000). Further studies revealed an interdomain interaction between the 
coiled-coil domain and the SH2 domain and C-terminal transactivation domain 
probably within the same Stat3 molecule, and such intramolecular interaction 
subsequently regulates the SH2-mediated receptor binding activity of Stat3 proteins 
(Zhang et al,. 2002). 
Roles of the coiled-coil domain in STAT nuclear translocation were brought into 
attention by the identification of several nuclear export signals in Stat1 (Begitt et al., 
2000; Mowen and David, 2000). Later, Arg214/215 residues in the second α-helix 
region of the Stat3 coiled-coil domain were identified as the essential nuclear import 
element for IL-6- and EGF-induced Stat3 nuclear translocation (Ma et al., 2003), 
possibly via the interaction with importin alpha5 (Ma and Cao, 2005).  
 
1.2.2.3 DNA-binding domain 
Located in the middle of all STAT proteins, except for Stat2, is the DNA-binding 
domain whose primary structure shows no significant similarity to any other proteins. 
Several natural STAT-binding DNA sequences have been reported and different STATs 
exhibit different binding affinities towards these binding elements. Stat1, Stat3 and 
Stat4 dimers show high affinity to a central TTCC(C/G)GGAA core (Horvath et al., 
1995; Xu et al., 1996), whereas Stat5a and 5b prefer a slightly different sequence 
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TTC(C/T)N(G/A)GAA (Imada 2000; Soldaini et al., 2000). 
STAT proteins bind to gamma interferon activated sequences (GAS), palindromic 
response elements with a general consensus sequence of TTCNmGAA, upon IFNγ or 
other cytokine stimulation. Stat1, Stat3, Stat4, Stat5a and 5b recognize a TTCN3GAA 
motif while Stat6 prefers a TTCN4GAA sequence (Leonard and O’shea, 1998). 
Induction of EGF, PDGF and CSF-1 leads to the binding of Stat1 and/or Stat3 to the 
sis-inducible element (SIE), which is located in the human c-fos promoter region 
(Schindler and Darnell, 1995). In addition, IL-6/LPS-activated acute-phase response 
factor APRF, later identified as Stat3, binds to acute-phase response element (APRE), 
CTGGGA for various genes such as α2-macroglobulin and fibrinogen (Wegenka et al., 
1993; Akira et al., 1994). 
Stat2 is the only STAT protein without a direct DNA-binding domain. Upon IFNα/β 
induction, the Stat1/Stat2 heterodimer, together with another DNA-binding protein p48, 
binds to a nonpalindromic ISRE sequence AGTTTNCNTTTCC (Fu et al., 1990; 
Horvath and Darnell, 1997). 
 
1.2.2.4 Linker domain 
The STAT linker region connects the DNA-binding domain with the SH2 domain, and 
was initially predicted as an SH3-like domain based on sequence homology. However, 
crystal structures of both Stat1 and Stat3β show no structural similarity between this 
region and the SH3 domain. The linker domain is well-conserved within STAT 
proteins, but so far rarely any function has been identified. The only evidence reported 
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is that double point mutations in the Stat1 linker region abolish its transcriptional 
activity in response to IFN-γ, but the underlying mechanism is still unclear (Yang et al., 
1999). 
 
1.2.2.5 SH2 domain 
Src-homology 2 (SH2) domains are modules of around 100 amino acids that bind to 
specific phosphotyrosine (pY)-containing peptide motifs. For STAT family proteins, 
the high homology regions around amino acid 600-700 are identified as the SH2 
domain, which is required for two crucial steps during STAT activation: binding to the 
tyrosine-phosphorylated intracellular domain of activated receptors and the formation 
of STAT dimers. Studies of Stat1 chimeras with the Stat2 SH2 domain, or vice versa, 
revealed that the STAT SH2 domains play crucial roles in determining the specificity at 
the receptor kinase complex and in subsequent dimerization (Heim et al., 1995). 
Therefore SH2-mediated STAT-receptor binding is highly specific and largely 
determines which STAT family members are activated by the different receptors. 
An invariant Arg residue in the SH2 domain is required to coordinate the phosphate 
oxygens of pY and essential for the high affinity phosphopeptide binding. Mutation of 
the Arg602 residue in Stat1 abolishes Stat1 tyrosine phosphorylation (Shuai et al., 
1993), and it has been shown to be critical for the binding to the receptor-kinase 
complex.  
 
1.2.2.6 STAT tyrosine phosphorylation 
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All the seven STAT members are phosphorylated on a conserved tyrosine residue at the 
C-terminus, which is essential for the ligand-induced STAT nuclear translocation, DNA 
binding and gene activation. The invariant phosphotyrosine residue is Tyr701 in Stat1, 
Tyr689 in Stat2, Tyr705 in Stat3, Tyr694 in Stat4 and Stat5a, Tyr699 in Stat5b and 
Tyr641 in Stat6. Such tyrosine phosphorylation of STATs is catalyzed by 
ligand-activated receptors with intrinsic tyrosine kinase following ligand-binding, or 
receptors that lack intrinsic kinase activity but to which JAK kinases are 
non-covalently associated.  
Following tyrosine phosphorylation, STATs dissociate from the receptors and undergo 
dimerization through reciprocal interaction of SH2 domains and phosphotyrosine 
residues. To date nine types of STAT dimers have been commonly mentioned in 
various studies. The specificity of SH2 binding is mainly determined by three residues 
immediately carboxyl to the pY residue, pYXXX (Songyang et al., 1993), and the four 
to five amino acids C-terminal to the pY in STATs are found to make extensive 
contacts with other amino acids in the SH2 domain. Therefore differences of these 
important amino acids between STAT family members probably explain the interaction 
specificity of STAT dimerization (Heim, 2003). 
 
1.2.2.7 Transactivation domain 
The least conserved domain between STATs is the C-terminal transactivation domain, 
whose structure has not been resolved. Interestingly fusion proteins of Stat1 amino 
acid 1-716 with the transcriptional activation domains of Stat2, 3 or 5 are able to 
Chapter 1: Introduction 
 15
induce interferon responsive genes and functionally replace Stat1 in inducing the 
antiviral response (Shen and Darnell, 2001). Nevertheless the detailed transactivation 
mechanisms of various STAT proteins are still not well understood.  
Interaction of the transactivation domain with different proteins involved in gene 
transcription has been reported, including the transcriptional coactivator CBP/p300 
(Bhattacharya et al., 1996; Zhang et al., 1996), adenoviral E1A oncoprotein (Look et 
al., 1998), DNA replication factors MCM3 and MCM5 (Zhang et al., 1998), and 
BRCA1 tumor suppressor (Ouchi et al., 2000). Since more than one cooperating 
factors associate with the same STAT, it is suggested that the same STAT can be 
involved in the activation of different genes (with binding sites for different 
cooperating factors) in different cell types or activation states, depending on which 
cooperating factor is expressed in the cells (Leonard and O’shea, 1998) 
In addition, phosphorylation of an invariant serine residue in STAT C-terminal domain 
has been suggested to play an important role in the regulation of STAT transcriptional 
activity, which will be discussed in detail in the section of STAT Serine 
Phosphorylation. 
 
1.3 STAT signaling pathway 
Cytokines play important roles in various biological responses by regulating the cell 
survival, proliferation and differentiation. The signaling process involving STAT 
family proteins and its upstream kinase JAKs, the JAK-STAT pathway, is identified as 
one of the major cytokine signaling pathways, in which STATs are phosphorylated by 
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JAKs upon cytokine stimulation, dimerized and translocated into the nucleus to induce 
the target gene expression. On the other hand, receptor tyrosine kinases (RTKs) with 
intrinsic enzymatic activities, or non-receptor tyrosine kinases such as Src and Abl 
have also been reported to phosphorylate STAT proteins under different conditions. 
 
1.3.1 JAK-STAT pathway in cytokine signaling 
The initial step of cytokine signaling involves the engagement of cytokines to their 
specific receptors. Currently two classes of cytokine receptors have been identified, in 
which the type I cytokine receptors comprise many interleukin receptors and carry a 
WSXWS motif in their extracellular regions. There are two subclasses for the class I 
receptors: the single chain receptors including receptors for EPO, G-CSF and GH, and 
the multiple chain receptors such as GM-CSF, IL-3, IL-6, LIF, receptors. Type II 
cytokine receptors mainly include the interferon-α, -β, -γ and IL-10 receptors. 
However unlike receptor tyrosine kinases, cytokine receptors lack intrinsic enzymatic 
activities and need receptor-associated kinases to pass the signals downstream. Janus 
kinases (JAKs) were identified in the early 90s, about the same time as STATs, which 
include four mammalian members: Jak1, Jak2, Jak3 and Tyk2. There are seven 
conserved JAK homology (JH) domains within the JAK proteins, from the N-terminal 
JH7 to the C-terminal JH1, among which the JH1 is the kinase catalytic domain with a 
conserved tyrosine site for phosphorylation-dependent activation, and the JH2 is a 
pseudokinase domain that may negatively regulate the JAK activity. Therefore upon 
cytokine binding to the receptors, JAK kinases undergo transphosphorylation and 
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become activated, subsequently phosphorylate the latent cytoplasmic transcription 
activator STAT proteins that eventually translocate into the nucleus and induce the 
downstream gene expression. A list of JAKs and STATs activated by different ligands 
is shown in Table 1.1.  
Here we use IL-6 signaling as a typical example to illustrate the complete JAK-STAT 
pathway in mammalian cytokine signaling. The cytoplasmic domain of the IL-6 
receptor is short, therefore all IL-6 family receptors share a gp130 common receptor 
subunit as the signal transduction component (Hirano et al., 2000). Binding of IL-6 to 
the receptors leads to the homodimerization of gp130, and the juxtaposition of the 
dimerized gp130 cytoplasmic region leads to the transphosphorylation and activation 
of the gp130-associated JAK kinases. A series of tyrosine residues on the gp130 are 
phosphorylated by JAKs, which serve as the docking sites to recruit the cytosolic 
STAT proteins via the SH2-phosphotyrosine interaction. Upon binding to the receptors, 
STATs are also phosphorylated by JAKs on the conserved C-terminal tyrosine residue, 
and undergo homo- or hetero-dimerization via the reciprocal SH2-phosphotyrosine 
interaction between two monomers. The STAT dimers drop off from the receptors and 
translocate into nucleus where they eventually induce the target gene transcription 
(Figure 1.4).  
 
1.3.2 STAT activation by receptor tyrosine kinases and other kinases 
Besides the cytokines, STAT proteins are also strongly activated by various growth 
factors such as EGF, PDGF and HGF. The ligand-activated growth factor receptors, for 
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Table 1.1 JAK-STATs activation 
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Hematopoietins transducer their signals through specific sets of JAKs and STATs as 
indicated. The assignment with the most confidence, based on knockout and 
biochemical studies, are show in boldfare. EPO, erythroproietin; GH, growth hormone; 
Prl, prolactin; Tpo, thrombopoietin; TSLP, thymic stromal derived lymphopoietin; LIF, 
Leukemia inhibitory factor; CNTF, ciliary neurotrophic factor; NNT-1/BSF-3, novel 
neurotrophin-1/B cell-stimulating factor-3; CT-1, cardiotropin-1; FISP, IL-4 secreted 
protein. ATSLP binds to a related but g c-independent receptor. BIn humans this family 
consist of 12 IFN-α’s IFN-β, IFN-ω, and limitin. CIL-10 homologue AK155 has not 
yet been functionally characterized. 
 
(This table is from Schindler, 2002) 
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example EGF receptors, possess intrinsic kinase activities which can directly 
phosphorylate and activate STATs (Sadowski et al., 1993; Zhong et al., 1994a; Darnell, 
1997). In addition to these receptor tyrosine kinases, other non-receptor tyrosine 
kinases such as Src family members have also been reported to activate STATs (Cao et 
al., 1996; Yu et al., 1995; Chaturvedi et al., 1997, Bowman and Garcoa, 2000).  
 
1.4 STAT Serine phosphorylation 
In addition to the tyrosine phosphorylation, a conserved serine phosphorylation site 
was also identified within the C-terminal of several STAT family members including 
Stat1, Stat3, Stat4, Stat5a and Stat5b, whereas a homologous site was not observed in 
mammalian Stat2 and Stat6. Currently, all cytokines known to induce STAT tyrosine 
phosphorylation also cause phosphorylation at the serine residue (Decker et al., 2003). 
 
1.4.1 Kinases involved in STAT serine phosphorylation 
The conserved serine phosphorylation sites at the C-terminal of Stat1, Stat3 and Stat4 
comply with the MAPK recognition site, Pro-X-Ser-Pro sequence, suggesting a 
possible role of MAP kinases in the regulation of serine phosphorylation (Zhang et al., 
1995). Thereafter various members of MAPK family have been reported to be 
involved in the serine phosphorylation of Stat1 and Stat3, including ERK (Chung et al., 
1997; Jain et al., 1998), JNK (Lim and Cao, 1999, Turkson et al., 1999) and p38 
MAPK (Schaeffer and Weber, 1999). Other kinases, such as protein kinase Cδ (PKCδ), 
CaMKII and mTOR kinase have also been suggested to play a possible role in the 
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serine phosphorylation of STATs (Jain et al., 1999; Uddin et al., 2002, Nair et al., 2002; 
Yokogami et al., 2000). 
1.4.2 Serine phosphorylation and STAT activity 
STAT transcriptional activities are further enhanced upon the serine phosphorylation, 
and mutations of the conserved serine residue of Stat1, Stat3 and Stat4 exhibit various 
degrees of compromise in their transactivation and downstream effects (Wen et al., 
1995; Horvath et al., 1995; Bromberg et al., 1995; Decker and Kovarik, 2000; Pilz et 
al., 2003; Shen et al., 2004; Morinobu et al., 2002). Mice expressing a Stat1 
Ser727Ala mutant showed impaired clearance of bacteria and reduced IFN-γ-induced 
gene expression in macrophages, suggesting the importance of Stat1 serine 
phosphorylation-mediated transactivation in IFN-γ-dependent innate immunity 
(Varinou et al., 2003). However, there are also evidences suggesting that serine 
phosphorylation of Stat3 may decrease its tyrosine phosphorylation and transcriptional 
activity (Chung et al., 1997; Jain et al., 1998, 1999). In contrast to the numerous 
studies on the mechanisms and kinases which induce STAT serine phosphorylation, the 
underlying mechanism of the serine phosphorylation-mediated transcriptional 
enhancement is still largely unknown. It is suggested that the positive impacts of serine 
phosphorylation probably involve facilitated interaction between Stat3 and coactivator 
molecules (Decker and Kovarik, 1999), however, a candidate protein to generally 
explain the transcriptional enhancement effect of serine phosphorylation of Stat3 
remains unidentified. Moreover serine phosphorylation-dependent STATs regulation 
other than the transactivation also remain to be further investigated (Decker et al., 




1.5 Negative regulation of STAT signaling 
Activities of STAT proteins are subject to down-regulation via several negative 
regulatory mechanisms. For instance, dephosphorylation of the critical tyrosine residue 
by specific tyrosine phosphatase leads to the inactivation of STAT proteins (Haspel et 
al., 1996). Evidence of inactivation of Stat1 through ubiquitin-proteasome mediated 
degradation of has also been reported (Kim and Maniatis, 1996). In addition, two 
major classes of physiological inhibitors for the JAK/STAT pathway have been 
identified, namely, the suppressors of cytokine signaling (SOCS) (Yoshimura et al., 
1995; Endo et al., 1997; Naka et al., 1997; Starr et al., 1997) and protein inhibitors of 
activated STATs (PIAS) (Chung et al., 1997; Liu et al., 1998; Takeda and Akira, 2000).  
 
1.5.1 Suppressors of cytokine signaling (SOCS) 
SOCS family proteins were identified independently by a few research groups using 
different strategies, and named as SOCS/JAK-binding protein (JAB)/STAT-induced 
STAT inhibitor (SSI)/cytokine-inducible SH2-containing proteins (CIS) (Yoshimura et 
al., 1995; Endo et al., 1997; Naka et al., 1997; Starr et al., 1997). To date there are 
eight SOCS/SSI/JAB/CIS family members, SOCS1-7 and CIS, which share a similar 
organization of functional domains: a variable N-terminal region, a central SH2 
domain and a conserved C-terminal SOCS box (Hilton et al., 1998). SOCS proteins 
inhibit JAK/STAT signaling activated by IL-6 family cytokines, growth hormone and 
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interferons, basically through binding to the tyrosine kinase domain of JAK and 
therefore reducing the JAK kinase activity. However, CIS has been reported to 
interfere with the phosphorylated tyrosine on the specific cytokine receptor instead of 
JAKs (Yoshimura et al., 1995). Expression of SOCS protein is inducible by cytokine 
stimulation, and mainly functions as a negative feedback loop for the JAK−STAT 
pathway (Yasukawa et al., 2000).  
 
1.5.2 Protein inhibitors of activated STATs (PIAS) 
The other family of negative regulators, PIAS, consists of several homologous proteins 
including PIAS1 and PIAS3, which are constitutively expressed and interact only with 
tyrosine-phosphorylated STATs. PIAS1 interacts specifically with Stat1 upon ligand 
stimulation, inhibiting Stat1 DNA binding activities and target gene activation (Liu et 
al., 1998), while PIAS3 selectively inhibits IL-6 stimulated Stat3 (Chung et al., 1997). 
The PIAS family proteins show significant sequence homology and have several 
highly conserved regions, including a putative zinc binding motif and a highly acidic 
region. Because there are no phosphotyrosine binding modules identified within PIAS 
proteins, tyrosine phosphorylation of STATs may actually induce a conformational 
change within STAT proteins, followed by the exposure of their PIAS interaction 
domains. 
 
1.5. 3 STAT ubiquitination and degradation 
In contrast to the studies made in the other areas of negative regulation of STATs, 
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physical degradation of STAT proteins is less understood. Evidence of 
ubiquitin-proteasome-mediated degradation of STAT protein was first reported in 1996, 
by showing proteasome inhibitor MG132 selectively blocked the degradation of 
phosphorylated Stat1 upon IFN-γ induction. Further studies revealed that the activated 
Stat1 was poly-ubiquitinated, and the ubiquitination of a double mutant of Stat1 at the 
conserved Tyr701 and Ser727 residues was severely impaired, which indicated the 
requirement of both tyrosine and serine phosphorylation for Stat1 ubiquitination (Kim 
and Maniatis, 1996).  
Ubiquitination of Stat3 protein is even less understood, with only the findings that 
extracellular ubiquitin can be conjugated to Stat3 in human hematopoietic cells and 
subsequently promotes the proteasome-dependent degradation of Stat3 (Daino et al., 
2000). Mumps virus (Ulane et al., 2003) and Golgi protein TMF/ARA160 (Perry et al., 
2004) have also been independently found to be involved in the Stat3 proteasome 
degradation.  
 
1.6 STAT deficient mice 
To date, knockout mice of all the seven members of STAT family genes have been 
generated, and phenotype studies of these STAT deficient mice display various 
impaired cytokine-mediated functions as shown in the Table 1.2 (Takeda and Akira, 
2000; Gadina et al., 2001).  
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Stat1 Defective macrophage activity; high sensitivity to 
viral infections 
IFN-α/β, IFNγ 
Stat2 Defective response to type I IFN IFN-α/β 
Stat3 Embryonic lethality To be determined 
Stat4 Impaired Th1 response IL-12 
Stat5a Impaired mammary gland development and 
lactation; partial defect in T cell growth  
Prolactin, IL-12 
Stat5b Impaired expression of sexual dimorphism; defect 
in T cell growth; defect in NK cell development 
GH; IL-2; IL-15 
Stat6 Impaired Th2 response IL-4; IL-13 
 
(This table is adapted from Takeda and Akira, 2000) 
 
Stat1 knockout mice exhibit selective defects in both type I and type II interferon 
signaling, impaired macrophage activity, and are highly sensitive to microbial 
pathogens and virus infections (Meraz et al., 1996, Durbin et al., 1996). Deletion of 
Stat2 in mice also leads to the loss of the type I interferon response and higher 
susceptibility to viral infection (Park et al., 2000). Stat4- and Stat6-null mice show 
impaired Th1 or Th2 responses respectively, which demonstrate that Stat4 and 6 genes 
are required for the respective IL-12- or IL-4- mediated T cell development (Kaplan et 
al., 1996; Thierfelder et al., 1996; Shimoda et al., 1996; Takeda et al., 1996). Stat5a 
and Stat5b proteins are closely related and share 96% similarity at the amino acid level. 
Stat5a knockout mice exhibit failure in lactation after parturition due to defects in the 
terminal differentiation of the mammary gland (Liu et al., 1997), and Stat5b knockout 
mice reveal that the gene is important for the sexually dimorphic effects of growth 
hormone pulses in liver and other target tissues (Udy et al., 1997). In spite of 
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phenotypes individually associated with gene disruption, female infertility is only 
observed in the Stat5a/b double knockout mice, but not the single knockout, which 
implies the functional redundancy of the Stat5 proteins in certain biological functions 
(Teglund et al., 1998).  
Distinct from the rest of STAT family members, targeted disruption of the Stat3 gene 
causes lethality at the early embryogenesis stage, which indicating the essential role of 
Stat3 protein in the early development of mouse embryos (Takeda et al., 1997). 
Therefore tissue-specific gene targeting has been employed to investigate the 
biological functions of Stat3 in different adult tissues. Individual phenotypes of 
conditional Stat3-knockout observed in various tissues are summarized in Table 1.3.  
 
1.7 STATs in Oncogenesis 
Activation of STAT family proteins, especially Stat3, and to a lesser extent Stat5, has 
been detected in various primary tumor samples and cancer cell lines, including 
lymphomas, leukemia, mycosis fungoides, multiple myeloma, brain, prostate, breast, 
lung, thyroid, cervical, pancreatic and head and neck cancers, which are listed in the 
Table 1.4. A large number of cancer cells exhibit dependence on STAT members, and 
inhibition of signaling of these STATs may result in cell cycle arrest and apoptosis. 
While Stat3 and Stat5 are closely associated with oncogenesis, Stat1 has been 
suggested as a tumor-suppressor due to its roles in cell growth arrest and promoting 
apoptosis (Bromberg 2002; Calo et al., 2003). 











Promoter used for Cre 
expression 
Phenotypes 
Impaired IL-6-mediated prevention of 
apoptosis 
T cells Lck 
Impaired IL-2-mediated expression of 
IL-2Rα 
B cells CD19 Compromised Ig production 
Myeloid cells LysM Enhanced inflammatory responses, 
leading to development of chronic 
enterocolitis 
Granulocytes Mx Enhanced G-CSF-dependent 
proliferation of granulocytes 
Skin K5 Impaired wound healing and hair 
cycle 
Thymic epithelium K5 Thymic hypoplasia in adults 
Mammary gland BLG 
WAP 
Delayed involution of mammary 
gland 
Mx Impaired expression of acute phase 
protein genes 
Liver 
Albumin Reduced growth during liver 
regeneration 
NF-L  Impaired survival of motoneurons 
after nerve injury 
Neurons 
Bal Increased apoptosis of sensory 
neurons 
NF-L, neurofilament-light; K5, Keratin 5; BLG, β-lactoglobulin gene; WAP, Whey 
acidic protein; LysM, Lysozyme M 
 
(This table is from Takeda and Akira, 2003)  






Table 1.4. Activation of STATs in human primary tumors and tumor cell lines 
 
Tumor types Activated STATs 
Breast cancer 
     Cell lines 










Head and neck cancer 




Leukemia (tumors and cell lines) 
     a. HTLV-I-dependent 
     b. Erythroleukemia 
     c. Acute lymphocytic leukemia (ALL) 
     d. Chronic lymphocytic leukemia (CLL) 
     e. Acute myelogenous leukemia (AML) 
     f. Chronic myelogenous leukemia (CML)  
     g. Megakaryotic leukemia 












Lymphoma (tumors and cell lines) 
     a. EBV-related/Burkitt’s 
     b. Mycosis fungoides 
     c. HSV saimiri-dependent (T cell) 







Lung cancer (cell lines) Stat3 
Renal cell carcinoma  Stat3 
Prostate carcinoma Stat3 
Melanoma Stat3 
Pancreatic adenocarcinoma Stat3 
Ovarian carcinoma Stat3 
 
 (This table is from Bowman et al., 2000) 
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1.7.1 STAT3 in oncogenic signaling and tumor evasion 
STATs can be activated by various oncogenic tyrosine kinase activities as shown in 
Table 1.5. Inappropriate activation of Stat3 in oncogenesis leads to the induction of 
multiple target genes involved in cell proliferation (Cyclin D1, c-Myc) and protection 
against apoptosis (Bcl-xL, Mcl-1) (Bowman et al., 2000; Buettner et al., 2003). 
Constitutively activated Stat3 has been observed in cells transformed by various 
oncogenes, such as v-Src and v-abl (Danial et al., 1995; Yu et al., 1995; Cao et al., 
1996), while several dominant-negative Stat3 mutants have been shown to inhibit the 
v-Src cell transformation (Bromberg et al., 1998). A constitutively active Stat3 mutant, 
Stat3C, was generated, which can dimerize spontaneously without tyrosine 
phosphorylation. Stat3C caused cell transformation in immortalized fibroblasts, and 
the Stat3C expressing cells were tumorigenic upon injection into nude mice (Bromberg 
et al., 1999). 
In the investigations of its roles in the progressive tumor growth, Stat3 has been 
identified as a direct transcriptional activator of the vascular endothelial growth factor 
(VEGF), the most potent angiogenic factor identified so far, and activated Stat3 has 
been shown to induce angiogenesis through regulation of VEGF (Niu et al., 2002; 
Buettner et al., 2003). Constitutive Stat3 activation in tumor also suppresses both the 
production and sensing of inflammatory signaling, hence leading to the tumor cell 
immune evasion. A recent study shows that Stat3 signaling restrains natural tumor 
immune surveillance, and inhibition of Stat3 signaling in the hematopoietic system 
actually elicits the multicomponent anti-tumor immunity (Kortylewski et al., 2005). 






Table 1.5. STATs activation by oncogenes 
 





Polyomavirus middle T antigen 

















   
Myeloid v-Src 
v-Fgr 
Stat1, Stat3, Stat5 
- 
   
T cell Lck Stat3, Stat5 
   
Mammary/lung epithelial v-Src 
Etk/BMX 
Stat3 
Stat1, Stat3, Stat5 




   
Pre-B lymphocytes v-Abl Stat1, Stat5 
   
Erythroleukemia/ blast 
cells/ basophils/ mast cells 
BCR-Abl Stat1, Stat5 
   





(This table is from Bowman et al., 2000) 
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1.8 Gene associated with Retinoid-IFN-induced Mortality (GRIM-19) 
Interferons regulate antiviral, antitumor and immune responses in vertebrates by 
activating Jak1, Tyk2, Stat1 and Stat2, and a number of IFN-stimulated genes (Stark et 
al., 1998). On the other hand, all-trans-retinoic acid (RA), a metabolite of vitamin A, 
binds to specific nuclear receptors (RARs) and activates the expression of various 
genes. RA inhibits growth of certain types of cancer and is effective in the prevention 
of primary cancers, and is used in clinical therapy (Love and Gudas, 1994). A 
combination of IFN-β and RA induces cell death in several breast cancer cell lines. To 
understand the underlying mechanism and molecular basis for the IFN-β and RA 
synergistic potency on breast cancer cell death, an antisense knock-out approach was 
employed and several genes were identified and named Genes associated with 
Retinoid-IFN-induced Mortality (GRIM) (Hofmann et. al. 1998.)  
 
1.8.1 Isolation of GRIM-19 
An antisense cDNA library of BT-20 cells was generated and introduced into HeLa 
cells. The cells were subjected to the selection with IFN-β and RA for 4 weeks. 
Episomes were rescued from the surviving colonies and further tested in some other 
tumor cell lines to confirm their resistance to the IFN/RA selection. GRIM-19 is the 
smallest of these cDNAs, with a molecular weight around 16KDa and comprising 144 
amino acids. The expression of GRIM-19 in human tissues is ubiquitous, with the 
highest level in the heart, skeletal muscle and to a lesser extent in liver, kidney and 
brain. While GRIM-19 antisense confers cell survival and growth against IFN/RA 
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treatment, overexpression of GRIM-19 is found to sensitize HeLa cells to the 
IFN/RA-induced nuclear fragmentation and cell death (Angell et al., 2000). Therefore, 
GRIM-19 was proposed to be a novel cell death regulatory gene, and homologue 
sequences were also identified in various other vertebrates such as bovine, pig, mouse, 
rat and chicken. In addition, the GRIM-19 gene has been mapped to human 
chromosome 19p13.2, a region essential for prostate tumor suppression (Chidambaram 
et al., 2000) 
 
1.8.2 Role of GRIM-19 in mitochondria 
Although GRIM-19 was initially identified as a nuclear protein in IFN/RA treated 
HeLa cells (Angell et al., 2000), a bovine homologue of GRIM-19 was co-purified 
with mitochondrial NADH:ubiquinone oxidoreductase (Complex I) in bovine heart 
during the process of identifying a novel complex I subunit on a gradient gel (Fearnley 
et al., 2001), implying a possible mitochondrial localization for GRIM-19 proteins. In 
the year 2003, human GRIM-19 was also identified as a subunit of Complex I from the 
human heart mitochondria preparation obtained by a rapid one-step 
immunopurification method (Murray et al., 2003). The consistence of data from 
human and bovine strengthen the possibility of GRIM-19 mitochondrial localization. 
Recently GRIM-19 deficient mice were generated by gene targeting in our laboratory. 
The homologous deletion of GRIM-19 has been found to cause embryonic lethality at 
embryonic day 9.5, and the histological analysis show the GRIM19-/- embryos to be 
much smaller in size when compared to the wild-type, failing to undergo gastrulation 
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at E7.5 and early organogenesis at E8.5. In vitro blastocyst culturing also reveals a 
significantly retarded inner cell mass outgrowth of GRIM19-/- blastocysts, which is 
probably due to the impaired DNA replication and cell proliferation in the ICM. More 
strikingly, the mitochondria in the GRIM19-/- blastocysts are rounded and appeared 
distended, with distorted internal structures. Meanwhile, deficiency in GRIM-19 also 
leads to the disruption of mitochondrial complex I assembly, and the electron transfer 
activity of the complex was also lost in the GRIM19-/- blastocysts (Huang et al., 2004). 
A recent report by Maximo et al. also shows evidences that somatic and germline 
mutation of GRIM-19 may be linked to the mitochondrion-rich (Hurthle cell) tumors 
of the thyroid gland (Maximo et al., 2005). 
 
1.8.3 GRIM-19 interacting proteins 
GRIM-19 has been found to interact with several proteins by using the yeast 
two-hybrid system, including the viral interferon regulatory factor 1 of Kaposi’s 
sarcoma-associated Herpesvirus (Seo et al., 2002), and a novel protein GW112 that 
demonstrates strong anti-apoptotic activity (Zhang et al., 2004). Recently, GRIM-19 
was also reported to interact with Nucleotide Oligomerization Domain 2 (NOD2), 
which belongs to the NOD family of intracellular bacterial sensors. Interaction 
between GRIM-19 and NOD2 is essential to the NOD-mediated NF-κB activation and 
innate anti-bacterial response of intestine epithelial cells (Barnich et al., 2005).   
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1.9 Peptidyl-prolyl isomerase Pin1 
Peptidyl-prolyl isomerases (PPIases) are proteins ubiquitously expressed in the 
prokaryotic and eukaryotic cells, which have been reported to catalyze the cis-trans 
isomerization of the peptidyl-prolyl bonds. PPIases are divided into three major classes, 
based on their drug binding specificity. The first class of PPIases, Cyclophilins, 
selectively bind to the immunosuppressive drug Cyclosporin A (CsA), and the second 
class, FK506-binding proteins (FKBPs), bind the immunosuppressants FK506 and 
rapamycin. The third class, the Parvulin family proteins have not been reported to bind 
any immunosuppressants, and so far only limited members of the parvulin family have 
been identified. The first parvulin Par10 was isolated from E. coli, and there are two 
eukaryotic parvulin members, human Pin1 and its yeast homologue Ess1 (Gothel and 
Marahiel, 1999; Shaw, 2000). 
 
1.9.1 Isolation and activity characterization of Pin1 
In the year 1996, Lu et al. identified human cDNA clones encoding Pin1, a protein 
with molecular mass around 18KDa, by yeast two-hybrid screening for NIMA (never 
in mitosis gene A) kinase interacting proteins. Pin1 was found to share 45% identity 
with its budding yeast orthologue Ess1, and comprised two known domains, a WW 
domain at the amino-terminal of the protein and a carboxyl-terminal PPIase catalytic 
domain. The WW domain was suggested to be a possible substrate interaction module 
for the Pin1 enzymatic activity. Interestingly, Pin1/Ess1 PPIase activity was found to 
be necessary for yeast cell growth, and depletion of Pin1/Ess1 in yeast or mammalian 
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HeLa cells resulted in mitotic arrest, which suggests an important role of Pin1 in the 
regulation of cell cycle and mitosis (Lu et al., 1996).  
Crystal structure of Pin1 complexed with a dipeptide was resolved in the following 
year (Figure 1.5), and a basic amino acid cluster at the entrance to the Pin1 PPIase 
active site implies the possibility that Pin1 preferentially recognizes an acidic residue 
N-terminal to the target Proline bond (Ranganathan et al., 1997). Later that year Pin1 
was reported to recognize specifically proline bonds preceded by a phosphorylated 
serine or threonine residue (phosphoSer/Thr-Pro motif), and the Pin1 isomerase 
activity to the pSer/Thr-Pro motif was 1300-fold higher compared to the 
unphosphorylated peptides. Substitution of both Arg68 and Arg69 in the basic cluster 
dramatically reduces the Pin1 isomerase activity, suggesting the importance of this 
cluster of basic residues in coordinating the phosphate of pSer or pThr residues (Yaffe 
et al., 1997). The WW domain of Pin1 was subsequently suggested to be the binding 
module of pSer- or pThr-Pro containing peptides and single point mutation of Tyr23 or 
Trp34 residues completely abolishes the phosphoprotein binding ability of WW 
domain (Lu et al., 1999). 
A Dodo gene product has been identified as Drosophila Pin1 homologue, which is 
suggested to be involved in the regulation of ubiquitin-proteasome degradation of 
Drosophila transcriptional factor CF2 upon the EGFR-MAPK-mediated 
phosphorylation of CF2 (Hsu et al., 2001). Pin1-type PPIases have also been reported 
in various plant species such as apple, tomato and soybean (Yao et al., 2001). 





















Figure 1.5. Overall fold of human Pin1 
(A). Ribbon representation of Pin1. Residues 1–6 and 40–44 are not visible in electron density maps and are disordered. Apostrophes 
distinguish the WW domain secondary structural elements from the PPIase domain's secondary structural features. Atoms are color coded for 
clarity (oxygen is red, nitrogen is blue, carbon is black, and sulfur is yellow). (B) Ribbon and molecular surface representation of the Pin1 
interdomain cavity. View is the same as in (A). The WW domain is orange and the PPIase domain is light blue. The dotted surface depicts the 
solvent-accessible surface for residues lining the interdomain cavity. The cavity presents a largely hydrophobic composite surface as indicated 
by the predominance of carbon atoms lining the cavity. (This Figure is from Ranganathan et al., 1997) 
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1.10 Biological Functions of Pin1 
1.10.1 Pin1 in cell-cycle regulation and apoptosis 
Following its identification, the Pin1 gene was immediately suggested to play an 
important role in the cell cycle regulation and mitosis progression, but with the 
substrates undetermined. Later Pin1 was found to directly interact with a set of 
mitotic–specific phosphoproteins through their phosphoSer/Thr-Pro motifs, among 
which the functional interaction of Pin1 with Cdc25 mitotic phosphatase was 
intensively studied. 
 
1.10.1.1 Pin1 and Cdc25 in cell cycle progression 
It has been reported independently by two different research groups that Pin1 interacts 
only with the phosphorylated, mitotically active form of Cdc25, and inhibits Cdc25 
ability to activate the important mitosis regulator Cdc2/cyclinB (Crenshaw et al., 1998; 
Shen et al., 1998). Absence of Pin1 in Xenopus egg extracts led to inappropriate 
replication checkpoint function and premature entry into mitosis, accompanied by the 
hyperphosphorylation of Cdc25 and activation of Cdc2/cyclinB. Therefore, Pin1 was 
suggested to be important for the checkpoint controlling incomplete replication 
(Winkler et al., 2000). Later, Pin1 was found to promote the dephosphorylation of 
Cdc25C by the Pro-directed phosphatase PP2A (Zhou et al., 2000), and Pin1 prolyl 
isomerization activity alters the Cdc25 conformation at stoichiometries less than 
0.0005 (Stukenberg et al., 2001). 
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1.10.1.2 Pin1 and p53, p73 tumor suppressor  
In the year 2002, two independent papers were published in the Nature, both 
describing the functional interaction between Pin1 and p53, the important tumor 
suppressor in cell cycle arrest and apoptosis. Pin1 interacts with p53 upon the DNA 
damage-induced phosphorylation on several Ser/Thr-Pro motifs of p53. Subsequently, 
Pin1 promotes the DNA-binding and transactivation ability of p53, which requires the 
PPIase enzymatic activity of Pin1. Both p53 transcriptional activation and 
accumulation of stabilized p53 protein are compromised in the Pin1-deficient cells, 
and the DNA damage-induced checkpoint was also significantly impaired in absence 
of Pin1. Consistency of the evidences from these two reports suggests the importance 
of Pin1 in the p53 regulation of the genotoxic response (Zheng et al., 2002; Zacchi et 
al., 2002). Recently, the proline 82 residue of p53 was identified to mediate its in vivo 
interaction with checkpoint kinase 2 (Chk2), and Pin1-dependent isomerization at the 
Pro82 bond upon DNA damage enhances this p53-Chk interaction (Berger et al., 
2005). 
In addition to the p53 tumor suppressor, Pin1 was also found to be involved in the 
regulation of p73, a gene closely related to p53. Overexpression of Pin1 upregulated 
p73 transcriptional activity, and p73 stability was impaired in absence of Pin1 protein. 
Pin1 constitutively interacts with a fraction of p73 in unstressed cells, and under stress 
conditions the DNA-damage-activated c-Abl tyrosine kinase, together with p38 MAP 
kinase, further increase the affinity of Pin1-p73 association. Pin1-dependent 
isomerization induces p73 binding to the p300 acetyltransferase and therefore 
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facilitates p73 acetylation by p300, therefore Pin1 is required for the c-Abl- and p300- 
mediated increase of p73 stability and transactivation (Mantovani et al., 2004). 
 
1.10.2 Pin1 in Alzheimer’s Disease  
Extracellular senile plaques mainly formed by amyloid β-peptide (Aβ) and 
intraneuronal neurofibrillary tangles composed of insoluble tau protein are the two 
major neuropathological hallmarks of Alzheimer’s disease (Selkoe, 1998; Mandelkow 
and Mandelkow, 1998). Tau protein binds and stabilizes axonal microtubules in normal 
cells, but in Alzheimer’s disease tau protein is abnormally hyperphosphorylated, which 
results in the loss of its ability to bind microtubules and promote the microtubule 
assembly.  
Pin1 was found to bind a single pThr231-Pro motif in tau and therefore co-purified 
with the aggregates, which led to the depletion of soluble Pin1 in the brains of 
Alzheimer’s disease patients (Lu et al., 1999). Similar to Cdc25C, binding of Pin1 
facilitates the dephosphorylation of tau protein by PP2A phosphatase (Zhou et al., 
2000). In addition, in vitro experiments suggest that Pin1 is able to restore the 
microtubule binding and stabilization ability of the phosphorylated tau. More strikingly, 
Pin1 deficient mice tend to develop age-dependent neurodegeneration, which is 
characterized by various phenotypes such as motor and behavioural deficits, 
hyperphosphorylation of tau, tau filament formation and neuronal degeneration (Liou 
et al., 2003). Taken together, Pin1 is likely to play an important role in neuronal 
functions and the prevention of neurodegenerative disease. 
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1.10.3 Pin1, Cyclin D1 and breast cancer 
Pin1 deficient mice were originally generated in 1999 and reported to grow normally 
(Fujimor et al., 1999). However, a close study of the Pin1-/- adult female mice revealed 
that their mammary epithelial compartment failed to undergo the usual massive 
proliferation and expansion during pregnancy, despite of the normal development of 
mammary epithelial ducts in Pin1-/- mice before pregnancy. Since the Pin1 deficient 
mice developed various phenotypes which are similar to the cyclin D1 deficient mice, 
the cyclin D1 level was monitored and found to be significantly lower in several 
tissues including the mammary gland of pregnant Pin1-/- female mice (Liou et al., 
2002). 
 
1.10.3.1 Pin1 and cyclin D1 upregulation  
Consistent with the findings in the knockout mice, Pin1 was shown to bind directly to 
the phophorylated Thr286 residue of cyclin D1 and stabilize the protein. 
Overexpression of Pin1 has been observed in human breast cancers, and the level is 
correlated with the cyclin D1 level in the tumor. Transfection of Pin1 into cells both 
increases the cellular cyclin D1 level and activates its promoter (Wulf et al., 2001). 
Additionally, Pin1 is also found to interact with transcriptional factor c-Jun through its 
phosphorylated Ser63 and Ser73 residues and therefore, cooperating with Ha-Ras or 
activated JNK, to increase c-Jun transcriptional activity on the cyclin D1 promoter. 
Meanwhile, overexpression of Pin1 increases the transcription of β-catenin 
downstream genes, which also include cyclin D1. A direct interaction between Pin1 
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and β-catenin has been reported. The phosphorylated Ser-Pro motif for Pin1 binding is 
just next to the APC-binding site of β-catenin, therefore interfering with the binding of 
β-catenin to APC and promoting its nuclear translocation. Pin1 also stabilizes cellular 
β-catenin, whose level is decreased in Pin1-/- mice but increased in Pin1 
overexpressing breast cancer (Ryo et al., 2001). 
Upon cytokine stimulation, Pin1 also binds to the p65/RelA subunit of NF-κB via the 
phosphoThr254-Pro residue and inhibits p65 binding to the inhibitor IκBα, which 
consequently promots the p65 nuclear accumulation, protein stability and NF-κB 
activity towards its target genes, such as Cyclin D1, in various breast cancer cells (Ryo 
et al., 2003, Wulf et al., 2005).  
 
1.10.3.2 Pin1 in Neu/Ras induced mammary epithelial cell transformation 
To further characterize the mechanism of Pin1 overexpression in mammary 
tumorigenesis, three putative E2F binding sites were identified within the Pin1 
promoter region. EMSA and luciferase reporter assays confirmed the E2F binding and 
activation to the Pin1 promoter (Ryo et al., 2002). Oncogenes Neu and Ras can induce 
mammary cancer development, and cyclin D1 has been reported to be essential for this 
oncogenic pathway (Yu et al., 2001). It was found that the E2F-mediated Pin1 
expression could be stimulated by Neu and Ras, and Pin1 was also essential in the 
Neu/Ras-induced transformation of mammary epithelial cells through the activation of 
cyclin D1 (Ryo et al., 2002).  
By studying the crossbreeding of active Neu/Ras transgenic mice with Pin1 deficient 
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mice, deletion of Pin1 was found to be highly effective in preventing the oncogenic 
Neu- or Ras-induced breast cancer and cyclin D1 expression. An ex vivo assay of 
primary mammary epithelial cells (MECs) suggested that deletion of Pin1 blocked 
various early transformation/malignant properties in Neu/Ras transgenic MECs, while 
such an effect could be fully rescued by overexpression of cyclin D1 (Wulf et al., 
2004).   
 
1.10.4 Pin1 and PP2A-mediated dephosphorylation 
As mentioned above, Pin1 dependent isomerization activity was required for the 
dephosphorylation processes of both Cdc25C and tau proteins (Zhou et al., 2000). 
Recently Raf-1 kinase in the Ras signaling pathway has been reported to undergo 
hyperphosphorylation via a negative feedback mechanism. Upon mitogen stimulation, 
Raf-1 is translocated to the membrane, and activated by Ras, therefore transmitting the 
signal to the downstream MEK and ERK. However Raf-1 undergoes 
hyperphosphorylation at six phosphorylation sites through a negative feedback of 
MEK and ERK, and to subsequently lose affinity for the Ras-GTP and become 
refractory to any further stimulation. PP2A phosphatase is required to dephosphorylate 
the desensitized Raf-1 in order to return it to an activation-competent form, and Pin1 is 
observed here to interact with Raf-1 and therefore promote the PP2A mediated 
dephosphorylation/recycling of Raf-1 (Dougherty et al., 2005). 
Such Pin1-dependent facilitation of the PP2A-mediated dephosphorylation was also 
reported in the regulation mechanism of c-Myc degradation. Previously c-Myc was 
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observed to be stabilized by phosphorylation at the Ser62 residue, while 
phosphorylation at Thr58 was required for its degradation. Recent investigation 
revealed that PP2A was responsible for the dephosphorylation at Ser62. Pin1 binds to 
c-Myc protein in a Thr58 phosphorylation dependent manner, and its isomerization 
action facilitates the PP2A-mediated dephosphorylation at the Ser62 residue, which 
subsequently promotes the ubiquitin-proteasome dependent c-Myc degradation (Yeh et 
al., 2004).  
 
1.11 Research Aims 
Cytokines exert multiple biological responses through interaction with their specific 
receptors, resulting in the activation of JAK−STAT pathways. Among all the seven 
STAT family members, Stat3 plays important roles in cell growth, anti-apoptosis and 
cell transformation, and is constitutively active in various cancers. Since the control of 
both activation and inactivation of Stat3 is equally important to maintain normal cell 
growth, we are interested in searching for the potential positive or negative biological 
regulators of Stat3. The major research aim of this thesis is to identify various 
associated proteins for Stat3 and further characterize the functional mechanisms 
involved. 
 
The crystal structure of Stat3 reveals the coiled-coil domain as a bundle of four 
antiparallel helices connected by short loops. The exposed position and predominantly 
hydrophilic surface of the coiled-coil structure suggest that this domain may play an 
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important role in mediating the interaction of Stat3 with other proteins. The full-length 
Stat3 leads to constitutive activation of reporter genes in the yeast two-hybrid system, 
therefore in the first part of this thesis we used the coiled-coil domain of Stat3 as bait 
to search for the potential associated protein of Stat3. GRIM-19, the death-regulatory 
gene product was subsequently identified as a Stat3-interacting protein and found to 
negatively regulate Stat3 activities. Further studies were carried out to reveal the 
molecular basis of this negative effect exerted by GRIM-19. 
 
In addition to the tyrosine phosphorylation, phosphorylation at a conserved serine 727 
residue within the C-terminal of Stat3 is also important for the regulation of Stat3 
transcriptional activity, and this phospho-Ser727 site is immediately followed by a 
Proline residue. Pin1, the human peptidyl-prolyl isomerase involved in diverse 
physiological and pathological processes, has been reported to specifically recognize 
and act on the phosphor-Ser/Thr-Pro motifs of various phosphoproteins. Therefore, the 
main objective of the second part of the thesis is to characterize the functional 
interaction between Stat3 and Pin1, and study the possible regulatory roles of Pin1 on 
Stat3 transcriptional activity.  












Materials and Methods 
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2.1 Cytokines, growth factors, chemicals and reagents 
Interleukin-6 (IL-6) was purchased from Genzyme (Cambridge, MA, USA). 
Oncostatin M (OSM) was from Calbiochem (San Diego, CA, USA). Epidermal growth 
factor (EGF) was from Sigma (St. Louis, MO, USA). Proteasome inhibiter MG132 
was bought from Biomol International L.P. (Plymouth Meeting, PA, USA). Enhanced 
chemiluminescence (ECL) reagents and Lumi-LightPLUS Western blotting substrates 
used in Western blotting were purchased from Amersham Biosciences (Piscataway, NJ, 
USA) and Roche Diagnostic (Mannheim, Germany) respectively. The protease 
inhibitors aprotinin, leupeptin and phenylmethylsulfonyl fluoride (PMSF) were 
obtained from Boehringer Mannheim (Mannheim, Germany). The Complete, mini, 
protease inhibitor cocktail tablets were bought from Roche Diagnostic. Luria-Bertani 
(LB) medium, ampicillin, kanamycin, bovine serum albumin (BSA) used in blocking 
buffers were acquired from Sigma. Glutathione-agarose beads were obtained from 
Amersham Biosciences. Protein A-agarose beads used for immunoprecipitation were 
purchased from Roche Diagnostics, and protein G plus/ protein A-agarose was from 
Oncogene Science (Cambridge, MA, USA). Isopropyl-β-D-thiogalactoside (IPTG) 
was bought from GIBCO BRL (Gaithersburg, MD, USA). Bacto™ yeast extract, 
peptone, agar and Difco™ yeast nitrogen base without amino acids were purchased 
from Difco, Becton Dickinson (Sparks, MA, USA). The dropout (DO) supplements in 
yeast nutritional selection medium were from Clontech Laboratories (Mountain View, 
CA, USA). The phosphate-buffered saline (PBS) used in all the experiments is 
composed of 137 mM NaCl, 2.7 mM KCl, 4.3 mM KH2PO4 and 1.4 mM 
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K2HPO4⋅7H2O at pH 7.3. 
 
2.2 Antibodies 
Monoclonal antibody of Stat3 was purchased from Transduction Laboratories 
(Lexington, KY, USA). Polyclonal antibody against phosphor-Tyr705 and monoclonal 
antibody against phospho-Ser727 of Stat3 were purchased from Cell Signaling 
Technology (Danvers, MA, USA). Rabbit polyclonal anti-Pin1 antibody was obtained 
from Upstate Inc. (Lake Placid, NY, USA). Goat polyclonal antibody of Pin1, rabbit 
polyclonal antibodies of Stat3 and p300, monoclonal and polyclonal antibodies of 
ubiquitin, c-Myc and HA-tag were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). Monoclonal antibody against FLAG-epitope (M2) was bought from 
Sigma (Saint Louis, MO, USA). Monoclonal antibody against Glutathione- 
S-Transferase (GST) was acquired from B.D. Pharmingen (San Diega, CA, USA). 
 
2.3 Cell culture 
COS-1 (monkey kidney fibroblast-like) and HepG2 (human hepatocellular 
carcinoma) cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Sigma, 
St. Louis, MO, USA) with 1000 mg/L glucose, supplemented with 10% fetal bovine 
serum (FBS) purchased from Gibco-Invitrogen (Carlsbad, CA, USA) or Hyclone 
Laboratories (Logan, UT, USA), 2 mM L-glutamine, 100 units/ml penicillin and 100 
ng/ml streptomycin (Sigma and Gibco-Invitrogen), 10 mM N-2-hydroxyethyl 
piperazine-N’-2-ethanesulfonic acid (HEPES), pH 7.3. Human neuroblastoma 
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SH-SY5Y, and NIH 3T3/v-Src, NIH 3T3/ST-3-ΔN cells derived from mouse NIH-3T3 
fibroblasts were grown in DMEM medium with 4500 mg/L glucose, while human 
breast carcinoma MCF-7 and cervical adenocarcinoma HeLa cells were grown in 
RPMI medium supplemented with similar ingredients plus 0.1 mM non-essential 
amino acid and 1 mM sodium pyruvate (Gibco-Invitrogen). Mouse C2C12 myoblasts 
from ATCC were grown in DMEM (4500 mg/L glucose) with 20% FBS, and rat 
pheochromocytoma PC-12 cells were cultured in the same high-glucose DMEM with 
10% FBS and 5% horse serum. Pin1-deficient mouse embryonic fibroblasts (MEFs) 
and the wild-type control cells (gift from Dr. T. Uchida, Tohoku university, Japan) 
were grown in DMEM (4500 mg/L glucose) with 10% FBS, supplemented with 
L-glutamine, non-essential amino acids, sodium pyruvate, penicillin and streptomycin, 
and additionally 0.001% tissue culture-grade β-mercaptoethanol (Sigma). All the cells 
are incubated at 37°C and 90% humidity level with 5% CO2.  
 
2.4 Yeast two-hybrid screening  
The coiled-coil domain (amino acids 138−318) of Stat3 was cloned into plasmid 
pGBKT7 (Clontech Laboratories) containing the GAL4 DNA-binding domain as bait. 
This plasmid was transformed into Saccharomyces cerevisiae strain AH109.  
The evaluation and screening procedures were performed according to the 
manufacturer's instructions. Briefly, S. cerevisiae strain Y187 pre-transformed with the 
MATCHMAKER library containing 17th day mouse embryonic cDNAs fused to the 
GAL4 activation domain (AD) (Clontech Laboratories) was mated with the AH109 
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strain harboring the bait, at 30°C for 24 h. The mating mixture was spread onto plates 
containing selection medium lacking Trp, His, Leu and Ade, and incubated at 30°C for 
~2 weeks. A β-gal colony-lift filter assay was performed to eliminate the false-positive 
colonies. The plasmids were isolated from the positive colonies and transformed into 
Escherichia coli strain DH5α by electroporation. Plasmid DNA was purified from 
E .coli and subjected to sequencing analysis. 
 
2.5 Molecular cloning 
2.5.1 Preparation of E. coli competent cells 
DH5α Eschoerichia coli (E. coli) was streaked onto a Luria Bertani (LB, pH 7.5) 
plate (1% bacto-tyrptone, 0.5% bacto-yeast extract, 1% NaCl and 1.5% agar) without 
antibiotics and incubated overnight. Single colonies were picked and grown in 2 ml of 
LB at 37°C overnight with shaking. The culture was added into 400 ml of LB and 
incubated for 3-4 h on a 37°C shaker until the absorbance at 600 nm reached 0.4-0.6. 
The culture was chilled and bacteria cells were collected by centrifugation at 4,000 
rpm for 5 min at 4°C. The resulting pellet was resuspended on ice in one-twentieth 
volume of TSS buffer [LB broth (pH 6.1), 10% polyethylene glycol (PEG, molecular 
weight 3350 or 8000), 5% dimethyl sulfoxide (DMSO), 10 mM MgCl2, 10 mM 
MgSO4, pH 6.5-6.8], and incubated on ice for 10 min. The competent cells were 
aliquoted and stored at -80°C.  
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2.5.2 Construction of expression plasmids 
The expression plasmid of murine Stat3α, pRC/CMV-Stat3 was a gift from J. E. 
Darnell, Jr. (The Rockefeller University, USA). Various deletion mutants of different 
Stat3 functional domains were generated by Dr. T. Zhang (Zhang et al., 2002) and me 
through PCR with primers containing BamHI site at 5’ and XhoI at 3’, using the 
murine Stat3 as the template, and the respective PCR products were cloned into 
pXJ40-FLAG or pXJ40-GST expression vectors. Mammalian expression plasmid 
vectors pXJ40-FLAG, a FLAG-tagged vector, and pXJ40-GST, a vector for expression 
of Glutathione S-Transferase (GST) fusion protein were obtained from Dr. Z. Zhao and 
Dr. E. Manser in our institute (Glaxo-IMCB, Singapore) respectively. Original Stat1 
and Stat5a expression plasmids were gifts from J.E. Darnell, Jr and A. Miyajima (The 
university of Tokyo, Japan), respectively, and cloned into vector pXJ40-FLAG using a 
similar PCR method as for Stat3 by Dr T. Zhang. Stat3 with a point mutant causing a 
Ser727Ala exchange were prepared by Dr. C. P. Lim in our laboratory, by substitution 
of the phosphorylation site Ser-727 to Ala with the QuickChangeTM site-directed 
mutagenesis kit from Stratagene (La Jolla, CA, USA). 
Clones containing the cDNA sequence of murine GRIM-19 were isolated from the 
MATCHMAKER library containing 17th day mouse embryonic cDNAs by yeast 
two-hybrid screening (Clontech Laboratories). Full-length GRIM-19 was generated by 
PCR with primers containing XhoI site at 5’ and XbaI site at 3’, and the respective 
PCR product was sequenced and cloned into pDMYCneo, a double Myc-tagged 
expression plasmid obtained from Drs. S. H. Wong and W. Hong from our institute 
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(Seet and Hong, 2001). The human homologue of GRIM-19 was isolated from a cDNA 
library of MCF-7 cells (a gift from Dr. V. Yu from our institute). The deletion mutants 
of GRIM-19 were generated by PCR, and the PCR products were cloned into 
GST-fusion expression vector pXJ40-GST with primers containing BamHI site at 5’ 
and XhoI site at 3’. 
The full-length human Pin1 cDNA sequence was generated by PCR with primers 
containing BamHI site at 5’ and XhoI site at 3’ from a human cDNA library (Clontech 
Laboratories), and the respective PCR product was sequenced and cloned into 
pXJ40-Myc and pXJ40-HA mammalian expression plasmids (gifts from Glaxo-IMCB, 
Singapore). All the point mutants for Pin1 were generated by site-directed mutagenesis 
using wild-type murine Pin1 as template. The GST-Pin1 fusion protein expression 
plasmid for bacterial was constructed by insertion of the full-length Pin1 cDNA into 
pGEX-6p-1 bacterial GST-fusion expression vector (Amersham Biosciences) and 
named GST-Pin1. The mammalian expression plasmid for HA-tagged ubiquitin in a 
pXJ40-HA vector was a gift from Mr. N. Fu from our institute. 
 
2.5.3 Techniques for expression plasmid construction  
2.5.3.1 Restriction digestion of DNA 
Typical restriction endonuclease digestion of DNA involved dilution of 1-3 μg of 
DNA in a total volume of 20 μl reaction mixture, together with 10 Units of each 
restriction enzyme and the appropriate restriction digestion buffer (Roche Diagnostic 
or New England Biolabs, Berverly, MA, USA). The reactions usually took place at 
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37°C for 1 h, and experimental details are subjected to change according to the 
manufacturer’s instruction for different restriction enzymes.  
For the digestion of plasmid vector during gene cloning, in order to prevent the 
singly-digested vector from self-ligation, calf intestinal alkaline phosphatase (CIP) 
(New England Biolabs) was used to remove the phosphate group from the 5’ end of the 
linearized vector. Typically, 1 unit of CIP was added directly to the restriction reaction 
mixture in the end of the 1 h digestion and incubated for another 30 min at 37°C. 
 
2.5.3.2 Gel extraction of DNA fragments 
Restriction reaction products were usually separated in agarose gel and recovery 
of DNA from the gel was performed by using the Qiaquick™ Gel Extraction Kit from 
QIAGEN (Valencia, CA, USA). Briefly, upon the visualization under long-wavelength 
UV-transilluminator, the DNA bands of interest were excised using scalpels and the gel 
slices were dissolved in appropriate volume of dissolving buffer QG (approximately 3 
volumes of buffer to 1 mg of gel). Complete melting of gel slice was achieved by 
incubation at 55°C for 10 min with repeated vortexing. The dissolved mixture was 
applied onto the Qiaquick column for DNA-binding. After two rounds of washing, the 
DNA fragments of interested were eluted with nuclease free water to a desired volume. 
 
2.5.3.3 DNA ligation 
During construction, the purified vector and DNA fragment were mixed at a molar 
ratio of 1:3, together with 1 unit of T4 DNA ligase (New England Biolabs, Roche 
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Diagnostic) and T4 ligation buffer in a total volume of 20 μl. The ligation was carried 
out in a 16°C waterbath overnight, and usually 5 μl of final ligation products was used 
for the bacterial transformation. Occasionally the Rapid DNA Ligation Kit from Roche 
Diagnostic was also employed for fast DNA ligation at room temperature according to 
the manufacturer’s instruction. 
 
2.5.4 Transformation of plasmids 
Transformation of plasmids into bacterial cells was achieved using the chemical 
transformation method. An aliquot of DH5α E. coli competent cells were pre-thawed 
on ice before transformation. DNA plasmid (10 ng) or construction products (5 μl) 
were added to 100 μl KCM solution (100 mM KCl, 30 mM CaCl2 and 50 mM MgCl2), 
and 100 μl of competent cells. The mixture was incubated on ice for 30-60 min, and 
the cells were pelleted by centrifugation at 14,000 rpm for 2 min. The cells were 
resuspended in 100 μl of supernatant. The suspension was directly spread onto LB 
plates containing 50 μg/μl ampicillin if the plasmids are ampicillin-resistant. For 
plamids carrying resistance gene to other drugs like kanamycin, 1 ml of 2X LB 
medium without antibiotics was added to the cells, followed by shaking at 37°C for 1 h 
and subsequent spreading onto the LB plate with corresponding antibiotics. The LB 
plates were incubated at 37°C overnight, and single colonies were picked for 
mini/maxi -scale DNA preparation and further characterization. 
 
2.5.5 DNA preparation 
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The Wizard Plus® SV Minipreps DNA Purification Kit (Promega, Madison, WI, 
USA) was used for the small-scale DNA preparation from E. coli cells. Bacteria were 
cultured in 5 ml LB medium overnight, and harvested by centrifugation at 14,000 rpm 
for 2 min, with the supernatant discarded. The pellet resuspended in the Cell 
Resuspension Solution (50 mM Tris-HCl, pH 7.5, 10 mM EDTA and 100 mg/ml 
RNase A) was subjected to lysis with Cell Lysis Solution (0.2 M NaOH and 1% SDS), 
followed by the adding of alkaline protease. The alkaline-lysed bacterial lysates were 
neutralized by the Neutralization Solution (4.09 M guanidine hydrochloride, 0.759 M 
potassium acetate and 2.12 M glacial acetic acid, pH 4.2). The resulting samples were 
centrifuged at 14,000 rpm for 10 min at room temperature, and the cleared lysates were 
added to the Miniprep Spin Column which binds the DNA. After centrifugation for 1 
min, the DNA-bound column was washed by Wash Solution (162.8 mM potassium 
acetate and 27.1 mM Tris-HCl, pH 7.5) diluted with ethanol, followed by another 
centrifugation. After two rounds of washing processes, the column-bound plasmid 
DNA was eluted in nuclease free water or TE buffer. 
The QIAGEN Plasmid Maxi Kit was used for the large-scale preparation of DNA. 
Typically, overnight bacterial culture in 400 ml LB was collected by centrifugation and 
subjected to the resuspension, lysis and neutralization steps that are similar to the 
above DNA miniprep procedure. The supernatant obtained from the bacteria lysates 
were added to the QIAGEN-tip 500 column which had been equilibrated in advance 
with equilibration buffer QBT (750 mM NaCl, 50 mM MOPS, pH 7.0, 15% 
isopropanol and 0.15% Triton X-100), followed by two times washing with Buffer QC 
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(1 M NaCl, 50 mM MOPS pH 7.0 and 15% isopropanol). DNA was eluted in Buffer 
QF (1.25 M NaCl, 50 mM Tris-Cl, pH 8.5 and 15% isopropanol) and precipitated by 
0.7 volume of isopropanol, and the DNA pellet was washed with ice-cold 70% ethanol 
and air-dried. The final large-scale plasmid DNA product was dissolved in a suitable 
volume of TE buffer pH 8.0. 
 
2.5.6 Agarose gel electrophoresis 
DNA samples were separated by electrophoresis in the 1.0-2.0% (w/v) agarose 
gels prepared with TAE buffer (40 mM Tris-acetate and 2 mM EDTA), supplemented 
with 1 μg/ml ethidium bromide. DNA loading buffer [0.25% (w/v) of bromophenol 
blue and eylene cyanol in 25% (w/v) ficoll (type 400)] was added to each DNA sample 
before loading to the agarose gel, and electrophoresis was performed in the TAE buffer. 
Appropriate DNA standards ladders (New England Biolabs) were employed to 
determine the DNA band-size, and the DNA bands were visualized under UV 
illumination.  
 
2.6 Polymerase chain reaction (PCR) 
Primers used in PCR were synthesized by Genset Inc. and Research Biolabs, 
Singapore. PCR reactions were mainly performed with the Expand™ Long template 
PCR System and Expand™ High Fidelity PCR System from Roche Diagnostic. 
Typical Long template PCR System reaction mixture included 20-50 ng of DNA 
template, 50 pM of the sense and anti-sense primers, plus 2.5 units of DNA 
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polymerase, together with the PCR buffer supplemented with 1.75 mM MgCl2, 250 
μM of deoxy-adenine, deoxy-cytosine, deoxy-guanine and deoxy-thymidine 
nucleotides (New England Biolabs). The reaction was carried out by 1 cycle of 
denaturation at 94°C for 2 min and primer annealing step at desired temperature 
(usually around 50°C) for 30 sec, followed by 30 cycles of DNA extension at 68°C for 
3 min, denaturation at 93°C for 15 sec, and primer annealing for 30 sec. The final cycle 
of DNA extension was carried out at 68°C for 4 min. The reagent mixture and thermal 
cycle set-up of the High Fidelity PCR kit or other PCR systems was slightly adjusted 
in order to optimize the product yield and specificity of each reaction. 
 
2.7 Site-directed mutagenesis 
The QuickChange™ Site-directed Mutagenesis Kit from Stratagene (La Jolla, CA, 
USA) was employed to introduce point mutations into the plasmid cDNAs. The 
complementary mutagenic oligonucleotide primers were designed with the desired 
mutant codon in the middle of the primers. The typical reaction assembly included 2.5 
units of Pfu Turbo™ DNA polymerase and reaction buffer, 30 ng of the original DNA 
template, 125 ng of each complimentary mutagenic primers and 1 μl of each 
deoxynucleotides, in a total volume of 50 μl. Following the initial denaturation step at 
95°C for 30 sec, there were 16 cycles of denaturation at 95°C for 30 sec, annealing at 
50°C for 1 min, and extension at 68°C for appropriate time (generally 2 min/kb of the 
plasmid length). The methylated wild-type parental DNA template was digested with 
DpnI at 37°C for 1 hour, and the newly-synthesized mutated plasmids were 
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transformed into E. coli for subsequent colony selection and DNA sequencing. 
 
2.8 Transfection in mammalian cells 
In most cases, DNA plasmids were transiently introduced into mammalian cells by 
using LIPOFECTAMINE™ and LIPOFECTAMINE 2000™ transfection methods, and 
siRNA oligonucleotides were introduced into cells using OligoFECTAMINE™. 
 
2.8.1 DNA plasmid transfection 
Typically, cells were seeded onto 100 mm culture dishes at approximate density of 
1~2 x 106 cells per dish, around 16 h prior to transfection. A total of 6-8 μg of plasmid 
DNA diluted in 800 μl of OPTI-MEM® I reduced serum medium (Gibco-Invitrogen, 
Carlsbad, CA, USA) was mixed with the second portion of 800 μl OPTI-MEM® I 
containing 30 μl of LIPOFECTAMINE transfection reagent (Gibco-Invitrogen). The 
mixture was incubated at room temperature for 20 min to allow the formation of 
DNA-liposome complex. Meanwhile the cells were rinsed with OPTI-MEM® I. The 
transfection mixture was topped up to 6.4 ml with additional 4.8 ml of OPTI-MEM® I, 
and overlayed onto the cells followed by incubation for 4-6 h at 37°C. Subsequently, 
the transfection mixture was removed and the cells were grown in appropriate growth 
medium for another 24-48 h before further analysis. Procedures of the 
LIPOFECTAMINE 2000™ transfection were very similar except for using only 6μl of 
transfection reagent instead of 30μl in the case of LIPOFECTAMINE™. 
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2.8.2 Transfection of siRNA oligonucleotides 
Commercial siRNA oligonucleotides were purchased from DHARMACON Inc. 
(Lafayette, CO, USA). Cells were seeded into 96-well culture plates at approximate 
density of 5,000 cells per well in growth medium without antibiotics. For each well of 
transfection, 0.5-1 μl of the 20 μM siRNA oligo stock was added in 16 μl of 
OPTI-MEM® I medium, and mixed with the second portion of 0.4-0.6 μl of 
Oligofectamine™ (Gibco-Invitrogen) in 3 μl of OPTI-MEM® I. While the complexes 
were forming, cells were rinsed and 80 μl of OPTI-MEM® I was added onto the cells. 
The transfection complex was mixed gently and added in each well, and incubated at 
37°C for 4-6 h. Finally 50 μl of growth medium with 3X the normal concentration of 
FBS was added, and cells were allowed to grow for another 24-72 h before subsequent 
assays. 
 
2.9 Cell harvesting, Immunoprecipitation and GST Pull-down assay 
Cells were rinsed 3 times with PBS and lysed in RIPA buffer (150 mM NaCl, 50 
mM Tris-HCl, pH 7.2, 1% deoxycholic acid, 1% Triton X-100, 0.25 mM EDTA, pH 
8.0), or cell lysis buffer (50 mM HEPES, pH 7.3, 150 mM NaCl, 0.2% NP-40, 5 mM 
EDTA) with protein inhibitors. The protein concentrations were estimated using the 
Bio-Rad protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA) and 
reading absorbance at 595 nm.  
For immunoprecipitation, cell lysates containing 500 to 1000 μg of total proteins 
were incubated with 1-2 μg of appropriate antibodies overnight at 4°C followed by 
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incubation with protein G PLUS/protein A-agarose (Oncogene Science) or Protein 
A-agarose (Roche Diagnostics) beads for another 1 h. The immunoprecipitates were 
washed twice with cell lysis buffer and followed by washing twice with PBS, 
subsequently boiled in 2X protein sample buffer before loading to the SDS-PAGE gel. 
For GST pull-down experiments against GST-fusion protein expressed in 
mammalian cells, the cell lysates containing 600 μg of total proteins were incubated 
with 40 μl of glutathione−Sepharose 4B beads (Amersham Pharmacia Biotech) for 1-2 
h at 4°C. The precipitates were washed with RIPA buffer and PBS and resolved by 
SDS−PAGE. For pull-down assays using purified bacterial GST-fusion proteins, 
mammalian cell lysates containing 800-1000 μg of total proteins were incubated with 
5-10 μg of bacterially produced GST-fusion protein for 3 h, then followed by the 
glutathione−Sepharose 4B beads. 
 
2.10 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western analysis 
Protein samples were resolved by SDS-PAGE, typically 40 mA per gel, using the 
Bio-Rad Mini-PROTEAN II system. The resolution gel for SDS-PAGE is comprised 
of 7.5-15% acrylamide from Genomic Solution (Chelmsford, MA, USA), 0.375 M 
Tris-HCl pH 8.8 and 0.1% (w/v) sodium dodecyl sulfate (SDS). Gel polymerization 
was accelerated by adding 0.01% (v/v) TEMED and freshly prepared 0.1% (w/v) 
ammonium persulfate. The stacking gel contains 4% acrylamide, 0.125 M Tris-HCl, 
pH 6.8 and 0.1% SDS. Protein samples were prepared by adding 2X protein sample 
buffer [125 mM Tris-HCl, pH 6.8, 4% SDS (v/v), 10% β-mercaptoethanol (v/v), 20% 
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glycerol (v/v) and 0.4% bromophenol blue (w/v)], and heated at 95°C for 5 min before 
loading to the gels. The electrophoresis buffer consists of 25 mM Tris-HCl, pH 8.3, 
192 mM glycine and 0.1% SDS.  
Proteins in the gel from SDS-PAGE were subsequently electroblotted to 
polyvinylidene difluoride (PVDF) memberane (Bio-Rad Laboratories) at 4°C using the 
Bio-Rad Trans-Blot™ system. The transfer buffer consists of 25 mM Tris-base, 192 
mM glycine and 20% methanol. The blots were incubated overnight at 4°C in blocking 
buffer [PBS containing 1% (w/v) BSA and 0.1% (v/v) Tween-20 (Sigma)]. After 
blocking, the membranes were incubated with primary antibodies diluted appropriately 
in the blocking buffer, for one hour at room temperature with gentle shaking, followed 
by washing for 6 times with PBS containing 0.2% Tween-20 in order to remove the 
unbound and nonspecifically-bound antibodies. Blots were then subjected to blotting 
with Horseradish peroxidase conjugated secondary antibodies for another 1 h at room 
temperature. Following the second round of washing, the membranes were subjected 
to chemiluminescence detection with the ECL kit (Amersham Biosciences) or 
Lumi-LightPlus kit (Roche Diagnostics). To reprobe the same membrane with another 
antibody, the immunoblot was subjected to stripping in the buffer containing 62.5 mM 
Tris (pH 6.8), 100 mM β-mercaptoethanol, and 2% SDS for 30 min at 60°C, followed 
by BSA blocking again. 
 
2.11 Bacterial GST fusion protein production 
The gene of interest was cloned into the bacterial GST-fusion expression vector 
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pGEX-6p-1 (Amersham Biosciences), which was transformed into E.coli strain 
BL21(DE3). A single bacterial colony was picked and grown in 400 ml of LB medium 
at  37°C until the absorbance at 600 nm reached 0.5. Expression of the GST fusion 
protein was induced by 0.1-1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 37 
°C for 2 h, and the bacteria were collected by centrifugation at 6,000 rpm for 10 min. 
The bacterial cells were subsequently broken by sonication and the supernatant was 
collected after another round of centrifugation at 10,000 rpm. The GST fusion proteins 
were purified with Glutathione−Sepharose 4B beads (Amersham Biosciences) and 
subsequently eluted in elution buffer (50 mM Tris-HCl, pH 8.0, and 10 μM 
glutathione). A small aliquot of fusion protein was subjected to SDS-PAGE and 
staining with Gel-Code® blue stain reagent (Pierce, Rockford, IL, USA) to verify the 
purity and integrity of the protein, and meanwhile the concentration of fusion protein 
was estimated against the BSA standards. 
 
2.12 Nuclear Extraction, Cell Fractionation  
For nuclear extraction, typically, cells in the 100 mm plates were washed with and 
harvested in ice-cold PBS. Cell pellets were obtained by centrifugation at 1,000 rpm 
for 5 min, and resuspended in 500-1000 μl of nuclear extraction buffer [10 mM 
HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl and 0.5% NP-40, complemented with 
protease inhibitors including 10 mM NaF, 0.5 mM Na3VO4, 0.5 mM dithiothreitol 
(DTT), 5 μg/ml leupeptin, 5 μg/ml aprotinin, 1 μg/ml pepstatin A and 1 mM PMSF]. 
The suspension was allowed to stand in ice for 10 min, followed by appropriate 
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homogenization with Teflon pestles. The crude nuclear fraction was collected by 
centrifugation of the homogenate at 4,000 rpm for 10 min at 4°C, and washed with the 
nuclear extraction buffer by another round of suspension and spinning. The nuclear 
preparation was lysed in RIPA buffer followed by centrifugation at 14,000 rpm for 10 
min at 4°C. 
The mitochondrial fraction was prepared using the ApoAlert™ Cell Fractionation 
Kit from Clontech Laboratories following the manufacturer’s instruction. Briefly, cells 
were rinsed and scraped down with PBS and collected by centrifugation, followed by 
washing with 1ml of the provided Wash Buffer. Cell pellets were subsequently 
resuspended in ice-cold Fractionation Buffer Mix supplemented with protease 
inhibitors and incubated on ice for 10 min, Homogenization of cells was performed in 
a chilled grinder on ice and the homogenates were centrifuged at 700 g for 10 min at 
4°C. Supernatants obtained were subjected to another spinning at 10,000 g for 25 min 
at 4°C and the resulting pellets were resuspended in RIPA as the mitochondrial 
fractions. 
 
2.13 Chloramphenicol acetyl transferase (CAT) assay 
During cell transfection, pCMV-βgal plasmid encoding the β-galactosidase gene 
and the CAT reporter construct pSIE-CAT were cotransfected with other plasmids. 
Upon harvesting, the cells were rinsed with and scraped into ice-cold PBS, and 
collected by centrifugation at 4°C. The cell pellet was resuspended in 0.25 M Tris-HCl, 
pH 8.0, followed by three freeze-thaw cycles with the freezing steps in a dry ice and 
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ethanol bath for 5 min and thawing steps in a 37°C waterbath for 2 min. The lysates 
were centrifuged at 14,000 rpm for 5 min and the supernatants (cytoplasmic portion) 
were used for the β-galactosidase and CAT assays. β-galactosidase assays for 
transfection efficiency normalization were performed by adding 5 μl of cytoplasmic 
lysate to buffer Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4 
and 40 mM β-mercaptoethanol) and incubation at room temperature for 5 min. 100 μl 
of 4 mg/ml O-nitrophenyl β-D-Galactopyranoside (ONPG) was added to the mixture 
and incubated at 37°C for the appropriate length of time. The reaction was stopped by 
adding 0.5 ml of 1 M Na2CO3 and the OD value of each sample was measured at 420 
nm.  
For CAT assays, appropriate amount of cytoplasmic lysates, which were 
normalized by their β-galactosidase activities, were mixed with 5 μl of 
[14C]-chloramphenicol (Amersham Biosciences), 20 μl acetyl-coenzyme A, and 0.25 
M Tris buffer in a total volume of 150 μl, and the reaction mixtures were incubated at 
37°C for the appropriate length of time. Acetylated and nonacetylated forms of 
[14C]-chloramphenicol were extracted by ethyl acetate, vaccum dried and resuspended 
in 10 μl of ethyl acetate. Samples were subjected to thin layer chromatography (TLC) 
using Baker-flex silica gel 1B2-F (J. T. Baker Inc., Phillipsburg, NJ, USA) in a 
pre-equilibrated solution of 95% chloroform and 5% methanol. The TLC gel plate was 
air dried and subjected to autoradiography and subsequent quantification using a 
Bio-Rad GS700 Imaging Densitometer.  
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2.14 Luciferase assay 
Cells were seeded in 24-well or 6-well dishes, and the firefly luciferase reporter 
gene construct (pGL3-α2M-215luc or pGL3-hSIE-luc) was cotransfected with other 
expression plasmids and pRL-TK (thymidine kinase promoter-dependent Renilla 
luciferase construct) used as an internal control for transfection efficiency (Promega). 
Cells were serum starved for 24 h prior to the overnight stimulation with IL-6 (40 
ng/ml), EGF (100 ng/ml) or OSM (10 ng/ml), respectively. Cells were washed three 
times with PBS, lysed with 100-300 μl of passive lysis buffer (Promega) and subjected 
to one freeze−thaw cycle at -80°C. A dual luciferase reporter assay (Promega) was 
performed according to the manufacturer's instructions using the Ascent Luminoskan 
(Thermo Labsystems, Waltham, MA, USA). Each transfection and luciferase assay 
was repeated at least three times prior to drawing any conclusions. 
 
2.15 Electrophoretic Mobility Shift Assay (EMSA) 
2.15.1 Probe labeling 
Mutant hSIE probe was used in the EMSA assay for Stat3. 100 ng of the annealed 
probe was incubated with 2 nmoles of dATP, dGTP and dTTP, and 75 μCi of [α-32P] 
dCTP in the Nick Translation (NT) buffer (0.5 M Tris-HCl, pH 7.2, 0.1 M MgSO4, 1 
mM DTT and 500 μg/ml BSA), plus 2 units of Klenow enzyme (New England 
Biolabs), at 37°C for 1 h. The NAP-5 column (Amersham Biosciences) was 
pre-washed with TE buffer (10 mM Tris-HCl, pH 8.0, and 0.5 mM EDTA) and used 
for the purification of the labeled probes. Eluates from the column were collected in 
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six aliquots of 400 μl TE buffer, and an aliquot with the highest cpm counts was 
selected for the EMSA. 
 
2.15.2 EMSA 
Cell lysate used for EMSA was prepared using the same protocol as for the CAT 
assay, but instead of the cytoplamic lysate, the nuclear portion was suspended in high 
salt buffer (20 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM EGTA, 420 mM NaCl, 20% 
glycerol, 60 mM Na4P2O7 and protease inhibitors) and subjected to the DNA binding 
assays. For each individual reaction, 10 μg of nuclear proteins were pre-incubated with 
2 mg of poly(dI-dC)⋅poly(dI-dC) (Amersham Biosciences) in low salt buffer (20 mM 
HEPES, pH 7.9, 0.5 mM EDTA, 5 mM MgCl2, 10 μM MnCl2, 5 mM DTT and 12% 
glycerol) on ice for 10 min, followed by adding of the labeled probes (50,000 cpm) 
and incubation for another 20 min at room temperature. Meanwhile, a 5% 
polyacrylamide gel was made and pre-run in TBE buffer (44.5 μM Tris base, 44.5 μM 
boric acid, 1 mM EDTA) at 100 V for 1.5 h. The DNA binding reaction samples were 




Cells grown on coverslips were transfected with various expression plasmids in 
6-well plates. After transfection for 24-48 h, cells were washed with PBSCM (PBS 
containing 1 mM CaCl2 and 1 mM MgCl2) and fixed with 4% paraformaldehyde in 
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PBS. After permeabilizing with methanol for 5 min, the cells were washed and 
incubated with FDB (PBSCM with 5% normal goat serum, 10% fetal bovine serum 
and 2% bovine serum albumin, pH 7.6), followed by incubation with primary 
antibodies diluted in FDB. After washing with PBS containing 0.1% Triton X-100, 
cells were incubated with the appropriate secondary antibodies conjugated with 
fluorescein isothiocyanate (FITC) (Molecular Probes, Invitrogen) or Cy3 (Amersham 
Biosciences) for 1 h. Cells were then washed three times with PBS containing 0.1% 
Trixon X-100, mounted with FluoroGuardTM Antifade Reagent (Bio-Rad Laboratories), 
and examined using a confocal microscope (Bio-Rad MRC 1024). The figures were 
processed with Adobe Photoshop software.  
 
2.17 Cell growth assay 
The Cell Proliferation Kit II (XTT) from Roche Diagnostics was used for the cell 
growth assay following the manufacturer's instructions. Briefly, cells were plated in 
96-well plates and either transfected with appropriate plasmids, or treated with desired 
drugs. Cells were incubated with XTT labeling mixture at 37°C for the appropriate 
length of time to allow the development of the color. Spectrophotometric absorbance 
of the samples was measured at 485 nm wavelength and reference wavelength 650 nm 
using SPECTRAFLuo Plus reader from Tecan (Männedor, Switzerland). 












GRIM-19 Suppresses Stat3 Activity via  
Functional Interaction 
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3.1 Identification of GRIM-19 as a Stat3-interacting protein by yeast two-hybrid 
system 
To study the regulations and functions of Stat3, we sought to identify the proteins that 
interact with Stat3 using a yeast two-hybrid system (Durfee et al., 1993). Full-length 
Stat3 resulted in the constitutive activation of the reporter genes. We therefore used the 
coiled-coil domain of Stat3, known to be important for protein−protein interaction, as 
bait (Becker et al., 1998). Four positive clones were identified to encode the mouse 
homolog of human GRIM-19, whose homologs have also been reported in bovine, 
mouse and Caenorhabditis elegans (Lai et al., 2000). The cDNAs we obtained in the 
yeast two-hybrid screening exhibited 100% identity in amino acid sequence with the 
reported murine GRIM-19, which shares 75% amino acid identity and 88% similarity 
to the human GRIM-19. The specificity of Stat3 and GRIM-19 interaction in yeast was 
further confirmed by survival assay on selection medium, in which only yeast cells 
harboring both Stat3 coiled-coil domain (ST3-4H) and GRIM-19 were found growing 
on the medium lacking all the four selection amino acids, indicating the specific 
interaction between Stat3 and GRIM-19 in yeast (Figure 3.1A).  
 
3.2 Association of Stat3 and GRIM-19 in vivo and in vitro  
To verify the interaction of full-length Stat3 and GRIM-19 in mammalian cells, we 
transfected COS-1 cells that express low levels of Stat3 with Flag-tagged Stat3 and 
Myc-tagged GRIM-19, or control plasmids. The cell lysates were immunoprecipitated 
with anti-Myc antibody, and subjected to Western blotting analysis to detect bound 
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Stat3 using anti-Flag antibody. As shown in Figure 3.1B, Stat3 was detected in 
anti-Myc immunoprecipitates when GRIM-19, but not the control plasmid, was 
co-transfected (top left panel). A reciprocal immunoprecipitation/blotting experiment 
also showed GRIM-19 co-precipitating with Stat3 (top right panel).  
Next, Flag-tagged Stat3 coiled-coil domain (Stat3-4H) and Myc-tagged GRIM-19, 
or control plasmids were cotransfected into COS-1 cells, and immunoprecipitation was 
performed using anti-Myc antibody. The results indicate that, consistent with the 
findings in yeast, Stat3 coiled-coil domain alone also interacts with GRIM-19 in 
mammalian cells (Figure 3.1C).  
To prove that the association between Stat3 and GRIM-19 is direct, in vitro GST 
pull-down assay was performed using the bacterially produced GST-GRIM-19 fusion 
protein and the baculovirus-produced Stat3 protein from insect cells (Zhang et al., 
2000). GST or GST-GRIM-19 was incubated with Stat3 protein, and subsequently 
immunoprecipitated with anti-GST antibody. The precipitates were subjected to 
Western blotting with anti-Stat3 antibody (Figure 3.1D, upper panel), and the 
associated Stat3 was only detected when incubated with GST-GRIM-19 fusion, but not 
GST protein alone, suggesting a specific direct interaction between Stat3 and 
GRIM-19 in vitro. 
 
3.3 Physiological association of endogenous Stat3 and GRIM-19 in various cell 
types 
To study the possible physiological significance, we investigated the interaction  















Figure 3.1.  Interaction of Stat3 and GRIM-19.  
(A) Confirmation of the interaction of Stat3-4H and GRIM-19 in Yeast. Yeast strain 
AH109 was transformed with various combinations of plasmids (pGBKT7: plasmid 
containing GAL4 DNA binding domain, pACT2: plasmid with GAL4 activation domain, 
pGBKT7-ST3-4H; ST3-4H fused to the GAL4 DNA binding domain, and pACT3-GRIM-
19: GRIM-19 fused to the GAL4 activation domain). The transformed cells were selected 
on plates containing selection medium SD-glucose-(-Trp, -Leu) lacking the indicated 
amino acids, then streaked onto the SD-glucose-(-Trp, -Leu) and SD-glucose-(-Trp, -Leu, 
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(B) Association of Stat3 and GRIM-19 in transfected cells. COS-1 cells were 
transfected with Flag-tagged Stat3 and/or Myc-tagged GRIM-19. The cell lysates were 
immunoprecipitated with either anti-Myc or anti-Flag as indicated. The precipitates were 
fractionated by 12.5% SDS−PAGE, and blotted with anti-Flag (top left panel) or anti-Myc 
(top right panel). The respective co-precipitated Stat3 and GRIM-19 are indicated. The 
blots were stripped and re-probed with anti-Myc or anti-Flag (middle panels). Total cell 
lysates (TCL) were subjected to Western blot analysis with anti-Flag or anti-Myc to 
monitor the expression of Stat3 and GRIM-19 (bottom panels). The molecular mass 
markers are indicated in kDa (Bio-Rad Laboratories). The strong bands are the heavy 





























(C) Interaction of the coiled-coil domain of Stat3 and GRIM-19 in mammalian cells. 
COS-1 cells were transfected with the truncation mutant of Stat3 expressing four α-helices 
of the coiled-coil domain (Flag-ST3-4H) in the absence (-) or presence (+) of GRIM-19. 
The cells were treated with proteasome inhibitor, MG132 (30 μM), for 20 h before 
harvesting and the immunoprecipitation/blot (IP/Blot) experiments were performed. The 
deletion mutant ST-4H (Stat3 coiled-coil domain) protein is indicated. The expression of 
ST3-4H was examined in the TCL by Western blot (bottom panel). 
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(D) Direct interaction of Stat3 and GRIM-19 in vitro. GRIM-19 was cloned into 
pGEX-6p-1 vector and transformed into E. coli strain BL21DE3. The fusion protein was 
induced by 1 mM IPTG and the bacteria were lysed by sonication. Most of the fusion 
proteins produced were found in inclusion bodies and dissolved with 6.4 M urea. The 
solution was centrifuged and the supernatant was dialyzed against PBS. GST (lane 1) or 
the refolded GST-GRIM-19 (lane 2) was incubated with the baculovirus-produced Stat3. 
GST-GRIM-19 and GST were immunoprecipitated with anti-GST antibody, and the 
associated Stat3 was detected by immunoblotting with anti-Stat3 antibody (upper panel). 
The blot was re-probed with anti-GST antibody (lower panel). 
GST-   
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between endogenous Stat3 and GRIM-19 in mammalian cells. For this purpose, a 
rabbit antiserum against bacterially produced mouse GRIM-19 was generated by Dr G. 
Huang in our laboratory. The antibody specifically recognizes GST−GRIM-19 
expressed in COS-1 cells (Figure 3.2A). A protein with a molecular mass of ~18 kDa 
that was likely to be endogenous GRIM-19 in COS-1 cells was also detectable. In 
contrast, the pre-immune serum and the anti-GRIM-19 antibody pre-absorbed with 
recombinant GRIM-19 protein reacted with neither the endogenous nor the transfected 
GRIM-19. The GRIM-19 antibody also recognized endogenous human GRIM-19 in a 
breast cancer cell line, MCF-7, induced by a combination of IFN-β and RA treatment 
for various durations (Figure 3.2B), which exhibited similar kinetics to those 
previously reported (Angell et al., 2000). 
We then evaluated the interaction of Stat3 and GRIM-19 in MCF-7 cells. A low 
amount of Stat3 was co-immunoprecipitated with GRIM-19 in unstimulated cells 
(Figure 3.2C, lane 2), which was increased in IFN-β/RA-treated cells (lane 3). As a 
control, Stat3 did not co-immunoprecipitate with pre-immune serum (lane 1). Since 
GRIM-19 is expressed at a high level in skeletal muscle (Angell et al., 2000) and rat 
brain (data not shown), we further tested the association between endogenous 
GRIM-19 and Stat3 in mouse myoblast C2C12, human neuroblastoma SH-SY5Y and 
rat pheochromocytoma PC-12 cells. Stat3 co-immunoprecipitated with GRIM-19 
antiserum, but not pre-immune serum, in these cell lines (Figure 3.2C). These data 
indicate a physiological interaction between GRIM-19 and Stat3, which is not limited 
to human breast cancer cells but extends to other cell types and species. 












































Figure 3.2 Association of endogenous Stat3 and GRIM-19.  
(A) Evaluation of the GRIM-19 antibody. COS-1 cells were transfected with GST vector 
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Western blot analysis using pre-immune serum (PI, lanes 1 and 2), purified GRIM-19 
antibody (α-G-19; lanes 3 and 4) or GRIM-19 antibody pre-absorbed by bacterially 
produced GRIM-19 (lanes 5 and 6). (B) Western blot analysis of endogenous GRIM-19 in 
MCF-7 cells induced by IFN-β (500 U/ml) and RA (1 μM) for various times. The blot was 
re-probed with anti-β-actin as a control. (C) Association of endogenous Stat3 and GRIM-
19 in various cell types. MCF-7 cells were left untreated (lanes 1 and 2) or treated with 
IFN-β and RA for 48 h (lane 3). C2C12, SH-SY5Y and PC12 cells were grown under 
normal conditions. Cell lysates were incubated with either pre-immune serum (PI) or anti-
GRIM-19 (α-G-19) as labeled on top of the figures, and blotted with anti-Stat3 (upper 
panels). The blots were stripped and re-probed with anti-GRIM-19 (lower panels). 
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3.4 GRIM-19 does not associate with Stat1 and Stat5a 
The interaction between GRIM-19 and other Stat proteins was also examined. In 
contrast to Stat3, only trace amounts of Stat1 co-precipitated with GST−GRIM-19, 
whereas no association was detected between Stat5a and GRIM-19 in the GST 
pull-down experiment (Figure 3.3). In agreement with these results, no co-localization 
between GRIM-19 and Stat1 or Stat5a in cells was observed by immunofluorescence 
staining (see Figure 3.6B). These data suggested a specific link between GRIM-19 and 
Stat3. 
 
3.5 Mapping the regions that mediate the interaction between Stat3 and GRIM-19 
Stat3 contains several functional domains, as illustrated in Figure 3.4A (Becker et al., 
1998). In addition to the coiled-coil domain, other regions may also interact with 
GRIM-19. To explore this possibility, we used a series of Flag-tagged Stat3 truncation 
mutants generated previously in our laboratory (Zhang et al., 2002), which were 
co-transfected with GST-tagged GRIM-19. GST pull-down experiments indicated that 
GST-GRIM-19 associated with ST3-DB.LK, a Stat3 protein consisting of the 
DNA-binding and linker domains, but not with the N-terminal domain, the SH2 
domain or the C-terminal domain (Figure 3.4B). We further delineated the interacting 
domains by subcloning the individual DNA-binding domain and linker domain. The 
immunoprecipitation/ blotting experiment results showed that both domains were able 
to interact with GRIM-19 (Figure 3.4C). 
There is little structural information available for GRIM-19. To determine the  























Figure 3.3. Lack of interaction between GRIM-19 and other STAT proteins.  
Flag-tagged Stat1, 3 or 5a were co-transfected with GST or GST−GRIM-19 expression 
plasmids in COS-1 cells. The cell lysates were incubated with glutathione−Sepharose 
beads. The bound proteins were subjected to Western blot analysis with anti-Flag antibody 
(top panel). Precipitated GST and GST−GRIM-19 were blotted with anti-GST (middle 
panel). The expression of Stat1 (lanes 1 and 2), Stat3 (lanes 3 and 4) and Stat5a (lanes 5 
and 6) was determined with anti-Flag (bottom panel). 
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Figure 3.4. Mapping of the interacting regions of Stat3 and GRIM-19. 
(A) Schematic diagram of Stat3 indicating its functional domains specified according to 
the amino acids (aa). (B and C) Identification of interacting regions of Stat3. (B) COS-1 
cells were co-transfected with GST−GRIM-19 and Flag-tagged Stat3, either full-length 
(ST3-FL) or deletion mutants containing the N-domain (ND), DNA-binding and linker 
domains (DB.LK), SH2 domain or C-terminal domain (CT) as labeled on top of the 
figure. GST pull-down was performed, and the associated proteins were probed with anti-
Flag antibody (top panel). The middle panel indicates the GST−GRIM-19 that has been 
pulled-down by beads. The bottom panel shows the expression of the Flag-tagged Stat3 
constructs in total cell lysates. (C) For further mapping, Flag-tagged Stat3 mutant 
expressing either the linker domain (ST3-LK) or the DNA-binding domain (ST3-DB) 
was co-transfected with Myc-tagged GRIM-19 (+) or vector alone (-). The cell lysates 
were immunoprecipitated with anti-Myc and blotted with anti-Flag. The blot was stripped 
and re-blotted with anti-Myc (middle panel). Expression of ST3-LK and ST3-DB in total 
cell lysate (TCL) was examined by western blot analysis using anti-Flag (bottom panel). 































(D) Identification of interacting regions on GRIM-19. GST−GRIM-19 fusions 
harboring various segments of GRIM-19 (as indicated by the aa numbers) were co-
transfected with Flag-Stat3, and GST pull-down experiments were performed. The top 
panels show Stat3 co-precipitated with GST−GRIM-19. The middle panels show GST and 
the various GST−GRIM-19 fusion proteins pulled-down by glutathione−Sepharose beads, 
and the bottom panels indicate the expression of Stat3. The schematic diagram of GRIM-
19 is displayed on top of the figure, in which the interacting region (aa 36−72) of GRIM-
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interacting region of GRIM-19, several deletion mutations were randomly selected 
(amino acids 1−35, 1−101, 36−144, 73−144 and 102−144). GST fusion constructs 
containing these fragments were generated and co-transfected with Flag-tagged Stat3. 
The GST pull-down experiments indicated that Stat3 co-precipitated with full-length 
GST−GRIM- 191−144, GST−GRIM-191−101 and GST−GRIM-1936−144, suggesting that 
amino acids 36−101 in the middle of the protein harbor the interacting region. Further 
subcloning revealed that the section containing amino acids 36−72 mediated its 
association with wild-type Stat3 (Figure 3.4D) and the individual coiled-coil domain, 
DNA-binding domain and linker domain (data not shown). 
 
3.6 Cellular Localization of GRIM-19 
To characterize further the nature of the interaction between Stat3 and GRIM-19, we 
attempted to determine where this interaction occurs. The cellular localization of 
Myc-tagged human GRIM-19 was first analyzed by immunofluorescence in MCF-7 
cells. GRIM-19 was detected exclusively in the cytoplasm as punctate structures, 
which co-localized with two endogenous mitochondrial proteins, cytochrome oxidase 
subunit IV (COX) (Figure 3.5A) and cytochrome c (data not shown), but did not 
co-localize with EEA1 or CD63, markers for early endosome and late 
endosome/lysosome, respectively (Metzelaar et al., 1991; Mu et al., 1995). Similar 
results were obtained with either a Myc-tagged mouse GRIM-19 or a hemagglutinin 
(HA)-tagged human GRIM-19 in MCF-7, as well as in COS-1 cells (data not shown). 
To determine further the region for mitochondrial localization, Myc-tagged truncation 
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mutants were generated. GRIM-191−101, deleting the C-terminus of the full-length 
GRIM-19, showed punctate staining in the cytoplasm which co-localized with COX, 
whereas the mutant GRIM-1936−144, deleting the N-terminal domain, or GRIM-1936−101, 
containing the middle region of GRIM-19, exhibited a loss of mitochondrial 
localization (Figure 3.5B). Therefore, the N-terminus of GRIM-19 seems to harbor the 
mitochondrial localization sequence. 
We further analyzed the cellular localization of endogenous GRIM-19 in MCF-7 
cells using the purified GRIM-19 antibody. Weak staining of GRIM-19 was observed 
as punctate structures predominantly in the cytoplasm of untreated cells, which was 
intensified as small dot-like structures aggregating at the perinuclear region and 
coincided with COX protein upon IFN-β/RA treatment. In addition, a weak staining 
was also noticeable in the nucleus, which was slightly increased after the treatment 
(Figure 3.5C). To verify these results further, the MCF-7 cells were fractionated into 
cytoplasmic, mitochondrial and nuclear portions, and GRIM-19 expression in these 
fractions was determined in the absence or presence of IFN-β/RA treatment. 
Consistent with the immunofluorescence results, the majority of GRIM-19 was 
detected in the mitochondrial fraction, which was increased upon IFN-β/RA treatment. 
A trace amount was detected in the nuclear portion, which was also increased slightly 
after treatment (Figure 3.5D). Together, these results suggest that in MCF-7 cells, 
GRIM-19 protein seems to be localized primarily in the mitochondria, with a minor 
distribution in the nucleus. (Some immunofluorescence data in section 3.6 and 3.7 are 
kindly provided by Ms. J. Ma in our laboratory, all of which has been indicated in the  










































Figure 3.5. Cellular localization of GRIM-19 in MCF-7 cells.  
(A and B) Cells were transfected with Myc-tagged GRIM-19 in (A), or the truncation 
mutants in (B). Cells were fixed and incubated with polyclonal anti-Myc, and stained with 
Cy3-conjugated anti-rabbit IgG (Amersham Pharmacia Biotech). The localization of the 
GRIM-19 protein was visualized using a laser scanning confocal microscope. Endogenous 
COX, EEA1 and CD63 were detected with monoclonal anti-COX subunit IV, anti-EEA1 
A GRIM-19        COX           merge 
GRIM-19        CD63          merge 
GRIM-19        EEA1          merge 
B G-191-101        COX           merge 
G-1936-144       COX           merge 
G-1936-101       COX           merge 
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or anti-CD63 antibody, as labeled, followed by staining with FITC-conjugated anti-mouse 































(C) Expression of endogenous GRIM-19 in MCF-7 cells, either untreated or treated with 
IFN-β and RA for 72 h, was detected with purified rabbit anti-GRIM-19 serum, followed 
by Cy3-conjugated anti-rabbit IgG. (D) MCF-7 cells were fractionated using the ApoAlert 
Cell Fractionation Kit from Clontech following the manufacturer's instructions. The 
fractions were collected and subjected to Western blot analysis with antibodies, as 
indicated. 
(Ms J. Ma in our laboratory kindly provided the immunofluorescence data for Figure 3.5A 
and 3.5C) 
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corresponding figure legends.) 
 
3.7 Co-localization of GRIM-19 with Stat3 and its effect on Stat3 nuclear 
translocation 
The cellular localization of Stat3 and its interaction with GRIM-19 were examined 
subsequently. We observed that in unstimulated MCF-7 cells, Stat3 protein was 
distributed in the cytoplasm and the nucleus, which was in agreement with a previous 
report in other cell lines (Meyer et al., 2002). Surprisingly, in cells co-expressing 
GRIM-19, the majority of Stat3 disappeared from the original locations and formed the 
dot-like dense structures at the nuclear periphery, which co-localized with GRIM-19 
(Figure 3.6A). Since a few domains of Stat3 can interact with GRIM-19, we next 
investigated their co-localization with GRIM-19. Strikingly, the Stat3 mutant 
containing the N-terminal and the coiled-coil domains (ST3-ND.4H) was detected 
exclusively in the nucleus, and co-expression with GRIM-19 resulted in its 
disappearance from the nucleus, and formation of perinuclear aggregates similar to 
those observed in full-length Stat3. On the other hand, Stat3 proteins containing either 
the DNA-binding and linker domains (ST3-DB.LK), or the SH2 and C-terminal 
domains (ST3-SH2.CT) localized mainly in the cytoplasm. Their cellular locations 
were not affected by GRIM-19, and no aggregates were detected, although 
ST3-DB.LK seemed to be co-localized with GRIM-19 (Figure 3.6A), which was 
consistent with its ability to interact with GRIM-19 (Figure 3.4B). These results 
indicated that the N-terminal and coiled-coil domains of Stat3 may harbor a nuclear 
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localization signal (NLS), which has been identified later (Ma et al., 2003), and the 
coiled-coil domain is required for the formation of the unique perinuclear aggregates 
which may block Stat3 nuclear translocation. 
We further addressed this issue in COS-1 cells stimulated by EGF. In untreated 
cells, the majority of Stat3 was localized in the cytoplasm, and was translocated into 
the nucleus in response to EGF in the absence of GRIM-19. However, it formed 
perinuclear aggregates in the presence of GRIM-19, and co-localized with GRIM-19. 
Stat1 and Stat5a were also localized in the nucleus in response to EGF stimulation. 
However, they remained in the nucleus and did not co-localize or form aggregates with 
the co-transfected GRIM-19 (Figure 3.6B). 
We further confirmed these results with cellular fractionation in COS-1 cells. A 
small amount of Stat3 was present in the nucleus in untreated cells, which was 
increased upon EGF treatment. However, the amount of nuclear Stat3 decreased when 
co-transfected with GRIM-19 in both cases, whereas expression of the nuclear protein 
poly(ADP-ribose) polymerase (PARP) (D'Amours et al., 1999) remained constant 
(Figure 3.6C). To study the physiological effect of GRIM-19, the nuclear translocation 
of endogenous Stat3 was evaluated further in HepG2 cells stimulated by IL-6. Stat3 
translocated into the nucleus after IL-6 stimulation. However, the amount of nuclear 
Stat3 decreased upon treatment with IFN-β/RA (Figure 3.6D, top panel, compare lanes 
2 and 4), which correlated with a concomitant increase in endogenous GRIM-19 
expression (bottom panel), suggesting a physiological role for GRIM-19 in the 
regulation of Stat3 nuclear localization. 














































Figure 3.6. Co-localization of Stat3 with GRIM-19. (A) MCF-7 cells were transfected 
with Flag-tagged Stat3 or truncation mutants with or without Myc-tagged GRIM-19. The 
distribution of Stat3 or GRIM-19 was detected using monoclonal anti-Flag or polyclonal 
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anti-Myc as primary antibody, followed by Cy3-conjugated anti-mouse IgG (Sigma) or 
FITC-conjugated anti-rabbit IgG. (B) COS-1 cell were transfected with Flag-tagged Stat3, 
Stat1 or Stat5a in the absence (-) or presence of Myc-GRIM-19. The cells were induced by 
EGF for 15 min and the cellular localization of Stat proteins and GRIM-19 was detected 




































(C) The effect of GRIM-19 on Stat3 nuclear translocation. COS-1 cells were 
transfected with vector, GRIM-19 and/or Stat3. The cells were untreated or induced with 
EGF for 15 min. Cells were lysed and fractionated into cytoplasmic and nuclear portions 
as described previously (Jain et al., 1999). The nuclear distribution of Stat3 was examined 
by western blotting. The blot was re-blotted with anti-PARP antibody as a control. The 
expression of GRIM-19 in the cytoplasmic portion was detected by blotting with anti-Myc 
antibody. (D) Induction of endogenous GRIM-19 reduced IL-6-stimulated Stat3 nuclear 
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translocation. HepG2 cells were either left untreated or treated with IFN-β and RA for 48 
h followed by IL-6 induction for 15 min. Nuclear Stat3 was measured with anti-Stat3 as 
described in (C). 
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3.8 GRIM-19 represses Stat3-dependent transcription 
The co-localization and impaired nuclear translocation of Stat3 by GRIM-19 may 
result in negative regulation of Stat3 transcriptional activity. To confirm this, we next 
investigated whether GRIM-19 affected Stat3 transcriptional activity using a reporter 
gene containing three copies of hSIE, the high affinity binding site of Stat3, upstream 
of a CAT gene. A basal level of transcriptional activity was detected in unstimulated 
COS-1 cells, which was enhanced by EGF treatment. However, ~86% inhibition of 
this EGF-induced activity was observed with co-transfection of GRIM-19. The basal 
activity in the unstimulated cells was also decreased, to a lesser extent (Figure 3.7A). 
The effect of GRIM-19 was also examined in MCF-7 cells. Consistent with its nuclear 
localization in MCF-7 cells, a constitutive transcriptional activity of Stat3 was 
observed without any stimulation. However, co-expression of GRIM-19 resulted in an 
~85% inhibition of this activity. Induction of endogenous GRIM-19 by IFN-β and RA 
also decreased the constitutively activated transcriptional activity of Stat3 (~15%). 
This inhibition was repressed further to 91% by co-transfected GRIM-19 (Figure 3.7B). 
The repression by GRIM-19 was delineated further with the GRIM-19 mutants. The 
C-terminal deletion mutant GRIM-191−101, but not the N-terminal deletion mutant 
GRIM-1936−144, showed inhibition of Stat3 activity (Figure 3.7C). These data indicate 
that GRIM-19 represses Stat3 transcriptional activity, and this suppression ability is 
correlated with its mitochondrial localization. 
We further examined the effect of GRIM-19 on a Stat3 target gene, 
α2-macroglobulin (α2-M), one of the acute-phase proteins that are upregulated via 
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activation of Stat3 in IL-6-stimulated hepatocytes (Heinrich et al., 1998). HepG2 cells 
were transfected with an α2-M promoter−luciferase gene construct (Terstegen et al., 
2001) or a control plasmid in the presence or absence of GRIM-19. The cells were 
either left untreated or treated with IL-6. IL-6 resulted in high transcriptional activity 
of α2-M which was inhibited up to 70% by co-expression of GRIM-19. The basal 
activity in unstimulated cells was also repressed by GRIM-19 (Figure 3.7D). The 
IL-6-inducible α2-M promoter activity was also suppressed by treatment of the cells 
with IFN-β and RA, which was partially restored by introduction of a plasmid 
encoding an antisense GRIM-19 (Figure 3.7E). These data provide evidence that 
GRIM-19 represses Stat3-dependent target gene expression. 
 
3.9 GRIM-19 inhibits cell growth 
Stat3 is constitutively activated in v-Src-transformed cells (Yu et al., 1995; Cao et al., 
1996), and is essential for Src-mediated cell transformation (Bromberg et al., 1998; 
Turkson et al., 1998). To determine whether the negative regulation by GRIM-19 of 
Stat3 activity leads to a physiological consequence, we tested the effect of GRIM-19 
on the oncogenic function of Stat3 by examining cell proliferation. We found that cell 
growth of v-Src-transformed cells was inhibited by GRIM-19, either introduced 
exogenously by transfection or induced by IFN-β and RA, in a dose-dependent manner 
(Figure 3.8A). Furthermore, inhibition was also observed in a stable cell line that 
expresses an active form of Stat3 mutant, ST3-ΔN (Zhang et al., 2000). These cells 
proliferated ~25% more rapidly than the control cells, which can be inhibited by  
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Figure 3.7. Effect of GRIM-19 on the transcriptional activity of Stat3 and target gene 
expression. (A−C) COS-1 and MCF-7 cells were co-transfected with a vector control, 
Stat3 and/or GRIM-19, the truncation mutant GRIM-191−101 or GRIM-1936−144 together 
with a reporter plasmid pSIE-CAT and pCMV-β-gal. Cells were either left uninduced or 
stimulated with EGF (100 ng/ml) for 6 h in (A) or IFN-β and RA for 24 h in (B). Cells 
were harvested and the lysates used for CAT assays were normalized with equivalent β-
galactosidase activity, and CAT assay was performed. The averages of the relative CAT 
activities from three independent experiments are shown in the graph, with error bars 






















































































(D and E) GRIM-19 inhibits α2-macroglobulin report expression. HepG2 cells were 
co-transfected with pGL3-α2M-215luc or the empty luciferase vector (pGL3), GRIM-19, 
antisense GRIM-19 plasmid or the empty vector as labeled, together with pRL-TK for 
normalization. Cells were left non-stimulated (-) or were induced overnight with IL-6 (+). 
Relative luciferase values are indicated, which represent the means of six samples with the 
standard deviation given as the error bars. Cells were pre-treated for 55 h with IFN-β (500 
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Figure 3.8. Inhibition of Stat3-mediated cell proliferation by GRIM-19.  
(A) v-Src-transformed NIH-3T3 cells were grown in a 96-well micro titer plate and 
transfected with two doses of GRIM-19 (low, 0.1 μg; or high, 0.3 μg) or empty vector (-, 
0.3 μg) (left panel), or treated with various concentrations of IFN-β and RA for 48 h (right 
panel). The cell proliferation assay was performed using the Cell Proliferation Kit II 
(XTT). Spectrophotometric absorbance was measured at 485 nm wavelength, and 
reference wavelength 650 nm, which presents a mean of three samples, with the standard 
deviation given as the error bars. (B) NIH-3T3 cells with stable expression of ST3-ΔN 
(bar with grid) or control vector (empty bar) were transfected with control vector (-) or 
with 0.1 μg of GRIM-19 (+), and cell proliferation was measured as described in (A). 
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GRIM-19, whereas GRIM-19 showed little effect on control cells (Figure 3.8B).  
 
3.10 Discussions 
GRIM-19 as a novel negative regulator of Stat3  
STAT proteins play central roles in transducing signals from cytokine receptors to the 
nucleus in a rapid and transient manner, and STAT activities are switched off 
subsequently via several negative regulatory mechanisms (O'Shea et al., 2002), 
including dephosphorylation of the critical tyrosine residue of STATs by specific 
tyrosine phosphatase (Haspel et al., 1996), or degradation of activated STATs via the 
ubiquitin-proteasome pathway (Kim and Maniatis, 1996). In addition, two families of 
negative regulators for JAK-STAT pathways have been identified: the SOCS family 
proteins that inhibit the JAK-STAT signaling in a negative feedback loop (Yasukawa et 
al., 2000), and the constitutively expressed PIAS proteins that selectively inhibit the 
DNA binding activities of tyrosine-phosphorylated STATs (Chung et al., 1997). 
In this thesis I have identified GRIM-19 as an interacting protein of Stat3 in 
different mammalian cell types and species. GRIM-19 suppresses Stat3 transcriptional 
activity and its target gene expression. Furthermore, the interaction of GRIM-19 is 
specific for Stat3, but not for Stat1 or Stat5a. These data suggest that GRIM-19 
functions as a novel negative regulator of Stat3. To explore the mechanism of the 
negative effect of GRIM-19 further, tyrosine phosphorylation of Stat3 stimulated by 
EGF was examined, and no obvious change was observed in the presence of GRIM-19 
(data not shown). We subsequently analyzed the cellular localization of these two 
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proteins and the immunofluorescence data further verified the physical interaction 
between Stat3 and GRIM-19 by showing their co-localization at the perinuclear region 
of the cells. The results also revealed that such co-localization actually appeared in 
unique punctuate-like aggregates distributed around the nucleus (Figure 3.6 A, B). 
Although the nature of the aggregates remains elusive, these unique structures partially 
co-localized with the mitochondria maker COX but not markers for other cellular 
organelles, and may represent mitochondrial aggregation as examined by electron 
microscopy (A. Hao and X. Cao, unpublished data). Further immunoprecipitation 
studies using various subcellular fractions also suggested that the interaction of 
endogenous Stat3 and GRIM-19 mainly occurs in the mitochondria (data not shown). 
Although Stat3 is basically regarded as a cytoplasmic protein in the unstimulated cells, 
we have detected certain amounts of Stat3 in the mitochondrial portion, which implies 
a possible mitochondrial presence of Stat3 that has not been reported before (Lufei et 
al., unpublished data). In addition, subsets of Stat3 have been observed in different 
cellular compartments such as plasma membrane rafts, early endosomes (Sehgal et al., 
2002; Guo et al., 2002; Shah et al., 2002; Shah et al., 2005) and focal adhesions 
(Silver et al., 2004). Recently Stat3 has also been found to localize in the Golgi 
apparatus (D. Ng and X. Cao, manuscript in preparation), and association of Stat3 to 
microtubule-bound protein stathmin can stabilize the microtubule network (Ng et al., 
2006), which suggests that the actual cellular distribution and function of Stat3 is much 
more complicated than previously thought. One of the possible consequences and the 
physiological roles of this aggregate formation is preventing Stat3 from entering the 
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nucleus. And it remains an interesting topic to elucidate the underlying mechanism by 
which GRIM-19 recruits the activated Stat3, which is supposed to enter the nucleus, 
into the unique mitochondrial aggregates. In conclusion, our data suggest that 
GRIM-19 is a novel type of inhibitor that specifically inhibits Stat3 activity by 
blocking its nuclear translocation. 
 
Cellular localization of GRIM-19 
The exact cellular localization of GRIM-19 remained controversial during our study of 
the interaction between Stat3 and GRIM-19. Although it was initially declared as a 
nuclear protein due to the predominant GRIM-19 immunostaining within the nucleus 
of IFN-β/ RA-treated HeLa cells (Angell et al., 2000), biochemical protein- 
purification data from both bovine and human heart implied a possible mitochondrial 
localization of GRIM-19 by showing its association with the mitochondrial electron 
transport complex I (Fearnley et al., 2001; Murray et al., 2003). In our study, both 
transfected human and mouse GRIM-19 were found localized predominantly in the 
mitochondria in MCF-7 and COS-1 cells, which provided direct evidence for the 
subcellular localization of GRIM-19, and this was further supported by the 
immunofluorescence data of the endogenous GRIM-19 in MCF-7 cells. These 
experimental findings were later verified by the study of GRIM-19 knockout mice, 
which revealed a critical role of GRIM-19 protein in maintaining the mitochondrial 
complex I integrity and electron transport activity (Huang et al., 2004). Direct 
interactions between GRIM-19 and various mitochondrial complex I subunits were 
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subsequently identified, and the GRIM-19 functional domain responsible for the 
complex I assembly was also delineated (H. Lu and X. Cao, unpublished data). 
Therefore the initial nuclear staining of GRIM-19 reported by Angell et al. appears to 
be an artifact probably resulted from the nonspecific binding of the anti-GRIM-19 
antibody used in that experiment. Similar to our results, following our publication 
Zhang et al. from the same group also reported GRIM-19 as an interacting protein of 
Stat3 that negatively regulates Stat3 transactivation (Zhang et al., 2003). However, 
they did not provide explanations on how GRIM-19 suppresses Stat3 activity or where 
the Stat3-GRIM-19 interaction happens. Since GRIM-19 is now demonstrated to be a 
mitochondrial protein, its role in suppressing Stat3 activity within the nucleus is 
unlikely. In addition, our results clearly demonstrated that the nuclear translocation of 
endogenous Stat3 was impaired with INF-β/RA-induced endogenous GRIM-19 
expression (Figure 3.6D). Therefore it is unlikely that the inhibition of Stat3 nuclear 
translocation by GRIM-19 is just due to overexpression. 
 
Regulatory roles of the Stat3 coiled-coil domain 
In order to examine the nature of the interaction, we defined the interaction regions in 
both Stat3 and GRIM-19. The results showed that in addition to the coiled-coil domain, 
the DNA-binding and linker domains of Stat3 are also capable of binding to GRIM-19. 
However, further study shows that among these several GRIM-19 interacting domains, 
only the coiled-coil region, but not the DNA-binding domain or linker domain, is 
involved in the formation of aggregates with GRIM-19 (Figure 3.6A), which exerts a 
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negative regulation on Stat3 nuclear translocation. These data suggest that interaction 
of GRIM-19 with the coiled-coil domain may actually play a physiological role. 
Surprisingly, we also found that the truncation mutant of Stat3 containing the 
N-terminal domain and the coiled-coil domain was constitutively localized in the 
nucleus (Figure 3.6A, the first small panel in the second row), which hints that a 
potential regulatory signal for Stat3 nuclear translocation may reside within these 
domains. This observation led to the later identification of an essential nuclear import 
element for the IL-6- and EGF-induced Stat3 nuclear translocation, which is localized 
in the second α-helix region of the coiled-coil domain (Ma et al., 2003) and probably 
mediates Stat3-importin α5 interaction (Ma and Cao, 2005). Taking all the evidences 
together, we think that the negative effect of GRIM-19 on Stat3 nuclear translocation is 
likely due to the interference with the interaction of Stat3 and its corresponding 
importin molecules, by masking the Arg214/215 nuclear import element in the 
coil-coiled domain through the binding of GRIM-19.  
As introduced before, the coiled-coil domain containing four antiparallel α-helices 
has often been inferred to be involved in protein-protein interaction (Becker et al., 
1998; Chen et al., 1998). Various transcription factors and coactivators, such as p48, an 
IFN response factor (IRF) family protein, c-Jun, and Nmi have been found to interact 
with Stat3 through this domain and therefore regulate Stat3 transcriptional activity 
(Horvath et al., 1996; Zhang et al., 1999; Zhu et al., 1999). This region is also 
involved in an interdomain interaction which regulates Stat3 SH2 domain-mediated 
binding activity to the cytokine receptors (Zhang et al., 2000; Zhang et al., 2002). In 
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this study, we provide evidence for new roles of the coiled-coil domain, by showing it 
regulating Stat3 nuclear translocation and mediating GRIM-19 binding that inhibits 
Stat3 transactivation. Collectively, these data indicate that the coiled-coil domain 
actively participates in the regulation of STAT activities in multiple processes by 
interacting with distinct proteins. 
 
GRIM-19 and Stat3 in cancer 
Stat3 is found to be constitutively activated in cells transformed by different oncogenes, 
such as v-Src and v-abl (Danial et al., 1995; Yu et al., 1995; Cao et al., 1996), as well 
as in various cancers including multiple myeloma, breast cancer, and head and neck 
cancer (Bowman et al., 2000). Furthermore, expression of a constitutively dimerized 
Stat3 (Stat3-C) is oncogenic (Bromberg et al., 1999). Constitutively activated Stat3 
elevates the expression of its target genes that are key regulators in the control of 
proliferation, cell cycle and programmed cell death, all of which may contribute to 
oncogenesis (Bowman et al., 2000). In contrast, a combination of IFN-β and RA 
inhibits cell growth and promotes cell death in cancer cells which does not involve 
known IFN-stimulated genes, such as RnaseL and protein kinase R, or a change of the 
level of p53 and the phosphorylation status of pRb (Hofman et al., 1998). It is obvious 
that Stat3 and GRIM-19 play opposite roles in cell growth, transformation and cell 
death. Our finding that GRIM-19 is a negative regulator of Stat3 is consistent with this 
observation. In this report, we have shown that GRIM-19 inhibits Stat3-mediated cell 
proliferation in both Src-transformed cells and Stat3-ΔN-stable-expressing cells 
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(Figure 3.8).  The next step will be to study whether GRIM-19 suppresses Stat3- 
mediated cell transformation, and the mechanisms involved. It will also be interesting 
to investigate whether GRIM-19 exerts its death effect by repressing Stat3 activity via 
inhibition of the expression of Stat3-regulated anti-apoptotic genes. 












Pin1 Positively Regulates Stat3 Activity via 
Serine Phosphorylation Site 
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Peptidyl-prolyl isomerase Pin1 specifically targets the phosphor-Ser/Thr-Pro motifs of 
various phosphoproteins. For Stat3, a conserved serine 727 residue within the 
C-terminal of the protein undergoes phosphorylation upon induction by various 
cytokines, which is important to the regulation of Stat3 transcriptional activity. This 
serine residue is immediately followed by a proline, which complies with the pSer-Pro 
element for Pin1 recognition. 
 
4.1 Association of Stat3 and Pin1 in vivo and in vitro 
To study the possible in vivo interaction of Stat3 and Pin1 in mammalian cells, COS-1 
cells expressing very low levels of endogenous Stat3 were transfected with 
Flag-tagged Stat3 and Myc-tagged Pin1, or control plasmids respectively. The cells 
were either left untreated or stimulated with EGF for 20 min. Cell lysates were 
immunoprecipitated with anti-Myc antibody, and the precipitates were resolved in 
SDS-PAGE and subjected to Western blotting analysis using anti-Flag antibody to 
detect the co-precipitated Stat3. As shown in Figure 4.1A, Stat3 was only detected in 
the immunoprecipitates from EGF-stimulated cells when Pin1, but not the control 
plasmid, was co-transfected (second lane of the top panel).  
Next we evaluated the interaction of endogenously expressing Stat3 and Pin1 in 
human cervical carcinoma HeLa cell line. HeLa cells were either left untreated or 
induced with oncostatin M (OSM) for 20 min. In order to determine the subcellular 
localization of the Stat3-Pin1 interaction, cells were harvested and nuclear extraction 
was performed to separate the nuclear fraction from the cytoplasm. Both the nuclear 
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and cytoplasmic fractions were subjected to immunoprecipitation with anti-Pin1 
antibody. Endogenous Stat3 was only co-immunoprecipitated with Pin1 in the nuclear 
portion of OSM stimulated cells (Figure 4.1B, second lane of top left panel), but not in 
the unstimulated cells (the forth lane, top left panel) nor the cytosolic portion (top right 
panel). As the control, Stat3 did not co-immunoprecipitate with normal rabbit IgG. 
These data suggest that Pin1 interacts physically with Stat3 in vivo, and such 
interaction only occurs in the nucleus upon cytokine stimulation. 
In order to further characterize the selective binding of Pin1 to the activated 
Stat3, GST-Pin1 fusion protein was produced in E. coli, and used in a GST pull-down 
assay against overexpressed flag-tagged Stat3. Since Pin1 only binds to the 
phosphoproteins, Stat3 and its S727A point mutant, in which the invariant Ser727 
residue was substituted with Ala and incompetent to phosphorylation, were 
overexpressed in PC3 cells that do not have endogenous Stat3. Only wild-type Stat3 
from the OSM-induced PC3 cells was detected in the precipitates after the GST 
pull-down assay, but not the serine phosphorylation-resistant S727A mutant (Figure 1C, 
top panel, compare lane 6 with lane 8), which indicates that the ligand-induced 
phosphorylation of Stat3 serine 727 residue in its C-terminal may play a crucial role in 
mediating the Pin1-Stat3 interaction. 
 
4.2 Pin1 promotes Stat3 transcriptional activity 
Because Pin1 specifically interacts with the ligand-activated form of Stat3 within the 
nucleus, we speculated that this binding may affect Stat3 transcriptional activity. 


















Figure 4.1.  Association of Stat3 and Pin1.  
(A) Interaction of Stat3 and Pin1 in vivo. COS-1 cells were transfected with 
Flag-tagged Stat3 and/or Myc-tagged Pin1, and either left untreated or stimulated with 
EGF (100 ng/ml) for 20 min. The cell lysates were immunoprecipitated with anti-Myc 
antibody and the precipitates were fractionated by SDS-PAGE, and blotted with 
anti-Flag (top panel). The blot was stripped and re-probed with anti-Myc (middle panel). 
Total cell lysates (TCL) were subjected to Western blot analysis with anti-Flag to 



















(B) Association of endogenous Stat3 and Pin1. HeLa cells were either left untreated 
or treated with OSM (10ng/ml) for 20 min. Cells were subjected to nuclear extraction 
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and both nuclear and cytoplasmic fractions were either incubated with normal IgG or 
anti-Pin1 antibody as labeled, and blotted with anti-Stat3 (top panels). The same blot 
was stripped and re-probed with anti-Pin1 (panels in the second row). The lysates of 
nucleus and cytoplasm portion were also directly probed with Stat3 and Pin1 
























(C). In vitro GST Pull-down assay. PC3 cells were transfected with Flag-tagged Stat3 
or Ser727Ala point mutant (S727A), and left untreated or induced with OSM (10ng/ml) 
for 20 min. The cell lysates were incubated with bacterially produced GST or 
GST-Pin1 fusion protein, followed by adding of the Glutathione beads. The 
precipitates from the pull-down test were immunoblotted with anti-flag (top panel) 
showing the Stat3, and re-probed with anti-GST (middle panel), with the GST and 
GST-Pin1 indicated. Western blot analysis of Stat3/S727A in total cell lysates was 
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To verify this possibility, we investigated the effects of Pin1 on Stat3-dependent 
transactivation using luciferase reporter assays. HepG2 cells were either transfected 
with the α2-macroglobulin (α2-M) promoter-luciferase or hSIE- luciferase reporter 
gene constructs in the presence or absence of overexpressed Myc-Pin1. Thymidine 
kinase promoter-dependent Renilla luciferase construct, pRL-TK was used in the 
experiments as a control for transfection efficiency. A low level of Stat3 basal 
transcriptional activity was detected in the unstimulated HepG2 cells, which was 
induced by IL-6 stimulation. Interestingly, the IL-6-induced Stat3 activity via the hSIE 
sequence was significantly enhanced with the overexpression of Pin1 (upper panel, 
Figure 4.2A), and such an increasing effect was also observed when using the reporter 
construct carrying the promoter sequence of the Stat3 target gene α2-macroglobulin, an 
IL-6-induced acute-phase protein (lower panel).  
We further investigated the endogenous Stat3 transcriptional activity in Pin1 
deficient MEFs (Pin1 KO) and the wild-type control (Pin1 WT) cells (Fujimor et al., 
1999). These two types of cells were transfected with the  hSIE-luciferase (left panel, 
Figure 4.2B) or α2-M promoter-luciferase reporter gene constructs (right panel), and 
pRL-TK plasmid for normalization. In both cases, OSM-induced Stat3 transcriptional 
activity was seriously impaired in the Pin1 knockout MEFs compared to the wild-type 
control, which suggested an important role of Pin1 in the regulation of Stat3 
transactivation, and loss of Pin1 expression leading to the compromised Stat3 activity.  
Substitutions of several key residues of Pin1 abolish its phosphoprotein binding 
or enzymatic activities. The Y23A and W34A point mutants of Pin1 have been 
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reported to lose their phosphoSer/Thr-Pro motif binding ability (Lu et al., 1999), while 
the R68,69A double point mutant was suggested to be impaired in the PPIase 
enzymatic activity (Yaffe et al., 1997). Therefore, we transfected Pin1 and its 
functionally-defective point mutants back into the Pin1 knockout cells in order to 
check whether these mutations will affect the Pin1 upregulation effects on Stat3 
transcriptional activity. Introducing back wild-type Pin1 to Pin1 knockout MEFs 
restored the Stat3 transcriptional activity to a level similar as the wild-type control 
cells. In contrast, expression of all the three point mutants, Y23A, W34A and R68,69A, 
had no significant effects on the OSM-stimulated Stat3 transcriptional activity (Figure 
4.2C). Overexpression of wild-type Pin1 and the point mutants in HeLa cells also gave 
similar results as in the Pin1 KO MEFs (Data not shown). Taken the results together, 
overexpression of Pin1 promoted both IL-6- and OSM-induced Stat3 transcriptional 
activity in different cell types, but such effect was impaired upon the loss of Pin1 
phospho-protein binding capacity or its isomerase activity. 
 
4.3 Pin1 upregulates Stat3 transcriptional activity via the Ser727 residue of Stat3 
Serine phosphorylation of STAT has been reported to be required for the maximal 
STAT-dependent transcriptional activation (Wen et al., 1995; Decker and Kovarik, 
2000), and the invariant Ser727 residue involved in Stat3 serine phosphorylation is 
followed by a proline, which just fits the phosphoSer/Pro motif specifically recognized 
by Pin1 prolyl isomerase. In order to study the possible role of Ser727 residue in the 
Pin1-mediated upregulation of Stat3 transcriptional activity, we transfected COS-1  
































Figure 4.2. Pin1 promotes Stat3 transcriptional activity and target gene 
expression. 
(A) HepG2 cells were cotransfected with control vector, or Pin1 together with 
p-hSIE-m16luc (top panel) or pGL3-α2M-215luc (bottom panel) luciferase reporter 
plasmid and pRL-TK for normalization. Cells were either left uninduced or stimulated 
overnight with IL-6 (40 ng/ml). Cells were harvested in passive lysis buffer and the 
lysates were used for Luciferase assays. Relative luciferase activity values are 
indicated, which represent a mean from 3 samples with the standard deviation given as 
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(B) Stat3 activity is impaired in Pin1 deficient MEFs. Wild-type MEFs (Pin1 WT) 
and Pin1 knockout MEFs (Pin1 KO) were cotransfected with p-SIE-m16luc (left panel) 
or pGL3-α2M-215luc (right panel) reporter together with pRL-TK. Cells were either 
left untreated or stimulated overnight with OSM (10 ng/ml). (C) Pin1 WT and Pin1 
KO MEFs were cotransfected with control vector, Pin1 or three Pin1 point mutants, 
together with hSIE luciferase reporter and pRL-TK. Cells were either left uninduced or 
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cells with wild-type Stat3 or the Ser727Ala (S727A) mutant, in the presence or 
absence of Pin1. The hSIE-luciferase reporter, and pRL-TK control plasmid were 
simultaneously transfected, and the COS-1 cells were stimulated with EGF before 
harvesting for the luciferase assay. Consistent with the observations in other cell lines, 
overexpression of Pin1 was also able to promote the EGF-induced wild-type Stat3 
activity in COS-1 cells. However it failed to have any significant effects on the 
transcriptional activity of the serine phosphorylation-defective S727A mutant (Figure 
4.3A).  
To further confirm the importance of Ser727 residue in the Pin1-dependent 
Stat3 activity upregulation, we used Stat3 knockout (Stat3 KO) MEFs lacking the 
endogenous Stat3 for similar luciferase reporter assays. Stat3, S727A mutant or a 
control vector were co-transfected with or without Pin1 into Stat3 KO MEFs, and it 
was found that Pin1 only upregulated the transcriptional activity of wild-type Stat3, but 
did not affect the S727A mutant (Figure 4.3B). These data suggest that the Ser727 
residue in the C-terminal of Stat3 may play an essential role in mediating the 
upregulation of Stat3 transcriptional activity by Pin1.   
 
4.4 Stat3 DNA binding ability is impaired in the Pin1 knockout MEFs 
Ligand-induced recruitment of STATs to membrane receptors leads to subsequent 
activation of STATs, including tyrosine phosphorylation, dimerization, and nuclear 
translocation, where the STAT dimer binds to the DNA. Firstly, we checked whether 
Pin1 affects these basic steps in Stat3 activation. OSM-induced Stat3 tyrosine  





































Figure 4.3. Pin1 does not promote the transcriptional activity of Stat3 S727A point 
mutant  
(A) COS-1 cells were transfected with wild-type Stat3 or S727A point mutant, in the 
presence (+) or absence (-) of Pin1, together with the p-SIE-m16luc luciferase reporter 
plasmid and pRL-TK. Cells were either left uninduced or stimulated with EGF (100 
ng/ml) overnight. (B) Stat3 knockout MEFs (Stat3 KO) were cotransfected with empty 
pCMV5 vector, wild-type Stat3 or the S727A mutant, together with Pin1 or its control 
vector. Cells were either left untreated or stimulated with OSM overnight. 
COS-1 A
















     Stat3            S727A 
EGF 
 -  +     -  +     -  +     -  +     -  +     -  + 
 -  -     +  +     -  -     +  +     -  -     +  +  
















Stat3 KO MEF B 
OSM 
Pin1 
Chapter 4: Pin1 positively regulates Stat3 activity 
 115
phosphorylation in HeLa cells, with the overexpression of Pin1 or its point mutants, 
was analyzed by Western blotting using anti-Stat3 phospho-Tyr705 antibody, and the 
results showed there was no significant difference in Stat3 phosphorylation level 
between the Pin1 transfected cells and other controls (Figure 4.4A). Consistent with 
this observation, Stat3 tyrosine phosphorylation in Pin1 deficient MEFs was also not 
affected in comparison to the wild-type control (data not shown). OSM-induced 
nuclear translocation of Stat3 was assessed in Pin1 WT and KO MEFs, which 
exhibited similar level of Stat3 nuclear translocation upon OSM stimulation (Figure 
4.4B). 
Since both Stat3 tyrosine phosphorylation and nuclear translocation were not affected 
by Pin1, next we monitored the activity of Stat3 dimer inside the nucleus by assessing 
the Stat3 DNA binding ability in the presence or absence of Pin1. Pin1 WT and KO 
MEFs were stimulated by OSM for different lengths of time (unstimulated, 15 min, 1 h 
and 2 h), and the nuclear extracts of MEF cells at each time point were used for the 
electrophoretic mobility shift assay (EMSA). As shown in Figure 4.4C, Stat3 in Pin1 
WT exhibited strongest DNA binding ability after 15 min of OSM stimulation, which 
was significantly reduced afterwards. The DNA binding ability of nuclear Stat3 was 
obviously reduced in the Pin1 knockout cells in comparison to the wild-type control 
(compare lane 8 with lane 4). The specificity of the Stat3-DNA complex was verified 
by the supershift with Stat3, but not Stat1, antibody. This data indicates that expression 
of Pin1 is required for optimal DNA binding of Stat3 to its DNA response element.  






























Figure 4.4. Pin1 effects on the activation of Stat3. (A) HeLa cells were transfected 
with Myc-tagged Pin1, various point mutants, or control plamid, and stimulated with 
OSM (10 ng/ml) for 15 min. Phosphorylation of Stat3 Tyr705 was detected by the 
specific anti-Tyr705 antibody (top panel), and the same blot was stripped and reprobed 
with anti-Stat3 and anti-Myc antibodies. (B) Pin1 knockout MEFs (Pin1 KO) and 
control cells (Pin1 WT) were stimulated with OSM for 15 min, and subjected to 
nuclear extraction. Endogenous Stat3 amounts in the nuclear/cytoplasm fractions were 
analyzed with anti-Stat3 antibody (top panels), with the endogenous PARP and tubulin 
levels as control for the fractionation and loading efficiency. 
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(C) STAT3 DNA binding ability is impaired in the Pin1 KO MEFs. Pin1 WT and 
KO MEF cells were induced with OSM (10 ng/ml) for different lengths of time 
(unstimulated, 15 min, 1 h, 2 h). The nuclear extracts (10 μg) of each sample were 
subjected to EMSA to monitor the endogenous Stat3 DNA-binding activities with the 
α-32P labeled hSIE probes. The gel was subsequently dried and subjected to 
autoradiography. Super-shift assays with Stat1 or Stat3 antibody were shown in lane 1 
and 2 as indicated. 
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4.5 Pin1 increases Stat3 and p300 binding 
The p300/CBP transcriptional coactivator has been reported to physically interact with 
Stat3 (Nakashima et al., 1999), and also acetylate Stat3 protein at the Lys685 residue 
(Yuan et al., 2005; Wang et al., 2005). In order to further illustrate the underlying 
mechanism of the upregulation effects of Pin1 on Stat3 transactivation, we next 
investigated whether Pin1 had a role in regulation of the interaction between Stat3 and 
p300 coactivator. MCF7 cells were transfected with Myc-tagged Pin1 and either left 
untreated or stimulated with OSM. Cells were harvested and the lysates were subjected 
to immunoprecipitation with anti-p300 antibody, using normal rabbit IgG as control. 
Interestingly, we found that the interaction between endogenous Stat3 and p300 was 
increased drastically upon Pin1 overexpression (Figure 4.5A, upper panel, compare 
lane 6 with lane 8), and such Pin1-dependent increase of Stat3-p300 interaction was 
only observed in cells treated with OSM but not the unstimulated cells (compare lane 4 
with lane 8). 
We also examined the Stat3-p300 interaction within Pin1 WT and KO MEFs. 
Both cells were stimulated with OSM and harvested for immunoprecipitation with 
anti-p300 antibody. Apparently the OSM-induced interaction between endogenous 
Stat3 and p300 was compromised in the Pin1 KO MEFs (Figure 4.5B, top panel, 
compare lane 4 with lane 8), which indicates that Pin1 also plays an important role in 
the ligand-induced Stat3-p300 interaction, and loss of Pin1 expression leads to 
impaired association between Stat3 and p300 transcriptional coactivator. 
 











































Figure 4.5. Pin1 increases Stat3 and p300 interaction. 
(A) MCF-7 cells were transfected with a control vector or Myc-tagged Pin1, and left 
untreated or stimulated with OSM (10 ng/ml) for 20 min. The cell lysates were 
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immunoprecipitated with normal rabbit IgG or anti-p300 antibody as labeled, and 
blotted with anti-Stat3 (top panel). The blot was stripped and re-probed with anti-p300 
(middle panel). Total cell lysates (TCL) were subjected to Western blot analysis with 
anti-Stat3 to monitor the endogenous Stat3 level in MCF-7 cells (bottom panel). (B) 
Pin1 WT and KO MEFs were either left untreated or stimulated with OSM for 20min. 
The cell lysates were immunoprecipitated with normal rabbit IgG or anti-p300, and 
blotted with anti-Stat3 and anti-p300. 
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4.6 Effects of Pin1 on Stat3 ubiquitination 
Inactivation of STAT can be achieved through protein degradation mediated by the 
ubiquitin-proteasome pathway. To study whether Pin1 also affects the stability of Stat3 
protein, we investigated the role of Pin1 in Stat3 ubiquitination. In COS-1 cells we 
cotransfected Flag-Stat3 with Myc-Pin1 or control vector, together with HA-tagged 
ubiquitin. The cells were stimulated with EGF and cell lysates were subjected to 
immunoprecipitation with anti-Flag antibody to pull down the Flag-Stat3. The 
immunoprecipitates were analyzed by Western blotting with anti-HA antibodies in 
order to detect the ubiquitinated Stat3 only. The data showed that ubiquitination level 
of Stat3 was obviously decreased when Pin1 was coexpressed (left panel, Figure 4.6A), 
and a reciprocal immunoprecipitation test with anti-HA antibodies against the 
HA-tagged ubiquitin also demonstrated the decreased level of ubiquitinated Stat3 in 
the presence of Pin1 (right panel, Figure 4.6A).  
We further evaluated the effect of Pin1 on the ubiquitination of endogenous 
Stat3 in HeLa cells. HeLa cells were transfected with a control vector or Pin1, and 
HA-tagged ubiquitin. Cells were pre-treated with proteasome inhibitor MG132 for 3 h, 
followed by OSM stimulation. OSM treatment was found to induce the ubiquitination 
level of endogenous Stat3 (lane 2, top panel, Figure 4.6B) in HeLa, whereas 
overexpression of Pin1 completely blocked this OSM-induced Stat3 ubiquitination and 
also decreased the basal level of ubiquitinated Stat3 (compare lane 2 with lane 4, lane 
1 with lane 3), which suggests that Pin1 also plays an important role in the protection 
of Stat3 from ubiquitination. 
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Next we checked ubiquitination of endogenous Stat3 in the absence of Pin1 
expression. Pin1 knockout (Pin1 KO) MEFs and control cells (Pin1 WT) were 
transfected with HA-tagged ubiquitin. The cells were pre-incubated with MG132 and 
left either untreated or induced with OSM. It was observed that the amount of 
ubiquitinated Stat3 was significantly increased in the Pin1 knockout MEFs in 
comparison to the wild-type cells, under both basel and stimulated condition (Figure 
4.6C). We also performed similar immunoprecipitations with the endogenous ubiquitin 
in Pin1 WT and KO MEFs, and the result obtained was consistent with the results 
obtained with overexpressed ubiquitin.  
We also managed to introduce Myc-tagged Pin1 and its functionally deficient 
point mutants back into the Pin1 KO MEFs together with HA-tagged ubiquitin. It was 
observed that the expression of Pin1 was able to bring the ubiquitination of 
endogenous Stat3 in Pin1 KO MEFs back to a lower level, while the point mutants 
could only partially decrease the Stat3 ubiquitination in Pin1 knockout cells (Figure 
4.6D). 
 
4.7 Role of Ser727 in Stat3 ubiquitination and protein degradation 
As reported in the previous section, Stat3 Ser727 residue was found to be 
critical for the upregulation effects of Pin1 on Stat3 transcriptional activity. In order to 
check whether the Ser727 residue was also involved in the regulation of Stat3 
ubiquitination by Pin1, COS-1 cells were transfected with either wild-type Stat3 or the 
S727A mutant, in the presence or absence of Pin1, together with HA-tagged ubiquitin. 
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All cells were treated with MG132 followed by EGF stimulation. Overexpression of 
Pin1 was found to be able to reduce the ubiquitination level of wild-type Stat3, but had 
no effect on the S727A mutant (Figure 4.6E). The same experiment was repeated in 
Stat3 deficient cells and a similar result was obtained (data not shown). These data 
suggested that the Stat3 Ser727 residue was also involved in the Pin1-mediated 
suppression of Stat3 ubiquitination. 
Since Pin1 was unable to protect the S727A mutant from ubiquitination in both 
Stat3 KO MEFs and COS-1 cells, we next investigated the protein degradation patterns 
of the wild-type Stat3 and S727A mutant. Stat3 KO MEFs were transfected with either 
Stat3 or S727A, and treated with cycloheximide to block the protein synthesis two 
days after transfection. Cells were harvested at different time points upon the 
cycloheximide treatment, and the lysates were subjected to immunoblotting with 
anti-Stat3 antibody to monitor the corresponding protein level of Stat3/S727A (Figure 
4.6F). Obviously the S727A protein degraded much faster compared to its wild-type 
counterpart, which implies that the S727A mutant is much more unstable. This 
observation might result from the failure of Pin1 in protecting the S727A mutant from 
excessive ubiquitination within the cell. 














































OSM   -   +   -  +  
HA-Ubiquitin 
IP: α-HA 









Pin1  -    + 
Flag-St3 
HA-Ubi +    + 








Pin1  -   + 
HA-Ubi +   + 




Chapter 4: Pin1 positively regulates Stat3 activity 
 125
Figure 4.6. Effect of Pin1 on Stat3 ubiquitination and protein degradation 
(A) COS-1 cells were transfected with Flag-tagged Stat3 and Myc-tagged Pin1/control 
vector, together with HA-tagged ubiquitin. The cell lysates were immunoprecipitated 
with anti-Flag or anti-HA antibodies as indicated. The precipitates were fractionated on 
SDS-PAGE, and western blotted with anti-HA (left panel) or anti-Flag (right panel) 
antibodies respectively. The blots were stripped and re-probed with anti-Flag or anti-HA 
respectively. Expression levels of Myc-tagged Pin1 in total cell lysates (TCL) are 
shown in the bottom panel. (B) HeLa cells were cotransfected with control vector or 
Myc-tagged Pin1, and HA-tagged ubiquitin. Cells were pre-incubated with proteasome 
inhibitor MG132 (10 μM) for 3 h and left either untreated or stimulated with OSM (10 
ng/ml) for another 2 h. The cell lysates were immunoprecipitated with anti-HA 
antibody, and blotted with anti-Stat3 (top panel). The blot was stripped and re-probed 
with anti-HA (middle panel) and the total cell lysates were subjected to Western 
























(C) Stat3 ubiquitination is increased in Pin1 deficient MEFs. Pin1 WT and KO 
MEFs were both transfected with HA-tagged ubiquitin. Cells were pre-incubated with 
MG132 and left untreated or stimulated with OSM. The cell lysates were 
immunoprecipitated with anti-HA antibodies, and western blotted with anti-Stat3 (top 
panel). The blot was stripped and re-probed with anti-HA. The total cell lysates were 
subjected to Western blot with anti-Stat3 and anti-Pin1 antibodies. 
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(D) Pin1 KO MEFs were transfected with the control vector, Myc-tagged Pin1 or three 
point mutants, together with HA-tagged ubiquitin. Cells were pre-incubated with 
MG132 and stimulated with OSM. The cell lysates were immunoprecipitated with 
anti-HA, and blotted with anti-Stat3 and anti-HA antibodies. Total cell lysates were 
analyzed using anti-Stat3 and anti-Myc antibodies to monitor the expression levels of 



















































(E) Pin1 does not protect S727A from ubiquitination. COS-1 cells were transfected 
with Flag-tagged Stat3 or S727A, with or without Pin1, together with HA-tagged 
ubiquitin. Cells were pre-incubated with MG132 and stimulated with OSM. The cell 
lysates were immunoprecipitated with anti-HA antibody, and western blotted with 
















(F) Protein degradation of Stat3 and S727A. Stat3 knockout MEFs were transfected 
with wild-type Stat3 or S727A point mutant. The cells were treated with cycloheximide 
(CHX) (100 μg/ml) for different lengths of time as indicated. The total cell lysates were 
subjected to Western blotting with anti-Stat3 antibody, and re-probed with anti-β-actin 
as control. 
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4.8 Discussions  
A novel role of Pin1 as a positive regulator of Stat3 
Since its discovery in 1996, roles of the peptidyl-prolyl isomerase Pin1 have been 
identified in various cellular events and responses. Involvement of Pin1 in multiple 
signaling pathways has been reported, and activities of various transcriptional factors, 
such as c-fos, c-Jun, NF-κB and β-caternin, are regulated by Pin1 via direct physical 
association and its PPIase activity (Monje et al., 2005, Wulf et al., 2001, Ryo et al., 
2001, Ryo et al., 2003). However due to its specific recognition towards the 
phosphoSer/Thr-Pro motif, in many cases, instead of constitutively interacting with the 
substrates, Pin1 only selectively binds to certain form of the proteins, namely the 
phosphorylated forms. For example, Pin1 does not interact with p53 in the basel 
condition, but binds its Ser/Thr- phosphorylated forms upon genotoxic insults (Zacchi 
et al., 2002). In this thesis, I reported a novel interaction between Pin1 and Stat3, a 
latent cytoplasmic transcription factor that plays important roles in cell proliferation, 
development and oncogenesis. Our results show that Pin1 only binds to Stat3 in 
ligand-stimulated cells and the endogenous interaction takes place only in the nucleus, 
suggesting that Pin1 may selectively target the activated form of Stat3. 
Ligand-stimulated phosphorylation of the serine 727 residue in the C-terminal of Stat3, 
which is followed by a proline, mediates the Stat3-Pin1 interaction, and replacement of 
this crucial residue with phosphorylation-resistant alanine totally abolishes the protein 
association (Figure 4.1C). The Stat3-Pin1 interaction leads to a significant increase of 
Stat3 transcriptional activity in various cell lines, which suggests that Pin1 is a positive 
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regulator for Stat3 activity.  
Generally, in addition to the phosphorylation of Tyr705, phosphorylation on the 
Ser727 residue also significantly contributes to the activation of Stat3. While the 
tyrosine phosphorylation plays a key role in all the basic events required for the Stat3 
activation, such as dimer formation and nuclear translocation, serine phosphorylation 
probably represents a second level of regulation by which, with the assistance of Pin1, 
maximal Stat3 transcriptional activity is achieved. Pin1 may in fact serve as a precise 
molecular switch specifically devoted to the serine-phosphorylation, by converting the 
“primarily-activated” form of Stat3 to the “optimally-activated” type. This second 
stage of regulation may involve various events such as enhanced Stat3 DNA binding, 
coactivator recruitment and protein stability, which will be discussed in detail in the 
following sections. 
 
Involvement of Pin1 in Stat3 DNA-binding activity 
As revealed by the crystal structure of Stat3, the homodimer grips the DNA like a pair 
of pliers with the eight-stranded β-barrel DNA-binding domain making contacts with 
the DNA double helix. However, factors involved in the regulation of Stat3 DNA 
binding ability are less understood. It was shown that addition of negative regulator 
protein PIAS-3 in vitro blocked Stat3 DNA-binding ability (Chung et al., 1997), but 
without further explanation about the underlying mechanism leading to such inhibition. 
In this study, we demonstrated that the DNA-binding ability of Stat3 was compromised 
in the Pin1 knockout cells, suggesting a potentially role of Pin1 in the regulation of the 
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Stat3 DNA binding process. It is worthy of note that such difference in Stat3 DNA 
binding is not due to shortened DNA binding time in the Pin1-/- cells, because both 
Pin1 deficient and wild-type cells exhibits similar kinetics of the ligand-stimulated 
DNA binding response (Figure 4.4C). One possible explanation is that the prolyl 
isomerization catalyzed by Pin1 in the C-terminal of Stat3 may subsequently induce a 
conformational or positional change in the DNA-binding domain, which turns the 
Stat3 protein into a higher DNA-affinity status. 
 
Regulation of Stat3 transactivation 
As described in the introduction, the structure of the transactivation domain of STAT is 
still unresolved, and the transcriptional activation mechanisms are also not well 
characterized. Here we demonstrate that Pin1 promotes Stat3 transactivation in various 
cell lines upon stimulation with different cytokines/ growth factor, and this positive 
effect depends on both the phospho-protein binding ability and PPIase catalytic 
activity of Pin1 protein. These data, for the first time raise the possibility that STAT 
transactivation can be significantly affected by isomerization at a single crucial 
peptidyl bond within its C-terminal. Although the structure of Stat3 C-terminal is still 
unclear, it makes a sensible speculation that conformational change within this domain 
plays a direct regulatory role in the Stat3-mediated transcriptions.  
Identification of Stat3-Pin1 interaction via the Ser727 residue also provides a 
potential explanation to the long-time undetermined mechanism of the serine 
phosphorylation-mediated enhancement to Stat3 transcription. Taking together the 
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facts that the interaction of Pin1 and Stat3 leads to upregulated Stat3 transactivation, 
and such interaction requires phosphorylated Ser727, we suspect that the 
transcription-enhancing effect of Stat3 serine phosphorylation may, at least partially, 
result from the specific binding and subsequent isomerization by Pin1 on the 
phoshphoSer727-Pro motif. This speculation is further supported by the findings that 
Stat3 transcriptional activity is significantly reduced in the Pin1 knockout cells, and 
substitution of the Ser727 residues with phosphorylation-incompetent Ala completely 
abolishes the positive effects of Pin1 on Stat3 transactivation. Considering the presence 
of invariant serine residue in some other STATs like Stat1 and Stat4, it is possible that 
Pin1 also accounts for the transcription-enhancing effects of serine phosphorylation in 
other STAT proteins. 
Besides serine phosphorylation, other potential regulatory events of STAT 
transactivation include the interaction of STATs with different coactivators, and the 
STAT protein stability. Interestingly we find that Pin1 is also involved in these two 
events. Physical interaction between Stat3 and the transcriptional coactivator p300 in a 
cytokine stimulation manner was initially identified in stimulated COS-7 cells, and 
p300 was suggested as a bridge protein within the synergistic complex formed between 
Stat3 and Smad1 (Nakashima et al., 1999). The C-terminal transactivation domain of 
Stat3 was reported to be sufficient for the recruitment of p300 (Paulson et al., 1999). In 
our study, experimental data demonstrated that Pin1 was able to dramatically increase 
the interaction of Stat3 and p300 upon cytokine stimulation, and the Stat3-p300 
association was compromised in the absence of Pin1. The fact that a Ser727Asp 
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mutant which mimic with the serine-phosphorylated Stat3 can constitutively interact 
with p300 (Schuringa et al., 2001) further supports the idea that the serine 
phosphorylation-mediated Pin1 binding is required for the optimal interaction of Stat3 
with p300. Pin1 has been shown to bind and isomerize p73 protein, therefore facilitate 
its acetylation by p300 (Mantovani et al., 2004). Coincidently, acetylation of Stat3 on a 
single Lys685 residue in the C-terminal by p300 acetyltransferase activity has been 
recently reported, and this acetylation is important for the Stat3 transcriptional 
activation (Yuan et al., 2005, Wang et al., 2005). Therefore it will be worthwhile to 
check whether the Pin1-enhanced Stat3-p300 interaction also facilitates the 
p300-dependent acetylation on Stat3, and consequentially contributes to the maximal 
Stat3 transactivation. 
 
Pin1 and serine phosphorylation in Stat3 ubiquitination 
Despite of evidence showing the proteasome-mediated degradation of Stat1 and Stat5 
proteins, the regulation of Stat3 ubiquitination and protein metabolism under 
physiological condition is still largely unknown. In this study we have observed in vivo 
ubiquitination of Stat3 protein in various mammalian cell types and the accumulation 
of ubiquitinated Stat3 upon pre-incubation with proteasome inhibitor MG132, which 
indicates the presence of a coordinated ubiquitin-proteasome pathway for Stat3. We 
also noticed that the ubiquitinated Stat3 only makes a small proportion of the total 
Stat3 proteins in the unstimulated cells, and the ligand stimulation further increases the 
Stat3 ubiquitination level (Figure 4.6B). This suggests that the ligand-activated Stat3 is 
Chapter 4: Pin1 positively regulates Stat3 activity 
 133
the major target of the ubiquitin-proteasome degradation, and such findings are 
consistent with several previous reports showing the preferential degradation of 
activated Stat1 and Stat5 by the proteasome pathway (Kim and Maniatis, 1996; Wang 
et al., 2000). All this evidence also supports the assumption that preferential 
ubiquitin-proteasome degradation of activated STAT proteins serves as one of the 
negative regulation mechanisms for STAT signaling. 
In our experiments, Stat3 ubiquitination was obviously suppressed by the 
overexpression of Pin1, while excessive ubiquitinated Stat3 was detected in the Pin1 
deficient cells in comparison to the wild-type control. This suggests that Pin1 actually 
protects activated Stat3 from ubiquitin-proteasome degradation. Consistent with this, 
Pin1 failed to decrease the ubiquitination level of the S727A mutant of Stat3. This is 
the first time that the invariant serine residue alone is shown to play a critical role in 
the regulation of STAT ubiquitination, and it has been further confirmed by the protein 
degradation assay in which the protein life of S727A mutant is significantly shorter 
than its wild-type Stat3 counterpart (Figure 4.6G). All these findings suggest that, at 
least in the case of Stat3, specific recognition of the activated STAT proteins by the 
ubiquitin-proteasome system is mainly through the phosphorylation at serine residue 
and subsequent Pin1 action, instead of the commonly-speculated tyrosine 
phosphorylation. The next step is to further examine the protein degradation pattern of 
cytokine-activated Stat3 in the Pin1 knockout cells. In addition, in the report of Stat1 
ubiquitination (Kim and Maniatis, 1996), only a slower migrating band instead of the 
major band of Stat1 was observed to undergo proteasome degradation. In most cases 
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the slower migrating band of STAT proteins specifically represents the serine- 
phosphorylated STAT, so it is sensible to check whether the corresponding serine 
phosphorylation also accounts for the ubiquitination of other STAT proteins, and if 
Pin1-dependent isomerization is a general mechanism in regulating the ubiquitination 
of those STATs with serine phosphorylation. 
 
Stat3 and Pin1 in human cancers 
Activation of STAT genes, especially Stat3, is frequently associated with various 
tumors (Figure 1.5). For instance, constitutive activation of Stat3 has been observed in 
various breast carcinoma cell lines (Bowman et al., 2000), and significantly elevated 
Stat3 activation was detected in many human malignant breast cancer tissues 
(Clevenger, 2004). On the other hand, overexpression of Pin1 has also been reported in 
multiple human cancers (Bao et al., 2004). Roles of Pin1 in the mammary gland 
development, breast cancer and the transformation of mammary epithelial cells have 
been intensively studied. The positive correlation between Pin1 and cyclin D1 
expression in breast cancer cells was well characterized (Wulf et al., 2005), and Pin1 is 
also essential in the Neu/Ras-induced transformation of mammary epithelial cells 
through cyclin D1 activation (Ryo et al., 2002). Stat3 activation has been linked to the 
increase of Cyclin D1 expression as well. Cells expressing the constitutively activated 
Stat3-C showed increased level of cyclin D1 (Bromberg et al., 1999), while the 
dominant negative Stat3 suppressed transcription on the cyclin D1 promoter in v-Src 
transfected cells (Sinibaldi et al., 2000). In our study, Pin1 has been shown to be 
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involved in various steps regulating the Stat3 activity, including the Stat3 DNA binding, 
transactivation and protein ubiquitination. Hence it will be interesting to see whether 
there is any correlation between the prevalent Pin1 overexpression and the constitutive 
Stat3 activation in various tumors and cancer cells, and if the PPIase activity of Pin1 is 
required for the Stat3-mediated cell transformation. In addition, accumulating evidence 
suggests that the constitutive serine phosphorylation also contributes to Stat3 signaling 
in oncogenesis. For instance, the S727A mutant of Stat3 has been reported to suppress 
Stat3-dependent Src transformation (Bromberg et al., 1998), and a similar effect can 
also be achieved by inhibition of the serine kinase activities. Thus, as a potential 
molecular switch specifically targeting the Stat3 serine phosphorylation, inhibition of 
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Signal transducer and activator of transcription 3
(Stat3) is a latent cytoplasmic transcription factor that
can be activated by cytokines and growth factors.
Stat3 plays important roles in cell growth, anti-apop-
tosis and cell transformation, and is constitutively
active in various cancers. We examined its potential
regulators by yeast two-hybrid screening. GRIM-19, a
gene product related to interferon-b- and retinoic
acid-induced cancer cell death, was identi®ed and
demonstrated to interact with Stat3 in various cell
types. The interaction is speci®c for Stat3, but not for
Stat1 and Stat5a. The interaction regions in both
proteins were mapped, and the cellular localization of
the interaction was examined. GRIM-19 itself co-loca-
lizes with mitochondrial markers, and forms aggre-
gates at the perinulear region with co-expressed Stat3,
which inhibits Stat3 nuclear translocation stimulated
by epidermal growth factor (EGF). GRIM-19
represses Stat3 transcriptional activity and its target
gene expression, and also suppresses cell growth in
Src-transformed cells and a Stat3-expressing cell line.





Cytokines exert multiple biological responses through
interaction with their speci®c receptors that results in the
activation of JAK±STAT pathways. STATs (signal trans-
ducers and activators of transcription) are a family of
latent cytoplasmic transcription factors which are acti-
vated by recruitment to the cytokine receptors and
subsequent phosphorylation by the receptor-associated
Janus kinases (JAKs). Stat proteins form homo- or
heterodimers by reciprocal interaction between SH2
domains and phosphorylated tyrosine residues, translocate
into the nucleus, bind to DNA and regulate their target
gene expression (Darnell et al., 1994). Seven mammalian
STAT genes have been identi®ed to be activated by
various cytokines and certain growth factors, and exhibit
distinct and overlapping functions (Schindler and Darnell,
1995; Ihle, 2001).
Stat3 originally was cloned as an acute-phase
response factor activated by interleukin-6 (IL-6) in
mouse liver, and also by homology to Stat1 (Akira et al.,
1994; Zhong et al., 1994a). Growth factors, such as
epidermal growth factor (EGF), platelet-derived growth
factor (PDGF) and colony-stimulating factor-1 (CSF-1),
can also stimulate Stat3 activity (Sadowski et al., 1993;
Zhong et al., 1994b). Stat3 plays crucial roles in early
embryonic development (Takeda et al., 1997), as well as
in other biological responses including cell growth and
anti-apoptosis (Akira, 2000). Stat3 is constitutively
activated in oncogenic tyrosine kinase v-Src- or v-abl-
transformed cells (Danial et al., 1995; Yu et al., 1995;
Cao et al., 1996), and various primary tumors and cell
lines. Stat3 itself acts as an oncogene in NIH-3T3 cells
(Bromberg et al., 1999; Bowman et al., 2000). Stat3
plays an anti-apoptotic role in gp130-mediated survival
in B cells, as well as in myeloma and head and neck
tumor cells (Fukada et al., 1996; Catlett-Falcone et al.,
1999; Grandis et al., 2000). In the latter cases,
activation of Stat3 may contribute to the loss of cell
growth control, therefore leading to carcinogenesis by
preventing apoptosis. Therefore, the control of both the
activation and inactivation of Stat3 is equally important
to maintain normal cell growth.
Interferons (IFNs) regulate antiviral, antitumor and
immune responses in vertebrates by activating Jak1,
Tyk2, Stat1 and Stat2, and a number of IFN-stimulated
genes (Stark et al., 1998). On the other hand, all-trans-
retinoic acid (RA), a metabolite of vitamin A, binds to
speci®c nuclear receptors (RARs) and activates the
expression of various genes. RA inhibits growth of
certain types of cancer and is effective in the prevention
of primary cancers, and is used in clinical therapy (Love
and Gudas, 1994). A combination of IFN-b and RA
induces cell death in several breast cancer cell lines. A
few genes that possibly are involved in this process
have been identi®ed and named as GRIM (genes
associated with retinoid±IFN-induced mortality)
(Hofman et al., 1998). One of these genes, GRIM-19,
was reported to encode a small protein primarily
distributed in the nucleus and was able to promote
cell death induced by IFN-b and RA (Angell et al.,
2000). Recently, a bovine homolog of GRIM-19 was co-
puri®ed with mitochondrial NADH:ubiquinone oxido-
reductase (complex I) in bovine heart (Fearnley et al.,
2001). Therefore, its exact cellular localization and
function are unclear.
To understand further the regulation and function of
Stat3, we investigated Stat3-interacting proteins using
yeast two-hybrid screening. We have identi®ed GRIM-19
as a speci®c interacting protein which negatively regulates
Stat3 activity.
GRIM-19, a death-regulatory gene product,
suppresses Stat3 activity via functional interaction
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Results
Identi®cation of GRIM-19 as a Stat3-interacting
protein by yeast two-hybrid screening
To study the regulation and function of Stat3, we sought to
identify the proteins that interact with Stat3 using a yeast
two-hybrid system (Durfee et al., 1993). Full-length Stat3
resulted in the constitutive activation of the reporter genes.
We therefore used the coiled-coil domain of Stat3, known
to be important for protein±protein interaction, as bait
(Becker et al., 1998). Four positive clones were identi®ed
to encode the mouse homolog of human GRIM-19, whose
homologs have been reported in bovine, mouse and
Caenorhabditis elegans (Lai et al., 2000). The cDNAs
we obtained in the yeast two-hybrid screening exhibited
100% identity in amino acid sequence with the reported
murine GRIM-19, which shares 75% amino acid identity
and 88% similarity to the human GRIM-19. The speci®city
of Stat3 and GRIM-19 interaction in yeast was con®rmed
further by survival assay in selection medium (see
Supplementary ®gure 1, available at The EMBO Journal
Online).
Association of Stat3 and GRIM-19 in vivo and
in vitro
To verify the interaction of Stat3 and GRIM-19 in
mammalian cells, we transfected COS-1 cells that express
low levels of Stat3 with Flag-tagged Stat3 and Myc-tagged
GRIM-19, or control plasmids. The cell lysates were
immunoprecipitated with anti-Myc antibody, and sub-
jected to western blotting analysis to detect bound Stat3
using anti-Flag antibody. As shown in Figure 1, Stat3 was
detected in anti-Myc immunoprecipitates when GRIM-19,
but not the control plasmid, was co-transfected (top left
panel). A reciprocal immunoprecipitation/blotting experi-
ment also showed GRIM-19 co-precipitating with Stat3
(top right panel). We further demonstrated that the coiled-
coil domain alone could interact with GRIM-19 in COS-1
cells, and Stat3 and GRIM-19 were able to interact directly
in vitro (see Supplementary ®gures 2 and 3).
Physiological association of endogenous Stat3 and
GRIM-19 in various cell types
To study the possible physiological signi®cance, we
investigated the interaction between endogenous Stat3
and GRIM-19 in mammalian cells. For this purpose, a
rabbit antiserum against bacterially produced mouse
GRIM-19 was generated. The antibody speci®cally
recognizes GST±GRIM-19 expressed in COS-1 cells
(Figure 2A). A protein with a molecular mass of ~18 kDa
that was likely to be endogenous GRIM-19 in COS-1 cells
was also detectable. In contrast, the pre-immune serum
and the anti-GRIM-19 antibody pre-absorbed with
Fig. 1. Association of Stat3 and GRIM-19 in transfected cells. COS-1
cells were transfected with Flag-tagged Stat3 and/or Myc-tagged
GRIM-19. The cell lysates were immunoprecipitated with either anti-
Myc or anti-Flag as indicated. The precipitates were fractionated by
12.5% SDS±PAGE, and blotted with anti-Flag (top left panel) or anti-
Myc (top right panel). The respective co-precipitated Stat3 and
GRIM-19 are indicated. The blots were stripped and re-probed with
anti-Myc or anti-Flag (middle panels). Total cell lysates (TCL) were
subjected to western blot analysis with anti-Flag or anti-Myc to monitor
the expression of Stat3 and GRIM-19 (bottom panels). The molecular
mass markers are indicated in kDa (Bio-Rad Laboratories). The strong
bands are the heavy chain of rabbit IgG (top left panel), or the heavy
and light chains of mouse IgG (top right panel). Fig. 2. Association of endogenous Stat3 and GRIM-19. (A) Evaluation
of the GRIM-19 antibody. COS-1 cells were transfected with GST vec-
tor (lanes 1, 3 and 5) or GST±GRIM-19 (lanes 2, 4 and 6). Cells were
lysed and subjected to western blot analysis using pre-immune serum
(PI, lanes 1 and 2), puri®ed GRIM-19 antibody (a-G-19; lanes 3 and 4)
or GRIM-19 antibody pre-absorbed by bacterially produced GRIM-19
(lanes 5 and 6). (B) Western blot analysis of endogenous GRIM-19 in
MCF-7 cells induced by IFN-b (500 U/ml) and RA (1 mM) for various
times. The blot was re-probed with anti-b-actin as a control.
(C) Association of endogenous Stat3 and GRIM-19 in various cell
types. MCF-7 cells were left untreated (lanes 1 and 2) or treated with
IFN-b and RA for 48 h (lane 3). C2C12, SH-SY5Y and PC12 cells
were grown under normal conditions. Cell lysates were incubated with
either pre-immune serum (PI) or anti-GRIM-19 (a-G-19) as labeled on
top of the ®gures, and blotted with anti-Stat3 (upper panels). The blots
were stripped and re-probed with anti-GRIM-19 (lower panels).
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recombinant GRIM-19 protein reacted with neither the
endogenous nor the transfected GRIM-19. The GRIM-19
antibody also recognized endogenous human GRIM-19 in
a breast cancer cell line, MCF-7, induced by a combination
of IFN-b and RA treatment for various durations
(Figure 2B), which exhibited similar kinetics to those
previously reported (Angell et al., 2000).
We then evaluated the interaction of Stat3 and GRIM-19
in MCF-7 cells. A low amount of Stat3 was co-immupre-
cipitated with GRIM-19 in unstimulated cells (Figure 2C,
lane 2), which was increased in IFN-b/RA-treated cells
(lane 3). As a control, Stat3 did not co-immunoprecipitate
with pre-immune serum (lane 1). Since GRIM-19 is
expressed at a high level in skeletal muscle (Angell et al.,
2000) and rat brain (data not shown), we further tested the
association between endogenous GRIM-19 and Stat3 in
mouse myoblast C2C12, human neuroblastoma SH-SY5Y
and rat pheochromocytoma PC-12 cells. Stat3 co-immuno-
precipitated with GRIM-19 antiserum, but not pre-immune
serum, in these cell lines (Figure 2C). These data indicate a
physiological interaction between GRIM-19 and Stat3,
which is not limited to human breast cancer cells but extends
to other cell types and species.
GRIM-19 does not associate with Stat1 and Stat5a
The interaction between GRIM-19 and other Stat proteins
was also examined. In contrast to Stat3, only trace amounts
of Stat1 co-precipitated with GST±GRIM-19, whereas no
association was detected between Stat5a and GRIM-19 in
the GST pull-down experiment (Figure 3). In agreement
with these results, no co-localization between GRIM-19 and
Stat1 or Stat5a in cells was observed by immuno¯uores-
cence staining (see Figure 6B). These data suggested a
speci®c functional link between GRIM-19 and Stat3.
Mapping the regions that mediate the interaction
between Stat3 and GRIM-19
Stat3 contains several functional domains, as illustrated
in Figure 4A (Becker et al., 1998). In addition to the
coiled-coil domain, other regions may also interact with
GRIM-19. To explore this possibility, we generated a
series of Flag-tagged Stat3 truncation mutants, which were
co-transfected with GST-tagged GRIM-19. GST pull-
down experiments indicated that GST±GRIM-19 associ-
ated with ST3-DB.LK, a Stat3 protein consisting of the
DNA-binding and linker domains. No association was
detected with the N-terminal domain, the SH2 domain or
the C-terminal domain (Figure 4B). We further delineated
the interacting domains by subcloning the individual
DNA-binding domain and linker domain. The immuno-
precipitation/blotting experiment results showed that both
domains were able to interact with GRIM-19 (Figure 4C).
There is little structural information available for
GRIM-19. To determine the interacting region of
GRIM-19, several deletion mutations were randomly
selected (amino acids 1±35, 1±101, 36±144, 73±144 and
102±144). GST fusion constructs containing these frag-
ments were generated and co-transfected with Flag-tagged
Stat3. The GST pull-down experiments indicated that
Stat3 co-precipitated with full-length GST±GRIM-
191±144, GST±GRIM-191±101 and GST±GRIM-1936±144,
suggesting that amino acids 36±101 in the middle of the
protein harbor the interacting region. Further subcloning
revealed that the section containing amino acids 36±72
mediated its association with wild-type Stat3 (Figure 4D)
and the individual coiled-coil domain, DNA-binding
domain and linker domain (data not shown).
Cellular localization of GRIM-19
To characterize further the nature of the interaction
between Stat3 and GRIM-19, we attempted to determine
where this interaction occurs. The cellular localization of
Myc-tagged human GRIM-19 was ®rst analyzed by
immuno¯uorescence in MCF-7 cells. GRIM-19 was
detected exclusively in the cytoplasm as punctate struc-
tures, which co-localized with two endogenous mitochon-
drial proteins, cytochrome oxidase subunit IV (COX)
(Figure 5A) and cytochrome c (data not shown), but did
not co-localize with EEA1 or CD63, markers for early
endosome and late endosome/lysosome, respectively
(Metzelaar et al., 1991; Mu et al., 1995). Similar results
were obtained with either a Myc-tagged mouse GRIM-19
or a hemagglutinin (HA)-tagged human GRIM-19 in
MCF-7, as well as in COS-1 cells (data not shown). To
determine further the region for mitochondrial localiza-
tion, Myc-tagged truncation mutants were generated.
GRIM-191±101, deleting the C-terminus of the full-length
GRIM-19, showed punctate staining in the cytoplasm
which co-localized with COX, whereas the mutant
GRIM-1936±144, deleting the N-terminal domain, or
GRIM-1936±101, containing the middle region of
GRIM-19, exhibited a loss of mitochondrial localization
(Figure 5B). Therefore, the N-terminus of GRIM-19 seems
to harbor the mitochondrial localization sequence.
We further analyzed the cellular localization of
endogenous GRIM-19 in MCF-7 cells using the puri®ed
GRIM-19 antibody. Weak staining of GRIM-19 was
observed as punctate structures predominantly in the
cytoplasm of untreated cells, which was intensi®ed as
small dot-like structures aggregating at the perinuclear
region and coincided with COX protein upon IFN-b/RA
treatment. In addition, a weak staining was also noticeable
Fig. 3. Lack of interaction between GRIM-19 and other Stat proteins.
Flag-tagged Stat1, 3 or 5a were co-transfected with GST or GST±
GRIM-19 expression plasmids in COS-1 cells. The cell lysates were
incubated with glutathione±Sepharose beads. The bound proteins were
subjected to western blot analysis with anti-Flag antibody (top panel).
Precipitated GST and GST±GRIM-19 were blotted with anti-GST (mid-
dle panel). The expression of Stat1 (lanes 1 and 2), Stat3 (lanes 3 and
4) and Stat5a (lanes 5 and 6) was determined with anti-Flag (bottom
panel).
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in the nucleus, which was slightly increased after the
treatment (Figure 5C). To verify these results further, the
MCF-7 cells were fractionated into cytoplasmic, mito-
chondrial and nuclear portions, and GRIM-19 expression
in these fractions was determined in the absence or
presence of IFN-b/RA treatment. Consistent with the
immuno¯uorescence results, the majority of GRIM-19
was detected in the mitochondrial fraction, which was
increased upon IFN-b/RA treatment. A trace amount was
detected in the nuclear portion, which was also increased
slightly after treatment (Figure 5D). Together, these
results suggest that in MCF-7 cells, GRIM-19 protein
seems to be localized primarily in the mitochondria, with a
minor distribution in the nucleus.
Co-localization of GRIM-19 with Stat3 and its
effect on Stat3 nuclear translocation
Cellular localization of Stat3 and its interaction with
GRIM-19 were examined subsequently. We observed that
in unstimulated MCF-7 cells, Stat3 protein was distributed
in the cytoplasm and the nucleus, which was in agreement
with a previous report in other cell lines (Meyer et al.,
2002). Surprisingly, in cells co-expressing GRIM-19, the
majority of Stat3 disappeared from the original locations
and formed the dot-like dense structures at the nuclear
periphery, which co-localized with GRIM-19 (Figure 6A).
Since a few domains of Stat3 can interact with GRIM-19,
we next investigated their co-localization with GRIM-19.
Strikingly, the Stat3 mutant containing the N-terminal and
the coiled-coil domains (ST3-ND.4H) was detected
exclusively in the nucleus, and co-expression with
GRIM-19 resulted in its disappearance from the nucleus,
and formation of perinuclear aggregates similar to those
observed in full-length Stat3. On the other hand, Stat3
proteins containing either the DNA-binding and linker
domains (ST3-DB.LK), or the SH2 and C-terminal
domains (ST3-SH2.CT) localized mainly in the cyto-
plasm. Their cellular locations were not affected by
Fig. 4. Mapping of the interacting regions of Stat3 and GRIM-19. (A) Schematic diagram of Stat3 indicating its functional domains speci®ed accord-
ing to the amino acids (aa). (B and C) Identi®cation of interacting regions of Stat3. (B) COS-1 cells were co-transfected with GST±GRIM-19 and
Flag-tagged Stat3, either full-length (ST3-FL) or deletion mutants containing the N-domain (ND), DNA-binding and linker domains (DB.LK), SH2 do-
main or C-terminal domain (CT) as labeled on top of the ®gure. GST pull-down was performed, and the associated proteins were probed with anti-
Flag antibody (top panel). The middle panel indicates the GST±GRIM-19 that has been pulled-down by beads. The bottom panel shows the expression
of the Flag-tagged Stat3 constructs in total cell lysates. (C) For further mapping, Flag-tagged Stat3 mutant expressing either the linker domain (ST3-
LK) or the DNA-binding domain (ST3-DB) was co-transfected with Myc-tagged GRIM-19 (+) or vector alone (±). The cell lysates were immunopreci-
pitated with anti-Myc and blotted with anti-Flag. The blot was stripped and re-blotted with anti-Myc (middle panel). Expression of ST3-LK and ST3-
DB in total cell lysate (TCL) was examined by western blot analysis using anti-Flag (bottom panel). (D) Identi®cation of interacting regions on
GRIM-19. GST±GRIM-19 fusions harboring various segments of GRIM-19 (as indicated by the aa numbers) were co-transfected with Flag-Stat3, and
GST pull-down experiments were performed. The top panels show Stat3 co-precipitated with GST±GRIM-19. The middle panels show GST and the
various GST±GRIM-19 fusion proteins pulled-down by glutathione±Sepharose beads, and the bottom panels indicate the expression of Stat3. The
schematic diagram of GRIM-19 is displayed on top of the ®gure, in which the interacting region (aa 36±72) of GRIM-19 is illustrated as a black box.
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GRIM-19, and no aggregates were detected, although
ST3-DB.LK seemed to be co-localized with GRIM-19
(Figure 6A), which was consistent with its ability to
interact with GRIM-19 (Figure 4B). These results indi-
cated that the N-terminal and coiled-coil domains of Stat3
may harbor a nuclear localization signal (NLS), and the
coiled-coil domain is required for the formation of the
unique perinuclear aggregates which may block Stat3
nuclear translocation.
We further addressed this issue in COS-1 cells stimu-
lated by EGF. In untreated cells, the majority of Stat3 was
localized in the cytoplasm, and was translocated into the
nucleus in response to EGF in the absence of GRIM-19.
However, it formed perinuclear aggregates in the presence
of GRIM-19, and co-localized with GRIM-19. Stat1 and
Stat5a were also localized in the nucleus in response to
EGF stimulation. However, they remained in the nucleus
and did not co-localize or form aggregates with the co-
transfeced GRIM-19 (Figure 6B).
We further con®rmed these results with cellular
fractionation in COS-1 cells. A small amount of Stat3
was present in the nucleus in untreated cells, which was
increased upon EGF treatment. However, the amount of
nuclear Stat3 decreased when co-transfected with
GRIM-19 in both cases, whereas expression of the nuclear
protein poly(ADP-ribose) polymerase (PARP) (D'Amours
et al., 1999) remained constant (Figure 6C). To study the
physiological effect of GRIM-19, the nuclear translocation
of endogenous Stat3 was evaluated further in HepG2 cells
stimulated by IL-6. Stat3 translocated into the nucleus
after IL-6 stimulation. However, the amount of
nuclear Stat3 decreased upon treatment with IFN-b/RA
Fig. 5. Cellular localization of GRIM-19 in MCF-7 cells. (A and B) Cells were transfected with Myc-tagged GRIM-19 in (A), or the truncation mu-
tants in (B). Cells were ®xed and incubated with polyclonal anti-Myc, and stained with Cy3-conjugated anti-rabbit IgG (Amersham Pharmacia
Biotech). The localization of the GRIM-19 protein was visualized using a laser scanning confocal microscope. Endogenous COX, EEA1 and CD63
were detected with monoclonal anti-COX subunit IV, anti-EEA1 or anti-CD63 antibody, as labeled, followed by staining with FITC-conjugated anti-
mouse IgG (Molecular Probes). Merged images are shown on the right. (C) Expression of endogenous GRIM-19 in MCF-7 cells, either untreated or
treated with IFN-b and RA for 72 h, was detected with puri®ed rabbit anti-GRIM-19 serum, followed by Cy3-conjugated anti-rabbit IgG. (D) MCF-7
cells were fractionated using the ApoAlert Cell Fractionation Kit from Clontech following the manufacturer's instructions. The fractions were collected
and subjected to western blot analysis with antibodies, as indicated.
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(Figure 6D, top panel, compare lanes 2 and 4), which
correlated with a concomitant increase in endogenous
GRIM-19 expression (bottom panel), suggesting a physio-
logical role for GRIM-19 in the regulation of Stat3 nuclear
localization.
GRIM-19 represses Stat3-dependent transcription
The co-localization and impaired nuclear translocation of
Stat3 by GRIM-19 may result in negative regulation of
Stat3 transcriptional activity. To con®rm this, we next in-
vestigated whether GRIM-19 affected Stat3 transcriptional
activity using a reporter gene containing three copies of
hSIE, the high af®nity binding site of Stat3, upstream of a
CAT gene. A basal level of transcriptional activity was
detected in unstimulated COS-1 cells, which was en-
hanced by EGF treatment. However, ~86% inhibition of
this EGF-induced activity was observed with co-transfec-
tion of GRIM-19. The basal activity in the unstimulated
cells was also decreased, to a lesser extent (Figure 7A).
The effect of GRIM-19 was also examined in MCF-7 cells.
Consistent with its nuclear localization in MCF-7 cells, a
constitutive transcriptional activity of Stat3 was observed
Fig. 6. Co-localization of Stat3 with GRIM-19. (A) MCF-7 cells were transfected with Flag-tagged Stat3 or truncation mutants with or without Myc-
tagged GRIM-19. The distribution of Stat3 or GRIM-19 was detected using monoclonal anti-Flag or polyclonal anti-Myc as primary antibody, fol-
lowed by Cy3-conjugated anti-mouse IgG (Sigma) or FITC-conjugated anti-rabbit IgG. (B) COS-1 cell were transfected with Flag-tagged Stat3, Stat1
or Stat5a in the absence (±) or presence of Myc-GRIM-19. The cells were induced by EGF for 15 min and the cellular localization of Stat proteins and
GRIM-19 was detected as described in (A). (C) The effect of GRIM-19 on Stat3 nuclear translocation. COS-1 cells were transfected with vector,
GRIM-19 and/or Stat3. The cells were untreated or induced with EGF for 15 min. Cells were lysed and fractionated into cytoplasmic and nuclear por-
tions as described previously (Jain et al., 1999). The nuclear distribution of Stat3 was examined by western blotting. The blot was re-blotted with anti-
PARP antibody as a control. The expression of GRIM-19 in the cytoplasmic portion was detected by blotting with anti-Myc antibody. (D) Induction
of endogenous GRIM-19 reduced IL-6-stimulated Stat3 nuclear translocation. HepG2 cells were either left untreated or treated with IFN-b and RA for
48 h followed by IL-6 induction for 15 min. Nuclear Stat3 was measured with anti-Stat3 as described in (C).
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without any stimulation. However, co-expression of
GRIM-19 resulted in an ~85% inhibition of this activity.
Induction of endogenous GRIM-19 by IFN-b and RA also
decreased the constitutively activated transcriptional
activity of Stat3 (~15%). This inhibition was repressed
further to 91% by co-transfected GRIM-19 (Figure 7B).
The repression by GRIM-19 was delineated further with
the GRIM-19 mutants. The C-terminal deletion mutant
GRIM-191±101, but not the N-terminal deletion mutant
GRIM-1936±144, showed inhibition of Stat3 activity
(Figure 7C). These data indicate that GRIM-19 represses
Stat3 transcriptional activity, and this suppression ability
is correlated with its mitochondrial localization.
We further examined the effect of GRIM-19 on a Stat3
target gene, a2-macroglobulin (a2-M), one of the acute-
phase proteins that is upregulated via activation of Stat3 in
IL-6-stimulated hepatocytes (Heinrich et al., 1998).
HepG2 cells were transfected with an a2-M promoter±
luciferase gene construct (Terstegen et al., 2001) or a
control plasmid in the presence or absence of GRIM-19.
The cells were either left untreated or treated with IL-6.
IL-6 resulted in high transcriptional activity of a2-M
which was inhibited up to 70% by co-expression of
GRIM-19. The basal activity in unstimulated cells was
also repressed by GRIM-19 (Figure 7D). The IL-6-
inducible a2-M promoter activity was also suppressed by
treatment of the cells with IFN-b and RA, which was
partially restored by introduction of a plasmid encoding an
antisense GRIM-19 (Figure 7E). These data provide
evidence that GRIM-19 represses Stat3-dependent target
gene expression.
GRIM-19 inhibits cell growth
Stat3 is constitutively activated in v-Src-transformed cells
(Yu et al., 1995; Cao et al., 1996), and is essential for Src-
mediated cell transformation (Bromberg et al., 1998;
Turkson et al., 1998). To determine whether the negative
regulation by GRIM-19 of Stat3 activity leads to a
physiological consequence, we tested the effect of
GRIM-19 on the oncogenic function of Stat3 by examing
cell proliferation. We found that cell growth of v-Src-
transformed cells was inhibited by GRIM-19, either
introduced exogenously by transfection or induced by
IFN-b and RA, in a dose-dependent manner (Figure 8A).
Furthermore, inhibition was also observed in a stable cell
line that expresses an active form of Stat3 mutant, ST3-DN
(Zhang et al., 2000). These cells proliferated ~25% more
rapidly than the control cells, which can be inhibited by
GRIM-19, whereas GRIM-19 showed little effect on
control cells (Figure 8B).
Discussion
Stat proteins play central roles in transducing signals from
cytokine receptors to the nucleus in a rapid and transient
manner. Stat activities are switched off subsequently via
several negative regulatory mechanisms (O'Shea et al.,
2002). For instance, dephosphorylation of the critical
tyrosine residue by speci®c tyrosine phosphatase leads to
the inactivation of Stat proteins (Haspel et al., 1996). The
inactivation can also be achieved through protein degrad-
ation mediated by the ubiquitin±proteasome pathway
(Kim and Maniatis, 1996). Furthermore, two families of
negative regulators for JAK±STAT pathways have been
reported. One was identi®ed and named as suppressors of
cytokine signaling (SOCS)/JAK-binding protein (JAB)/
STAT-induced STAT inhibitor (SSI)/cytokine-inducible
SH2-containing proteins (CIS) by several groups using
different strategies (Yoshimura et al., 1995; Endo et al.,
1997; Naka et al., 1997; Starr et al., 1997). The expression
of these negative regulators is inducible by cytokine
stimulation, which inhibits the JAK±STAT pathway in a
negative feedback loop (Yasukawa et al., 2000). The other
family is named protein inhibitors of activated STAT
(PIAS), which consists of several homologous proteins
including PIAS1 and PIAS3, which are constitutively
expressed and interact only with tyrosine-phosphorylated
Stats to inhibit their DNA binding activities (Chung et al.,
1997). In this report, we have identi®ed GRIM-19 as an
interacting protein of Stat3 in different mammalian cell
types and species. GRIM-19 suppresses Stat3 transcrip-
tional activity and its target gene expression. Furthermore,
the interaction of GRIM-19 is speci®c for Stat3, but not for
Stat1 or Stat5a. These data suggest that GRIM-19
functions as a negative regulator of Stat3. To explore the
mechanism of the negative effect of GRIM-19 further,
tyrosine phosphorylation of Stat3 stimulated by EGF was
examined, and no obvious change was observed in the
presence of GRIM-19 (data not shown). We subsequently
analyzed the cellular localization of these two proteins.
The results not only veri®ed the physical interaction
between Stat3 and GRIM-19, but also revealed the co-
localization of these two proteins in unique aggregates
distributed around the nucleus. Although the nature of the
aggregates remains elusive, these unique structures par-
tially co-localized with COX and may represent mito-
chondrial aggregation as examined by electron micro-
scopy (A.Hao and X.Cao, unpublished data). One of the
possible consequences and the physiological roles of this
aggregate formation is preventing Stat3 from entering the
nucleus. Our data suggest that GRIM-19 is a novel type of
inhibitor that speci®cally inhibits Stat3 activity by block-
ing its nuclear translocation.
The cellular localization of GRIM-19 was unclear.
Originally, it was observed predominantly in the nucleus
of IFN-b- and RA-treated HeLa cells (Angell et al., 2000),
and recently shown to be in both the nucleus and the
cytoplasm (Hu et al., 2002). However, its bovine homolog
was co-puri®ed with mitochondrial electron transport
complex I, implying a mitochondrial localization
(Fearnley et al., 2001). In our study, both transfected
human and mouse GRIM-19 were found localized pre-
dominantly in the mitochondria in MCF-7 and COS-1
cells. However, although the majority of endogenous
GRIM-19 was observed in the mitochondria, it was also
detectable in the nucleus in MCF-7 cells (Figure 5C and
D). These data suggest that GRIM-19 may distribute in the
mitochondria and/or nucleus depending on the cell type.
Alternatively, its cellular localization may be regulated by
post-translational modi®cations such as phosphorylation
and acetylation. Lastly, GRIM-19 may exist in different
isoforms that may be distributed in distinct cellular
locations.
To examine the nature of the interaction, we de®ned the
interaction regions in both Stat3 and GRIM-19. The results
showed that in addition to the coiled-coil domain, the
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DNA-binding and linker domains of Stat3 are also capable
of binding to GRIM-19. However, further study shows that
the coiled-coil region, but not the N-terminal domain (data
not shown), DNA-binding domain or linker domain, is
involved in the formation of aggregates with GRIM-19
(Figure 6A), which exerts a negative regulation on Stat3
nuclear translocation. These data suggest that interaction
with the coiled-coil domain may play a physiological role.
Surprisingly, we also found that the truncation mutant of
Stat3 containing the N-terminal domain and the coiled-coil
domain is constitutively localized in the nucleus. Our
preliminary results de®ned an NLS in the coiled-coil
domain (J.Ma and X.Cao, unpublished data). The coiled-
coil domain contains four antiparallel a-helices, and has
often been inferred to be involved in protein±protein
interaction (Becker et al., 1998; Chen et al., 1998). Indeed,
the coiled-coil domains of Stat proteins have been reported
to mediate association with other transcription factors and
coactivators, such as p48, a protein from an IFN response
factor (IRF) family, c-Jun, and Nmi, an N-Myc interactor,
which regulate Stat transcriptional activity (Horvath et al.,
1996; Zhang et al., 1999; Zhu et al., 1999). Recently, we
have demonstrated a novel role for the coiled-coil domain
of Stat3 in the regulation of its SH2 domain-mediated
binding activity to the cytokine receptor (Zhang et al.,
2000). This regulation is probably achieved via inter-
domain interaction between the coiled-coil domain and the
C-terminal domain of Stat3 (Zhang et al., 2002). In this
study, we provide evidence for new roles for the coiled-
coil domain. Collectively, these data indicate that the
coiled-coil domain actively participates in the regulation
of Stat activities in multiple processes by interacting with
distinct proteins.
There is evidence correlating Stat3 activation and
cancer. Stat3 is found to be constitutively activated in
cells transformed by oncogenes, such as v-Src and v-abl
(Danial et al., 1995; Yu et al., 1995; Cao et al., 1996), as
well as in various cancers including multiple myeloma,
breast cancer, and head and neck cancer (Bowman et al.,
2000). Furthermore, expression of a constitutively dimer-
ized Stat3 (Stat3-C) is oncogenic (Bromberg et al., 1999).
Constitutively activated Stat3 elevates the expression of its
target genes that are key regulators in the control of
proliferation, cell cycle and programmed cell death, all of
Fig. 7. Effect of GRIM-19 on the transcriptional activity of Stat3 and target gene expression. (A±C) COS-1 and MCF-7 cells were co-transfected with
a vector control, Stat3 and/or GRIM-19, the truncation mutant GRIM-191±101 or GRIM-1936±144 together with a reporter plasmid pSIE-CAT and
pCMV-b-gal. Cells were either left uninduced or stimulated with EGF (100 ng/ml) for 6 h in (A) or IFN-b and RA for 24 h in (B). Cells were har-
vested and the lysates used for CAT assays were normalized with equivalent b-galactosidase activity, and CAT assay was performed as described
(Jain et al., 1998). The averages of the relative CAT activities from three independent experiments are shown in the graph, with error bars representing
the standard deviation of the means. (D and E) GRIM-19 inhibits a2-macroglobulin report expression. HepG2 cells were co-transfected with pGL3-
a2M-215luc or the empty luciferase vector (pGL3), GRIM-19, antisense GRIM-19 plasmid or the empty vector as labeled, together with pRL-TK for
normalization. Cells were left non-stimulated (±) or were induced overnight with IL-6 (+). Relative luciferase values are indicated, which represent the
means of six samples with the standard deviation given as the error bars. Cells were pre-treated for 55 h with IFN-b (500 U/ml) and RA (1 mM) before
stimulation by IL-6 in (E).
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which may contribute to oncogenesis (Bowman et al.,
2000). In contrast, a combination of IFN-b and RA inhibits
cell growth and promotes cell death in cancer cells which
does not involve known IFN-stimulated genes, such as
RnaseL and protein kinase R, or a change of the level of
p53 and the phosphorylation status of pRb (Hofman et al.,
1998). It is obvious that Stat3 and GRIM-19 play opposite
roles in cell growth, transformation and cell death. Our
®nding that GRIM-19 is a negative regulator of Stat3 is
consistent with this observation. In this report, we have
shown that GRIM-19 inhibits Stat3-mediated cell prolif-
eration in both Src-transformed cells and Stat3-DN-stable-
expressing cells (Figure 8). The next step will be to study
whether GRIM-19 suppresses Stat3-mediated cell trans-
formation, and the mechanisms involved. It will also be
interesting to investigate whether GRIM-19 exerts its
death effect by repressing Stat3 activity via inhibition of
the expression of Stat3-regulated anti-apoptotic genes.
Materials and methods
Construction of expression plasmids
Murine Stat3 and its deletion mutants were cloned into pXJ40-FLAG, as
described previously (Zhang et al., 2002). Stat1 and Stat5a, obtained from
J.E. Darnell,Jr and A.Miyajima, respectively, were also cloned into vector
pXJ40-FLAG. The clones containing the cDNA sequence of murine
GRIM-19 were isolated from the MATCHMAKER library containing
17th day mouse embryonic cDNAs by yeast two-hybrid screening
(Clontech). Full-length GRIM-19 was generated by PCR, and the
respective PCR product was sequenced and cloned into pDMYCneo, a
double Myc-tagged expression plasmid (Seet and Hong, 2001). The
human homolog of GRIM-19 was isolated from a cDNA library of
MCF-7 cells (a gift from V.Yu from our institute). The deletion mutants
of GRIM-19 were generated by PCR, and the PCR products were cloned
into pXJ40-GST, a plasmid expressing GST in mammalian cells (Manser
et al., 1998).
Yeast two-hybrid screening
The coiled-coil domain (amino acids 138±318) of Stat3 was cloned into
plasmid pGBKT7 containing the GAL4 DNA-binding domain as bait.
This plasmid was transformed into Saccharomyces cerevisiae strain
AH109.
The evaluation and screening procedures were performed according to
the manufacturer's instructions. Brie¯y, S.cerevisiae strain Y187 pre-
transformed with the MATCHMAKER library containing 17th day
mouse embryonic cDNAs fused to the GAL4 activation domain (AD)
(Clontech) was mated with the AH109 strain harboring the bait, at 30°C
for 24 h. The mating mixture was spread on plates containing selection
medium lacking Trp, His, Leu and Ade, and incubated at 30°C for ~2
weeks. A b-gal colony-lift ®lter assay was performed to eliminate the
false-positive colonies. The plasmids were isolated from the positive
colonies and transformed into Escherichia coli strain DH5a by
electroporation. Plasmid DNA was puri®ed from E.coli and subjected
to sequencing analysis.
Generation of antibody against mouse GRIM-19
GRIM-19 cDNA was ampli®ed by PCR and cloned into the bacterial
expression vector pET32B (Novagen) which was transformed into E.coli
BL21DE3. The expression of the His-tagged fusion protein was induced
by 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 3 h, and the
fusion protein was puri®ed with nickel-nitrilotriacetic acid±agarose resin
(Qiagen) under urea-denaturing conditions. Bead-bound GRIM-19 was
then refolded in phosphate-buffered saline (PBS) and used to immunize
rabbits. The antiserum was puri®ed further as described (Olmsted, 1981).
Cell culture and DNA transfection
COS-1, SH-SY5Y, NIH-Src and ST-3-DN cells were grown in
Dulbecco's modi®ed Eagle's medium (DMEM), and MCF-7 in RPMI
with 10% fetal bovine serum (FBS) purchased from Gibco-Invitrogen.
Mouse C2C12 myoblasts from the ATCC were grown in DMEM with
20% FBS, and PC-12 cells were cultured in DMEM with 10% FBS and
5% horse serum. Transient transfections were performed with
LipofectAMINE or LipofectAMINE 2000 (Gibco-Invitrogen) following
the manufacturer's instructions.
Immunoprecipitation, GST pull-down and western blotting
The lysates containing 600 mg of total proteins were subjected to
immunoprecipitation/blotting as described previously (Cao et al., 1996).
For GST pull-down experiments, the cell lysates containing 600 mg of
proteins were incubated with 40 ml of glutathione±Sepharose 4B beads
(Amersham Pharmacia Biotech). The precipitates were washed, separated
by SDS±PAGE and transferred to a polyvinylidene di¯uoride (PVDF)
membrane, followed by western blotting analysis with the respective
antibodies.
Immuno¯uorescence
Cells grown on coverslips were transfected with various expression
plasmids. After transfection for 24 h, cells were ®xed with 1%
paraformaldehyde in PBS, and washed with PBS. After permeabilizing
with methanol for 5 min, the cells were washed and incubated with FDB
(PBS with 1 mM CaCl2, 1 mM MgCl2, 5% normal goat serum, 10% fetal
bovine serum and 2% bovine serum albumin pH 7.6), followed by
incubation with primary antibodies in FDB. After washing with PBS
containing 0.1% Triton X-100, cells were incubated with the appropriate
secondary antibodies conjugated with ¯uorescein isothiocyanate (FITC)
or Cy3. Cells were then washed three times with PBS containing 0.1%
Trixon X-100, mounted with FluoroGuardÔ Antifade Reagent (Bio-Rad
Laboratories), and examined using a confocal microscope (Bio-Rad MRC
1024). The ®gures were processed with Adobe Photoshop software.
Fig. 8. Inhibition of Stat3-mediated cell proliferation by GRIM-19.
(A) v-Src-transformed NIH-3T3 cells were grown in a 96-well micro-
titer plate and transfected with two doses of GRIM-19 (low, 0.1 mg; or
high, 0.3 mg) or empty vector (±, 0.3 mg) (left panel), or treated with
various concentrations of IFN-b and RA for 48 h (right panel). The cell
proliferation assay was performed using the Cell Proliferation Kit II
(XTT). Spectrophotometric absorbance was measured at 485 nm wave-
length, and reference wavelength 650 nm, which presents a mean of
three samples, with the standard deviation given as the error bars.
(B) NIH-3T3 cells with stable expression of ST3-DN (bar with grid) or
control vector (empty bar) were transfected with control vector (±)
or with 0.1 mg of GRIM-19 (+), and cell proliferation was measured as
described in (A).
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Luciferase assay
HepG2 cells were seeded at 0.75 3 105 cells per well in a 24-well dish.
The ®re¯y luciferase reporter gene construct (pGL3-a2M-215luc) was
co-transfected with expression plasmid and pRL-TK (thymidine kinase
promoter-dependent Renilla luciferase construct) used as an internal
control for transfection ef®ciency (Promega) using LipofectAMINE 2000
(Invitrogen). Cells were serum starved for 24 h prior to stimulation with
IL-6 (40 ng/ml) overnight. Cells were washed three times with PBS, lysed
with 100 ml of passive lysis buffer (Promega) and subjected to one
freeze±thaw cycle at ±80°C. A Dual Luciferase Reporter assay (Promega)
was performed according to the manufacturer's instructions using the
Ascent luminoskan (ThermoLabsystems).
Cell growth assay
The assay was performed using the Cell Proliferation Kit II (XTT) from
Roche Diagnostics following the manufacturer's instructions. Brie¯y,
cells were plated in 96-well plates and either transfected with proper
plasmids, or treated with IFN-b/RA without transfection. Cells were
incubated with XTT labeling mixture at 37°C for the appropriate time to
allow the development of the color. Spectrophotometric absorbance of the
samples was measured at 485 nm wavelength and reference wavelength
650 nm using SPECTRAFLuo Plus reader from Tecan.
Stable transfection of Stat3
NIH-3T3 cells were co-transfected with pXJ40-¯ag-ST3-DN, a mutant
lacking the N-terminal domain of Stat3 with a constitutive activity with
pXJ41-neo containing the G418 resistance in a ratio of 20:1. After 48 h,
the cells were trypsinized and seeded in different densities with DMEM
containing 375 mg/ml G418 (Sigma). After 2 weeks, single colonies were
isolated and tested for protein expression by western blot analysis using
Flag-M2 antibody (Sigma). A control cell line that expresses the empty
vector was established with a similar method.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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